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Abstract 
 
 
The bacterial meningitis caused by Neisseria meningitidis is responsible for 
considerable morbidity and mortality throughout the world. Given the limitations of 
existing diagnostic tests and the severity of the illness associated with the disease, 
there is a clear requirement for a rapid and specific diagnostic assay. This thesis 
describes the development of nanoparticle based tests for the detection of Neisseria 
meningitidis specific cell surface markers. 
 
The highly conserved outer membrane protein 85 (OMP85) antigen was selected as 
initial target antigen for the development of the diagnostic assays. A recombinant 
form of OMP85 with an attached hexa his-tag was cloned and expressed in E. coli and 
purified successfully by the use of various methods including Ni-NTA metal affinity 
column chromatography and a sonic gel extraction method. Within the OMP85 
protein sequence, a predicted antigenic sequence between residues 720 and 745 was 
identified and found to be unique to this organism. This amino acid sequence was 
synthesised as peptide (SR1) with a gly-gly-cysteine spacer sequence at the N-
terminus using t-boc chemistry. Also, the major virulence factor, capsular 
polysaccharide of N. meningitidis serogroup B bacteria was purified by a simple 
procedure developed during the course of this work. 
 
Polyclonal antibodies were raised against purified OMP85 antigen in rabbits and 
against SR1 peptide and also against formalin inactivated N. meningitidis serogroup B 
whole cell bacteria in sheep. Commercial anti-capsular monoclonal antibodies were 
shown to be equally reactive both with the bacteria and the purified capsular 
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polysaccharide. In addition, screening of an Immunoglobulin New Antigen Receptor 
(IgNAR) library was attempted to identify novel receptors against OMP85 and other 
antigens for use in the diagnostic tests. This panel of different antibodies were 
examined for cross reactivity against a range of closely related Gram negative 
bacteria. Based on these cross-reactivity studies, a highly specific anti-NM antibody 
was developed following purification of the anti-SR1 antiserum by immuno-affinity 
chromatography.  
 
Monodisperse 13 nm gold nanoparticles were synthesised by the Turkevich citrate 
reduction method. Larger particles (30nm, 40 nm, 50 nm and 60 nm) were purchased 
from British Biocell, UK for use in these studies. Coupling of the gold nanoparticles 
results in a shift of the the respective surface plasmon peak toward longer 
wavelengths resulting in a change of the colour of the colloidal suspension from red 
to purple to blue. Purified OMP85 antigen and protein A purified anti-OMP85 
antibody were successfully conjugated on 13, 30, 40, 50 and 60 nm gold nanoparticles 
by an electrostatic adsorption method.  
  
An attempt was made to develop a rapid diagnostic assay based on gold 
nanoparticle induced colour shift assay for N. meningitidis by utilising the specific 
interaction of OMP85 and anti-OMP85 antibody conjugated to gold nanoparticles as 
a model system. This interaction between 50 nm gold nanoparticles conjugated with 
OMP85 and anti-OMP85 antibody resulted in an increase in absorbance in the range 
of 600-800 nm, with a resulting colour shift. However, this system was not 
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reproducible and is likely to be due to problems with stability of gold nanoparticles 
during the conjugation process. 
 
As an alternative approach, a highly selective quartz crystal microbalance (QCM)-
based immunosensor was designed using the OMP85/anti-OMP85 antibody system 
as a model diagnostic test for meningococcal infection. Following initial attempts 
with self-assembled monolayer model experiments, a method was developed using 
polyvinylidene fluoride (PVDF) coated QCM crystals with protein A for for the 
directional orientation of the antibodies. The resonant frequency of the sensor 
decreased over time due to the binding of OMP85 antigen onto the immobilised 
antibodies, within a time frame of 5 to 10 minutes. 
 
To further enhance the sensitivity of the test, OMP85-conjugated gold nanoparticles 
were used as signal amplification probes for the reproducible detection of the target 
down to 300 ng/mL, corresponding to a five fold increase in sensitivity compared to 
detection of OMP85 antigen alone. In addition, the immunosensor was successfully 
regenerated using glycine-HCl solution pH 3.0 to release antigen–antibody 
complexes from the protein A layer, thus enabling the immunosensor to be used 
multiple times. Also, this sensor has successfully been employed to detect whole cell 
bacteria at a concentration as low as 100 cfu/mL. Thus, in this study using the real-
time QCM measurements, a novel strategy has been developed for the sensitive 
detection of both N. meningitidis bacteria and the protein antigen at very low 
concentrations, using gold nanoparticles as signal amplification probes. This work 
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advances the design and evaluation of a QCM based model biosensor for the rapid 
diagnosis of meningococcal meningitidis. 
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Chapter 1 
 
 
Introduction and Review of Literature 
 
 
 
1.1. Neisseria meningitidis – A role in meningococcal disease 
The meninges, the membranes that line the brain and the spinal cord can become 
inflamed leading to the potentially fatal disease known as meningitis (Rosenstein, 
Perkins et al. 2001).  Most cases of meningitis are due to bacterial infections that start 
elsewhere in the body and spread to the brain or spinal cord via the bloodstream. 
Bacterial pathogens that may cause meningitis include Haemophilus influenzae 
(Hubert, Watier et al. 1992), Escherichia coli (Glode, Sutton et al. 1977; Yang, Lu et al. 
2005), Streptococcus pneumoniae (Hirst, Gosai et al. 2003) and Neisseria meningitidis 
(Nadel and Kroll 2007). Other types of meningitis which occur less commonly 
include cryptococcal meningitis (Bicanic and Harrison 2004), syphilitic meningitis 
(Hsieh, Hung et al. 1996), pneumococcal meningitis (Wasier, Chevret et al. 2005), 
staphylococcal meningitis (Perez-Camarero, Escalante-Boleas et al. 2000), tuberculous 
meningitis (Theron, Andronikou et al. 2006) and aseptic meningitis (Lee and Davies 
2007). Meningitis can also be caused by a number of other factors including viruses 
(Chadwick 2005), chemical irritation (Marinac 1992), or tumors (Lee, Cromwell et al. 
2005). Although, different cocci cause meningitis, the term meningococcus is retained 
for the Neisseria meningitidis (N. meningitidis), a Gram-negative, diplococcus bean-
shaped bacterium. 
  
Reports of illness resembling meningococcal infection dates back to the 16th century. 
Vieusseux in 1805, described an outbreak of meningococcal disease which caused 33 
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deaths in the vicinity of Geneva, Switzerland (Rosenstein, Perkins et al. 2001). The 
Italian pathologists Marchiafava and Celli (1884) first described the presence of 
intracellular oval micrococci in a sample of cerebrospinal fluid (CSF) (Marchiafava 
and Celli 1884). However, the first bacterium known to cause meningococcal disease 
was first identified in CSF by Anton Weichselbaum in 1887, which he detected in six 
out of eight patients suffering  from bacterial meningitis and this bacterium was 
named Neisseria intracellularis (Manchanda, Gupta et al. 2006). It was later named as 
Neisseria meningitidis.   
 
 
1.1.1. Structure and Classification 
Based on genome sequencing studies, Neisseria meningitidis is categorised as 
belonging to the family Neisseriaceae and class α-proteobacteria related to the genera 
Bordetella, Moraxella, Burkoholderia, Kingella and Methylomonas and more distantly 
related to Vibrio, Haemophilus and Escherichia coli (Manchanda, Gupta et al. 2006). The 
genus Neisseria includes two important human pathogens, N. gonorrhoeae which 
causes gonorrhoea and N. meningitidis (Todar 2006), which is responsible for acute 
bacterial meningitis. These are Gram-negative, bean-shaped aerobic diplococci are 
isolated on chocolate/blood agar and infect humans exclusively. Like most other 
members of its genus Neisseriae, these organisms are aerobic, non-motile, produce 
catalase, oxidase positive, susceptible to drying while their growth is stimulated by 
CO2 and humidity and their growth is inhibited by free fatty acids (Platt and Snell 
1976; Manchanda, Gupta et al. 2006). N. meningitidis is surrounded by an outer 
membrane composed of lipids, outer membrane proteins (OMPs) and 
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lipopolysaccharides. Pathogenic meningococci bacteria are enveloped by a 
polysaccharide capsule attached to this outer membrane. 
 
The capsular polysaccharide (CPS), lipo-oligosaccharide (LOS) and outer membrane 
proteins (OMPs) are considered as important virulence factors in meningitis. The 
main distinguishing structural feature between N. meningitidis and N. gonorrhoeae is 
the presence of an anti-phagocytic polysaccharide capsule in the former (Spinosa, 
Prodiga et al. 2007). As the name suggests, the anti-phagocytic capsular 
polysaccharide helps in evading phagocytosis as well as providing the basis for 
grouping of the organism. The chemical composition of these capsular 
polysaccharide types is known. Based on this capsular structure, 13 serogroups in 
total have been identified and designated as serogroups A, B, C, H, I, K, L, M, X, Y, Z, 
29E, and W135 (Sippel 1981; Frasch, Zollinger et al. 1985). The most important 
serogroups associated with the disease in humans are A, B, C, Y, and W135. 
Meningococci reveal more genetic diversity than most other pathogenic human 
bacteria and this is explained partly by horizontal intra-species recombination and 
incorporation from closely related Neisseria species (Caugant 1998).  
 
Meningococci are further subdivided (Table 1) into 20 serotypes (on the basis of class 
2 or class 3 OMP antigens), 10 subtypes (based on class 1 OMP antigen differences) 
and 13 immunotypes (based on differences in lipooligosaccharide antigens) 
(Mandrell and Zollinger 1977; Frasch, Zollinger et al. 1985; Scholten, Kuipers et al. 
1994). 
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Component Function Classification 
System 
Number 
of 
Groups 
Names 
Capsule Protects against complement 
dependent bacteriolysis and 
phagocytosis 
Serogroups 13 A, B, C, E-29, 
K, I, K, L, M, 
W-135, X, Y, 
Z 
Outer membrane 
proteins (Porins) 
Creates pores through which 
small hydrophilic solute 
pass, cation selective or 
anion selective 
   
Por A (Class1 OMP)  Subserotypes 10 P1.1, P1.2, 
P1.3……P1.10 
Por B (Class 2/3 
OMP) 
 Serotypes 20 1, 2a, 2b, ….2l 
Lipooligosaccharide 
(LOS) 
Has potent immunotoxic 
activity 
Immunotypes 13 L1, L2,…..L13 
Pili Promotes initial adherence to 
epithelial/ehdothelial cells 
and red blood cells  
 2 I, II 
 
Table 1.1.: Classification based on outer-membrane components of N. meningitidis 
(Manchanda, Gupta et al. 2006) 
 
The bacterial outer membrane proteins of N. meningitidis have been classified from 
class 1 to class 5 proteins. Although meningococcal outer membranes contain as 
many as five major proteins, much of the observed serotype specificity can be 
attributed to class 2 and class 3 proteins, both of which are mutually exclusive within 
different meningococcal strains (Frasch, Zollinger et al. 1985). The class 2 and 3 
proteins function as porins, which function as molecular sieves in Gram-negative 
bacteria where they mediate the aqueous diffusion of solutes through the water-filled 
channels derived from their unique folding assembly (Nikaido 1994; Minetti, Tai et al. 
1997). Serogroups B and C meningococci have been further subdivided on the basis 
of subtype determinants located on the class 2 and 3 porin proteins. Most of the 
known serogroup A strains have the same protein serotype antigens in the outer 
membrane. Another serotyping system exists based on the antigenic diversity of 
meningococcal lipo-oligosaccharide (LOS) (Tsang, Law et al. 2001).  
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1.1.2. Incidence and risk factors 
Viral meningitis is a mild form of meningitis and occurs more commonly than 
bacterial meningitis. It usually develops in the winter and affects people under 30 
(Durand, Calderwood et al. 1993) with 70% of the infections occurring in children 
under the age of 5 years.  
 
In the case of bacterial meningitis caused by N. meningitidis, the meningococcus 
organism usually inhabits the human nasopharynx resulting in an asymptomatic 
carrier state, prior to invasion of the central nervous system via the bloodstream with 
a rapid onset of signs and symptoms at this stage (Nowak, Boehmer et al. 2003). Most 
individuals in close contact with a person suffering from meningococcal meningitis 
become carriers of the organism. This carrier state, which may last from a few days to 
months is important because it not only provides a reservoir for meningococcal 
infection but also stimulates host immunity and leads to exposure to asymptomatic 
carriers and is responsible for 10-25% of infections (Manchanda, Gupta et al. 2006). 
This carrier rate may reach 20% of the total population before the first case is 
recognized, and may reach up to 80% at the height of an epidemic. Transmission rate 
is 500- to 800- fold greater among household contacts than among the general 
population due to their close association with infected individuals. Between 5% and 
30% of normal individuals are carriers at any given time, yet few develop 
meningococcal disease. Attack rates are highest in infants, usually less than one year 
old while carriage rates are highest in older children and young adults. The infection 
typically occurs in winter or spring, and may cause local epidemics at, for example 
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boarding schools or military bases. Meningococci spread via respiratory droplets, 
and transmission requires aspiration of infective particles. 
 
1.1.3. Virulence Factors 
Meningococci are diverse organisms and are usually commensal bacteria present in 
the nasopharynx of humans with only a minority of the nasopharyngeal isolates 
causing invasive disease. Studies on strains from African epidemic outbreaks show 
that clonal characteristics of carrier and disease isolates are similar (Greenwood, 
Bradley et al. 1985). For a time, the virulence of Neisseria meningitidis was attributed to 
the production of an exotoxin that was later found out to be the released parts of 
their cell walls in a soluble form. Hence, a major factor in the virulence of the 
organism is the release of outer-membrane vesicles that consist of 
lipooligosaccharide (endotoxin), outer-membrane proteins, phospholipids and 
capsular polysaccharides (Rosenstein, Perkins et al. 2001).  
 
The endotoxin of N. meningitidis is structurally different from the lipooligosaccharide 
of enteric Gram negative bacteria. Lipid A molecules of lipooligosaccharide (LOS) act 
as endotoxins and their effects are due to the interaction with innate immune 
receptors (Manchanda, Gupta et al. 2006). Purified meningococcal LOS is found to be 
highly toxic and lethal for mice similar to the LOS of E. coli and Salmonella 
typhimurium. However, meningococcal LOS is 5 to 10 times more effective than 
enteric LPS in eliciting dermal haemorrhages due to endothelial damage and 
haemorrhages and microthrombi in small vessels (Sanarelli-Shwartzman reaction) in 
rabbits (Quakyi, Hochstein et al. 1997). The lesions are a reflection of the endotoxin 
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mediated upregulation of activated neutrophils (van Deuren, Brandtzaeg et al. 2000). 
Also, up to 16% of the cells present in the nasal mucosa are monocytes and 
inflammation increases polymorpho nuclear (PMN) leukocyte infiltration. 
Meningococcal LOS has also been shown to suppress leukotriene B4 synthesis in 
human polymorphonuclear (PMN) leukocytes (Salari, DeVoe et al. 1982). The loss of 
leukotriene B4 deprives the leukocytes of a strong chemokinetic and chemotactic 
factor (Virji 1996). The other important determinants of virulence of N. meningitidis 
include its antiphagocytic polysaccharide capsule, pili , IgA protease and opacity 
proteins (Opa and Opc) (Virji, Kayhty et al. 1991; Lorenzen, Dux et al. 1999).  
 
N. meningitidis associated with invasive disease has a capsule, which provides 
protection from desiccation during transmission and aids in the evasion of host 
immune mechanisms. The capsule and sialylated lipopolysaccharides (LPS) are 
expressed in disseminated isolates and are believed to protect the organism against 
antibody/complement and phagocytic killing (Vogel, Hammerschmidt et al. 1996). 
The LPS of carrier strains tend to be structurally different and often asialylated but, 
sialylation of LPS has functional consequences similar to the capsule as it imparts 
resistance to immune mechanisms of the host and in doing so, masks the functions of 
many outer membrane proteins (Estabrook, Christopher et al. 1992). The relationship 
between surface polysaccharides and various adhesins and invasins is a complex 
area of investigation, while other components like antigenicity and phase variation 
adds further complexity (Virji, Makepeace et al. 1995).  
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In studies to determine bacterial factors that increase phagocyte interactions, it was 
shown that capsulate bacteria resist phagocytosis in the absence of opsonins, but 
acapsulate bacteria are internalized and the bacterial opacity proteins Opa and Opc 
mediate bacterial uptake (Ward, Fleer et al. 1987). Pili proteins which are involved in 
adhesion to glycoconjugate structures in the host epithelial cells, were ineffective in 
mediating interactions with phagocytic cells (McNeil and Virji 1997). Meningococcal 
phase variable opacity proteins (Opc, Opa) and pili are widely expressed in case 
isolates (McNeil, Virji et al. 1994; McNeil and Virji 1997). Bacterial components that 
mediate cellular interactions in the absence of added opsonins are of importance 
from the point of view that immunocompromised phagocytes acts as potential 
‘Trojan Horse’ carriers of bacteria (Gagnon, Duclos et al. 2002). 
 
Pili also may target the CD46 receptor, a host cell membrane cofactor protein and 
subsequently the opacity-associated proteins, Opa and Opc, bind to CD66 and 
heparan sulphate proteoglycan receptors respectively (Rosenstein, Perkins et al. 
2001). Other differences may include the expression of distinct porins (class 1 / 2 / 3) 
which have been implicated in impairment of host cell functions (Wetzler, Ho et al. 
1996). Putative toxic factors (e.g. RTX-like proteins) have been reported in some 
meningococcal strains (Osicka, Kalmusova et al. 2001). These are environmentally 
regulated and their expression could also increase the pathogenic potential of a 
strain.  
 
Invitro investigations on the toxicity of carrier and case isolates indicate that both 
possess the capacity to damage human endothelial cells. In addition, specific 
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nutrient-acquisition factors, especially mechanisms for acquiring iron from human 
lactoferrin, transferrin and hemoglobin, enhance their pathogenic potential 
(Rosenstein, Perkins et al. 2001; Donna, Melanie et al. 2004). Multiple meningococcal 
components (pili and LPS) act together to destroy endothelial integrity characteristic 
of meningococcal septicemia (Virji, Makepeace et al. 1995). Finally, the expression of 
pili, class 5 OMPs, capsule and LOS is highly variable and subject to phase switching 
(on/off) and antigenic variation (van Deuren, Brandtzaeg et al. 2000) and this means 
can be used by the bacterium to circumvent host immunity. 
 
1.1.4. Host factors and Pathogenesis of meningitis 
In the case of invasive meningococcal disease, although the majority will recover 
fully, 10-15% of those infected will die, and around 20% will have permanent 
disabilities, ranging from learning difficulties, sight and hearing problems, to liver 
and kidney failure, scarring caused by skin grafts as well as loss of fingers, toes and 
limbs (Maiden 2004). Various pathological outcomes associated with the meningitis 
are influenced by different factors like type of bacteria, environmental and social 
conditions, preceding or concomitant to viral infections as well as the immune status 
of the person (Manchanda, Gupta et al. 2006). 
 
The integrity of the nasopharyngeal epithelium appears is important in protection 
against invasive disease. Any factors that cause damage to mucosa such as chronic 
irritation of the mucosa due to dust or low humidity, a concurrent upper respiratory 
infection (Mycoplasma pneumoniae or influenza A virus), smoking (active or passive), 
chronic underlying illness such as hepatic failure, systemic lupus erythematosis, 
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multiple myeloma and prior infection of the host etc. may be predisposing factors for 
invasive disease and increased host susceptibility (Kleemola and Kayhty 1982; 2000; 
Booy, Iskander et al. 2007). For nasopharyngeal colonization of bacteria, it requires 
equilibrium between the host and bacteria and in most individuals; it results in 
acquisition of serum bactericidal antibodies (Goldschneider, Gotschlich et al. 1969; 
Stephens 1999). At the age of 6 to 24 months, the incidence of meningococcal disease 
is highest due to the disappearance of maternal antibodies (Goldschneider, 
Gotschlich et al. 1969; Moore, Reeves et al. 1989).  
 
Because of the shared antigenic determinants, individuals who are infected with non-
groupable strains (without a capsule) also develop high titres of antibody against 
groupable strains (Goldschneider, Gotschlich et al. 1969; Gold 1983; Moore, Reeves et 
al. 1989). For example, Bacillus pumilus and Escherichia coli K1 possess the capsule that 
is structurally and immunologically identical to the capsule of serogroup A and 
serogroup B meningococci respectively (Grados and Ewing 1970; Vann, Liu et al. 
1976). This type of response does not necessarily eliminate the carrier state, but it 
may protect them from obvious disease by the induction of cross-reacting antibodies 
(Vann, Liu et al. 1976). The time of exposure to meningococci and cross reacting 
enteric bacteria may be critical in determining the fate of disease in each individual. 
Despite having the protective antibody response, persons with complement 
deficiencies (C5, C6, C7, or C8) may also develop meningococcaemia (Mandrell, 
Azmi et al. 1995; Borrow, Balmer et al. 2005). 
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Meningococci overcome host defences and attach by fimbriae to the microvillous 
surface of non-ciliated columnar mucosal epithelial cells of the nasopharynx, where 
they colonise (Stephens, Hoffman et al. 1983). Events involved after bloodstream 
invasion and how the meningococcus enters the central nervous system are not clear. 
The brain capillary endothelial cells (ECs) which make the blood-brain barrier (BBB), 
limits the paracellular flux by the formation of the tight junctions. It was suggested 
that, the possible routes for bacteria to traverse this barrier include, a transcytosis 
event and the bacteria may undergo fimbrial phase variation and cross the blood 
brain barrier (Collier, Balows et al. 1996).  
 
Others have reported that, the bacteria cross the blood brain barrier by internalising 
themselves in phagocytes (Nassif, Bourdoulous et al. 2002). The subarachnoid space 
in phagocytic cells lacks the principal humoral and cellular host defense mechanisms. 
It was suggested that, bacteria may gain access to this subarachnoid space, where an 
uncontrolled proliferation of meningococci may occur (Collier, Balows et al. 1996). 
This in turn elicits compartmentalised activation of proinflammatory cytokines 
(Waage, Halstensen et al. 1989), which ultimately contributes to the development of 
clinically overt meningitis. The functional ability of a phagocyte to deal with 
internalised bacteria may also depend on the number of bacteria engulfed (Ison, 
Heyderman et al. 1995). Studies on the infant rat model of Haemophilus influenzae, 
have shown that bacteraemia may arise due to the survival of even a single organism 
in the blood stream (Moxon and Murphy 1978). Meningeal infection, resulting from 
haematogenous route, occurs in about 50 to 55% percent of patients and in about 75% 
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of the patients N. meningitidis was be isolated from the bloodstream (Connolly and 
Noah 1999). 
 
Different bacterial strains vary in their capacity to invade the nasopharynx. 
Serogroups A, B and C are more invasive than other serogroups of meningococci. 
However, experimental problems in determining the intracellular survival of 
meningococci are considerable since they often grow more rapidly extracellularly 
(Spinosa, Progida et al. 2007). Another characteristic of human pathogenic Neisseriae 
is the production of an immunoglobulin IgA1-specific protease that cleaves 
preferentially human IgA1 and thus helps in survival in epithelial cells (Lorenzen, 
Dux et al. 1999; Rosenstein, Perkins et al. 2001). 
 
Other factors responsible for increased risk of sporadic meningococcal disease 
include infection with the human immunodeficiency virus and Streptococcus 
pneumoniae (Rosenstein, Perkins et al. 2001). Also, any genetic immune defects 
including, polymorphisms in the genes encoding mannose-binding lectin and tumor 
necrosis factor-alpha, may also affect the susceptibility to meningococcal disease 
(Rosenstein, Perkins et al. 2001). Factors influencing the outcome of the disease 
depend on the duration of disease before treatment; the site, severity and the 
prognosis. 
 
1.1.5. Clinical manifestations of N. meningitidis infection 
During meningococcal infection, the patients can be classified into one of following 
clinically recognisable groups (i) bacteraemia without shock (acute mild 
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meningococcaemia), (ii) bacteraemia with shock but no meningitis (fulminant 
meningococcaemia), (iii) shock and meningitis, (iv) meningitis alone and (v) chronic 
benign meningococcemia (D’Alessandro 2006; Manchanda, Gupta et al. 2006). After 
tolerating the potentially lethal bacteria for several weeks in the bloodstream, about 
20% will later develop meningitis. 
 
Infection with N. meningitidis may result in meningitis or as septicaemia (blood 
poisoning), or as a combination of both, depending on which part of the body the 
bacteria invade (Riordan, Marzouk et al. 1995). The mildest form of the disease is 
characterised by transient bacteraemic illness with fever and malaise and symptoms 
resolve spontaneously in 1 to 2 days. Meningococcaemia is characterised by skin 
lesions, which may appear more prominently in areas of the skin subjected to 
pressure, such as the axillary folds, the belt line, or the back (Beek, Gans et al. 2004).  
 
The most serious form is the fulminant disease complicated further by meningitis. 
Fulminant meningicoccaemia disease (with or without meningitis) is characterised 
by multisystem involvement and high mortality (Edwards 1971). Fulminant 
meningococcaemia which occurs in 5 to 15% of patients, begins abruptly (Singh and 
Arrieta 2004). Typically, signs of meningitis may not be present. Pulmonary 
insufficiency develops within a few hours, and septicaemia can lead to death within 
24 hours of being hospitalized despite giving appropriate antibiotic therapy (Devoe 
1982; Hameed and Riordan 2002). Sometimes the disease is responsible for 
permanent neurological damage in the event of late diagnosis. Increasing antibiotic 
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resistance, which is being observed worldwide, further adds grounds to the concern 
(Quagliarello and Scheld 1997). 
 
The rapid symptoms of meningococcal meningitis in children include irritability and 
refusal to take food and vomiting leading to dehydration (Augustine 2005). Fever 
may not be observed in children younger than 2 months of age, but hypothermia is 
more common in neonates. In 30 to 60% of patients with meningococcal disease, with 
or without meningitis, the appearance of petechiae or purpura occurs from the first 
to the third day of illness. As the disease progresses, symptoms like high fever, 
severe headache, nausea and vomiting, sensitivity to light (photophobia), altered 
mental status, apnoea, seizures and coma due to disturbances in motor tone may 
develop (Beek, Gans et al. 2004; Milonovich 2007). In older children and adults, 
chronic benign meningococcaemia with one or more specific symptoms and signs, 
with spiking fever and altered mental status, arthralgia, or arthritis and a recurrent 
rash may occur (van Deuren, Brandtzaeg et al. 2000).  
 
The examination of CSF may show normal chemistry and cell counts but signs of 
meningeal irritation such as spinal rigidity, hamstring spasms and exaggerated 
reflexes are commonly observed (Goldschneider, Gotschlich et al. 1969). Additional 
symptoms that may be associated with this disease are: speech impairment, stiff 
neck, muscle pain, hallucinations, facial paralysis, brain damage, eye lid drooping, 
drowsiness, consciousness decreased, rapid breathing, agitation, positive Babinski's 
reflex (occurs when the great toe flexes toward the top of the foot and the other toes 
fan out after the sole of the foot has been firmly stroked (Milonovich 2007). In 
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addition, bulging of the fontanelles, opisthotonos (a condition of abnormal posturing 
characterised by rigidity and severe arching of the back, with the head thrown 
backward), deafness, paralysis of various muscles, and loss of vision may be seen 
(Voss, Lennon et al. 1989; Milonovich 2007). 
 
1.1.6. Complications associated with N. meningitidis infection 
Complications such as arthritis or pericarditis, cellulitis and endophthalmitis can 
develop (Blaser, Reingold et al. 1984; Lin, Parekh et al. 1995; Wells and Gibbons 1997). 
Other complications associated with meningococcal infection include multiple organ 
damage due to insufficient blood flow (shock), increased intracerebral pressure, 
myocarditis and hydrocephalus. Additionally, primary meningococcal conjunctivitis, 
pneumonia, adnexitis, or pelvic inflammatory disease may be seen (Lin, Parekh et al. 
1995). Meningococcal pneumonia is generally uncommon and may occur in 
immunocompromised or elderly patients (Stephens, Hajjeh et al. 1995). 
 
1.1.7. Treatment and Prognosis 
The symptoms of disease caused by N. meningitis ranges from occult bacteremia, 
which clears spontaneously, to fulminant sepsis resulting in serious complication 
which may lead to death within a few hours after the first symptoms, occur. This 
latter occurrence explains much of the challenge and anxiety surrounding the 
diagnosis, since early symptoms may be difficult to distinguish clinically from more 
common but less serious illnesses (Wang, Malley et al. 2000). Before the 1920s, 
meningococcal disease was fatal in up to 70 percent of cases (Flexner 1913). 
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In the case of bacterial meningitis, due to the high risk of complications involved, 
anti-microbial therapy must be started immediately (Wang, Malley et al. 2000). 
Therapy with horse serum containing anti-NM antibodies, introduced at the 
beginning of this century by Jochmann in Germany and Flexner in the United States, 
reduced the mortality rate from nearly 100% to 30% (Jochmann 1906; Flexner 1913). 
Antibiotics are prescribed for bacterial meningitis and the type varies depending on 
the infecting organism (Fitch and Beek 2007). Penicillin is the drug of choice in the 
treatment of meningococcaemia and meningococcal meningitis (Wang, Malley et al. 
2000). Under normal conditions, penicillin does not penetrate the normal blood-brain 
barrier, but it readily penetrates the blood-brain barrier when the meninges are 
acutely inflamed.  
 
The discovery of sulphonamides and other antimicrobial agents led to a further 
decline in fatality rates (Suntur, Yurtseven et al. 2005). Sulphonamides were the 
chemoprophylactic agent of choice until the emergence of sulphonamide-resistant 
meningococci (Moore, Reeves et al. 1989; Paap and Bosso 1992). Nearly 25% of 
clinical isolates of N. meningitidis in the United States appear to be resistant to 
sulphonamides. Either chloramphenicol or third-generation cephalosporins such as 
cefotaxime, ceftriaxone or rifampin are used in patients allergic to penicillins (Smith 
and Ryan 1987; Paap and Bosso 1992). Intravenous mannitol administration can be 
used to treat the complications arising from the increased intracerebral pressure. 
Sometimes systemic corticosteroids are also used. 
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Viral meningitis is usually not serious and symptoms disappear within 2 weeks with 
no residual complications. Antibiotics are ineffective in viral meningitis but the 
treatment of secondary symptoms including brain swelling, shock, and seizures will 
require other medications and intravenous fluids (Chitkara, Ryan et al. 2002). 
Hospitalisation may be needed depending on the severity of the illness. 
 
1.1.8. Prevention of meningitis 
The transmission of meningitis from one person to another occurs by direct contact 
or via inhalation of respiratory droplets (van Deuren, Brandtzaeg et al. 2000). Apart 
from avoiding the direct contact with infected people, other preventive measures 
may be taken to avoid serious infection.   
 
N. meningitidis serogroups A, C, Y, and W135 capsular polysaccharide vaccines are 
available (Robbins, Schneerson et al. 2003). However, these vaccines are ineffective in 
very young children (under 1 year old) since antibody levels decline rapidly after 
immunisation. Also, it has been shown that the duration of protection is limited in 
children vaccinated at 1 to 4 years of age (Ramsay, Andrews et al. 2001).  As the risk 
of infection is low in this age group, routine vaccination is not currently 
recommended before the age of 5. Also, these meningococcal capsular 
polysaccharide vaccines are not effective against group B (the most common isolate) 
because of its poor immunogenic profile. The group B capsular polysaccharide is a 
homopolymer of sialic acid and is not immunogenic in humans due to the antigenic 
mimicry with the polysialosyl gangliosides and glycoproteins in fetal and adult 
neural and extra-neural tissues (Park, Choi et al. 2004). A group B meningococcal 
vaccine consisting of outer membrane protein antigens has recently been developed 
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(Boslego, Garcia et al. 1995). Though, an overall efficacy of 51% was observed, a 
substantial drop in the antibody levels was observed by 6 months time. 
 
1.1.9. Epidemiology 
Meningococcal infections occur worldwide as an endemic disease with mortality rate 
at times reaching upto 85% (Moore, Reeves et al. 1989; Schwartz, Moore et al. 1989; 
Caugant 1998). Epidemiological studies by modern molecular methods have 
revealed a multifaceted picture of pathogenic meningococcal clones spreading 
worldwide. Of the five common serogroups (A, B, C, Y and W135) responsible for 
about 90% of infections caused by N. meningitidis, serogroups A, B and C are more 
often associated with disease than other serogroups or acapsulate bacteria. With the 
highest incidence during late winter and early spring, N. meningitidis infections occur 
both sporadically (serogroups B and C) and in epidemics (mainly serogroup A). For 
the past 200 years, epidemics of meningococcal infection have been occurred in 
Europe, Africa, Asia, the United States, and New Zealand. In USA alone, about 5000 
cases of new bacterial meningitis occur each year, a 50% increase in incidence 
compared to the number of cases recorded in the last decade. Although, it is classed 
as a rare disease in Australia, 700 people are affected each year approximately, (Jelfs 
and Munro 2001; Rosenstein, Perkins et al. 2001; Skull and Butler 2001).  
 
Serogroup A and C predominate throughout Asia and Africa and are responsible for 
epidemic spread, whereas serogroups B and C prevail in the Europe and West 
(Caugant, Kristiansen et al. 1988; Schwartz, Moore et al. 1989; Rosenstein, Perkins et 
al. 1999; Pollard 2004). Serogroup B strains related infections are common in 
developing countries (Caugant 1998). In recent years (1996-98), one third of reported 
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infections in United States were due to serogroup Y (Rosenstein, Perkins et al. 1999). 
Israel and Sweden are the other countries that have reported an increase in 
serogroup Y disease (ET-508) (Connolly and Noah 1999). The serogroup W-135 
infections were reduced from 15-20% between 1978 and 1980 to only 4% of currect 
cases in the United States (Band, Chamberland et al. 1983). During 2002-2003, 
serogroup W135 has been associated with a large epidemic in Burkina Faso (Vogel 
2003). 
  
In the last 30 years, major epidemics of meningococcal disease have occurred 
through out Asia (China 1979 and 1980, Vietnam 1977, Mongolia 1973-1974 and 1994-
1995, Saudi Arabia 1987, Yemen 1988) (van Deuren, Brandtzaeg et al. 2000). One of 
the largest outbreaks, which originated in China and later became global, was caused 
by two clones of serogroup A (Schwartz, Moore et al. 1989; Caugant 1998; van 
Deuren, Brandtzaeg et al. 2000). One of these clones, after causing an outbreak in the 
Indian subcontinent during 1983 to 1987, reached African countries through the 
Middle East between 1987 to 1996, causing epidemic among pilgrims during the Haj 
in Mecca (Schwartz, Moore et al. 1989; Caugant 1998; van Deuren, Brandtzaeg et al. 
2000). Between September 1985 and March 1986, Bhutan was also hit by meningitis 
with 247 cases and 41 deaths (WHO 2005). In the Kathmandu valley in Nepal, 1475 
cases occurred during 1982-1984, especially in children less than one year of age 
(Caugant 1998). 
 
The semi-arid area of sub-Saharan Africa has a special epidemiological pattern. A 
region of savannah that extends from Ethiopia in the east to Senegal in the west, 
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designated the “meningitis belt”, was first described by Lapeyssonnie in 1963 and 
comprised of 10 countries i.e., Burkina Faso, Ghana, Togo, Benin, Niger, Nigeria, 
Chad, Cameroon, Central African Republic, and The Sudan (Lapeyssonnie 1963). The 
“expanded meningitis belt” includes three more countries, Ethiopia, Mali, Guinea, 
Senegal, and the Gambia (Riedo, Plikaytis et al. 1995). Over 100 years, serogroup A 
meningococcal disease had been a continuous threat to public health in this region 
(Greenwood, Bradley et al. 1985). In 1996, the largest outbreak ever reported occurred 
with a total number of cases 152,813 was reported, with 15,783 deaths (WHO 1997). 
Following these large outbreak in Africa, the International Coordinating Group (ICG) 
for Vaccine Provision for Epidemic Meningitis Control was established in 1997, to 
ensure rapid and equal access to vaccines and antibiotics. The ICG was established 
by partners from the UN, including WHO, non-governmental organisations and the 
private sector. 
 
Epidemic rates of meningococcal disease vary between different nations and the 
precise bacterial factors responsible for these geographic differences are not clear 
(Stephens 1999; van Deuren, Brandtzaeg et al. 2000). Despite the development of the 
vaccines for serogroups A and C) and appropriate treatment available, the overall 
case fatality rates have remained relatively stable over the past 20 years, at 9 to 12%, 
while the rate rises up to 40 % among patients with meningococcal sepsis (Rosenstein 
and Perkins 2000). 
 
1.1.10. Methods for Diagnosis of meningococcal infection 
Current methods of diagnosis of meningococcal infection in patients with 
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meningococcal disease include Gram staining of a CSF sample, direct antigen 
detection using latex agglutination, CSF smear or bacteriological culture of CSF and 
blood growing meningococci culture. In addition, molecular diagnostic methods are 
available including amplification of a meningococcal serotype specific gene by 
polymerase chain reaction (PCR) and CSF serology to detect meningococci antigen. 
Radiological examination including X-ray of the skull, sinuses, chest and head CT 
scan can detect abscess or swelling (Daoud, Omari et al. 1998; De Gaspari 2000; Berry, 
Boese et al. 2005; Fernandez-Rodriguez, Vazquez et al. 2005; Martin, McCallum et al. 
2005; Bronska, Kalmusova et al. 2006; Jolley, Brehony et al. 2007). 
 
N. meningitidis are oxidase-positive, Gram-negative diplococci. These are fastidious 
and fragile bacteria and the clinical material must be examined as soon as possible 
after collection to increase the isolation rates (CDCP 1998; WHO 1998). Gram staining 
is still considered as an important method for rapid detection of N. meningitidis. 
Direct examination of the CSF or a skin lesion biopsy specimen reveals the presence 
of Gram-negative diplococci both inside and outside of polymorphonuclear cells 
(Dunbar, Eason et al. 1998). Heavily capsulated strains may be seen with a distinct 
pink halo around the cells.  
 
Meningococcal capsular polysaccharide in CSF, serum or urine may be detected 
using specific antibodies. This method is rapid and can provide a serogroup-specific 
diagnosis. However, false negative results are common, especially in cases of 
serogroup B disease due to the shared structural similarity with the host tissues as 
described previously (Zollinger and Boslego 1997). Antigen tests of urine or serum 
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are found to be less reliable for the diagnosis of meningococcal disease. Negative 
Gram staining or antigen detection does not necessarily rule out the meningococcal 
disease and so confirmation of meningococcal infection requires bacteriologic 
culture.  
 
N. meningitidis may be recovered from CSF, blood and aspirates and may be cultured 
on a selective Thayer-Martin agar or in a peptone-blood base medium or other 
suitable non-selective media like chocolate agar and sheep blood agar with 
incubation in 5-10% CO2 at 37 oC for 48-72 hours (Zollinger and Boslego 1997). 
Positive colonies of N. meningitidis appear as gray coloured, low convex colonies, 
with entire smooth moist edge and glistening surface with a size of approximately 
1mm in diameter. However, prior antibiotic therapy reduces the sensitivity and 
jeopardises the recovery of bacteria from cultures of blood and CSF but not from skin 
biopsy specimens (van Deuren, van Dijke et al. 1993). Following initiation of 
antibiotic therapy, analysis of blood or CSF samples by PCR is performed as it is not 
affected by prior antibiotic therapy (Fernandez-Rodriguez, Vazquez et al. 2005). 
 
Molecular diagnosis of N. meningitidis specific DNA by PCR analysis offers the 
advantages such as serogroup-specific detection and may not require live organisms. 
A study comparing the results of Gram staining and culture of CSF with a rapid PCR 
assay (2 hours) of 281 cases of suspected showed that PCR had a sensitivity of 97% 
compared to a 55 % sensitivity for culture (Richardson, Louie et al. 2003). PCR for the 
identification of N. meningitidis, based on various primers encoding ctr A, por A, crgA, 
16S rRNA, siaD and nsp A genes have been developed (Mothershed, Sacchi et al. 2004; 
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de Filippis, do Nascimento et al. 2005; Fernandez-Rodriguez, Vazquez et al. 2005; 
Jordens and Heckels 2005; Taha, Alonso et al. 2005). Real-time PCR analysis of the 
capsule transfer gene ( ctrA ) has also been reported, but fails to detect non-capsular 
strains associated with nasopharyngeal carriage (Jordens and Heckels 2005). The 
same authors have developed a novel porA-based TaqMan assay that is more 
sensitive than the ctrA assay for detecting meningococcal carriage (Jordens and 
Heckels 2005). A multiplex PCR assay for the simultaneous detection of N. 
meningitidis, Streptococcus pneumoniae and Haemophilus influenzae type B, has also been 
developed based on the ctrA, ply and bex gene targets respectively, and this has 
enabled the detection of 5-10 pg bacterial DNA (Tzanakaki, Tsopanomichalou et al. 
2005). 
 
Other molecular typing techniques that may be used for detection include Restriction 
fragment length polymorphism (RFLP), rRNA probe technology (ribotyping), PCR 
amplification and restriction endonuclease analysis of chromosomal dhps 
(dihydropteroate synthase), pil A, pil B and porA genes of N. meningitidis, repetitive 
sequence-based PCR and pulsed-field gel electrophoresis (PFGE) (Janda and Knapp 
2003; Healy, Huong et al. 2005). Antimicrobial susceptibility testing using minimum 
inhibitory concentration (MIC) determination is also the method of choice in case the 
patient doesn’t demonstrate an appropriate response to the antimicrobial agents 
(Hughes, Biedenbach et al. 1993; Institute 2005; Vazquez 2007).  
 
This disease may also alter CSF glucose levels and CSF cell count. N. gonorrhoeae 
oxidises glucose only whereas N. meningitidis oxidises both glucose and maltose and 
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tests may be performed to analyse these levels (Fox, Taha et al. 2007). Thus, 
carbohydrate utilisation tests may be used for confirmation of isolates as N. 
meningitidis. Also, Kovac's oxidase test may be performed on the growth of a blood 
agar plate and then the serogroup may be identified (Prevention 1998). 
 
Skin lesions and blood cultures may not always be revealing but CSF samples are 
generally positive (van Deuren, Brandtzaeg et al. 2000; Arend, Lavrijsen et al. 2006). 
In summary, the current methods of diagnosis used to identify the causative 
organism rely upon time consuming methods such as culture of organisms from 
cerebrospinal fluid (CSF) (Olcen, Kjellander et al. 1979) and blood samples followed 
by confirmation using techniques such as PCR for meningococcal serotype specific 
gene (Taha 2000; Freeman, Mai et al. 2004). These are rather time-consuming relative 
to the rapid pathogenesis of the disease itself. Although the introduction of 
antibiotics made it curable, morbidity and mortality rates from the disease remain 
unacceptably high.  
 
CSF culture will definitely identify the bacteria involved, but it is a very time 
consuming test indicating the need for a rapid, accurate and uncomplicated detection 
technique. The key to successful treatment of bacterial meningitis is rapid diagnosis 
followed by appropriate antibiotic therapy (Chanteau, Dartevelle et al. 2006). In light 
of the rapid onset of the disease and its devastating effects, it is critical to diagnose 
and implement appropriate treatment as soon as possible to monitor and control the 
disease. Early detection, and prompt treatment with antibiotics is essential to prevent 
permanent neurological damage, and it can mean the difference between life and 
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death (Brennan, Somerset et al. 2003). Thus there is a need for a rapid (in minutes), 
sensitive and accurate diagnostic technique to detect the presence of meningococci in 
patients. 
 
The main objective of this research project is to develop a rapid but simple, sensitive 
and highly specific diagnostic test for the detection of Neisseria meningitidis, the most 
common causative pathogen of meningitis. The proposed research plan involved a 
combination of techniques spanning biotechnology, chemistry and nanotechnology 
to develop novel detection systems involving nanoparticles and binding through 
specific biomolecular interactions between bacterial cell surface antigens and cognate 
receptors.  
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1.2. A History of Colloidal Gold Nanoparticles 
Gold is a rare metallic element with a melting point of 1064 °C and a boiling point of 
2808 °C. Several properties of gold such as its excellent conductive properties and its 
inability to react with water or oxygen, have made it very useful to mankind over 
time. During the 5th millennium B.C., the extraction of gold started near Varna 
(Bulgaria) and it is believed that “soluble” gold appeared around the 5th or 4th 
century B.C. in Egypt and China. The marvellous statue of Touthankamon, which 
was constructed around that time stands as proof. It was referred with different 
names such as soluble gold and drinkable gold, before the term “colloid” (from the 
French word, colle) was coined by Graham in 1861 (Graham 1861).  
 
Colloidal gold and its beautiful ruby-red colour has fascinated people for many 
centuries, that can be traced back to ancient times. It was used extensively for 
cosmetic, decorative as well as for medicinal purposes (Kunckels 1676; Zsigmondy 
1926; Savage 1973). In the Middle Ages, “Aurum potabile” or “drinkable gold” was 
used to cure diseases like arthritis and heart problems, venereal diseases, dysentery, 
epilepsy and tumours and also for the diagnosis of syphilis, a method which 
remained in use until the 20th century (Kahn 1928; Hauser 1952; Brown and Smith 
1980; Daniel and Astruc 2004). 
 
The use of colloidal gold as the name of soluble gold for therapeutic purposes was 
well detailed in a book on soluble gold, published by the philosopher and medical 
doctor Francisci Antonii in 1618 (Francisci 1618). The authour had briefly described 
the formation of colloidal gold suspensions and their medical uses, including 
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successful practical cases. By the end of 16th century, colloidal gold was routinely 
used to make ruby glass and for colouring ceramics, methods that are still in use 
now. The most famous examples of the use of colloidal gold in ruby glass are the 
Lycurgus Cup that was manufactured in the 5th to 4th century B.C. and  the “Purple 
of Cassius”, that has been known since the 17th century (Savage 1973). The Lycurgus 
Cup appears ruby red in transmitted light and turns green in reflected light, due to 
the presence of gold colloids. In 1794, Mrs. Fuhlame reported that she had used 
colloidal gold to dye silk (Fulhame 1794). Thus it appears that, these kinds of ideas 
about colloidal gold were common in the 18th century. 
 
Ostwald carried out several studies on metal colloids and subsequently wrote a book 
titled “The World of Neglected Dimensions” (Ostwald 1915). Nearly half a century 
later, Feynman visualised the field of nanotechnology quoted that “There’s plenty of 
room at the bottom” (Feynman 1959). Since then, with availability of several 
sophisticated tools, this area of research has shown tremendous progress (Cushing, 
Kolesnichenko et al. 2004; Daniel and Astruc 2004; Burda, Chen et al. 2005; Love, 
Estroff et al. 2005). 
 
Being the subject of one of the most ancient themes of investigation in science, gold 
and its past glory now leads to an exponentially increasing number of applications, 
especially in the context of emerging nanoscience and nanotechnology. Metallic gold 
can be reduced to gold nanoparticles by a variety of reducing agents. By definition, 
nanoparticles can range in size from 1 to 100 nanometers (Cervellino, Giannini et al. 
2005). The nanoparticles have highly interesting optical, electronic, and catalytic 
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properties, which are very different from those of the corresponding bulk materials 
(Zharov, Galitovsky et al. 2003). 
 
Colloidal gold nanoparticles present interesting aspects such as, the behavior of the 
individual particles, size-related electronic and optical properties, and their 
applications to catalysis and biology. The possibility to control and tune these unique 
optical and electronic properties, can allow these gold nanoparticles to be used as 
versatile analytical probes. Due to the promises offered by the nanotechnology, these 
nanoparticles are becoming key materials and building blocks in the 21st century.  
 
1.2.1. Synthesis of gold nanoparticles 
Nanoparticles from various materials can be prepared by relatively simple methods. 
During the past few decades, a variety of different methods have been reported and 
reviewed for synthesizing gold colloids of monodisperse and uniform sizes particles 
(Turkevich, Stevenson et al. 1951; Frens 1973; Hayat 1991; Schmid 1992; Watson, Zhu 
et al. 1999). Currently, there are two kinds of approaches generally carried out to 
prepare nanoparticles, (a) The “top down approach”, which involves the constant 
division of bulk metals into nanoparticles and (b) The “bottom-up approach”, which 
involves the building up of nanoparticles from the atomic level.   
 
1.2.1.1. Top- Down Approach 
This method is based on dissolution of metallic gold and various methods included 
in the “top- down” approach are laser ablation methods, evaporation under high 
vacuum (Aiyer, Vijayakrishnan et al. 1994), solvated metal atom dispersion (SMAD) 
methods (Lin, Franklin et al. 1986; Smetana, Klabunde et al. 2005), an electric arc 
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reduction method (Bradley, Schmid et al. 2005) and electrochemical reduction 
methods (Reetz and Helbig 1994).  
 
In the SMAD method (Lin, Franklin et al. 1986), the gold suspension is vapourised 
under vacuum and the metal atoms are co-deposited with a vapour such as acetone 
on the walls of a reactor. This method helps to stabilise the particles sterically as well 
as electrostatically. Using this method, silver and copper nanoparticles have also 
been prepared (Smetana, Klabunde et al. 2005). Gold and siver nanoparticles have 
also been prepared by electric arc reduction of metal filings (Bradley, Schmid et al. 
2005). Reetz and Helbig (Reetz and Helbig 1994) have described the preparation of 
palladium nanoparticles by an electrochemical reduction method. Sibbald et al.. 
reported about the laser ablation method to generate silver nanoparticles (Sibbald, 
Chumanov et al. 1996). 
 
1.2.1.2. Bottom- Up Approach 
This method is based on preparation of colloid particles from gold halides such as 
tetrachloroauric acid, HAuCl4 (Dykman, Lyakhov et al. 1998). The bottom- up 
approach of preparing nanoparticles has become very popular, because one can have 
a good control on size and monodispersity of the nanoparticles (Toshima and 
Yonezawab 1998). Cushing and co- workers published a review in which they 
discussed about various preparative strategies in detail (Cushing, Kolesnichenko et 
al. 2004). In this approach, different reducing agents such as sodium borohydride, 
trisodium citrate, tannic acid, hydrazine, ascorbic acid and tartaric acid are used to 
reduce the metal ions into nanoparticles (Cushing, Kolesnichenko et al. 2004). 
Nanoparticles from metals such as Au, Ag, Pt, Pd and Rh, having high positive redox 
 34
potentials (E0>0.7V) can be prepared using mild reducing agents under ordinary 
conditions, whereas electronegative metals (E0< -0.2V) requires strong reducing 
agents with extreme reaction conditions (Goia and Matijevi 1998). Daniel and Astruc 
have reviewed the methods available for the preparation of Au nanoparticles (Daniel 
and Astruc 2004). 
 
 
1.2.1.2.1. Citrate Reduction 
For many biological applications, it is desirable to have the nanoparticles suspended 
in water with no loss of physical and chemical properties (Lewis 1993). At first, 
Faraday prepared aqueous colloidal Au suspensions using phosphorous vapour as 
the reducing agent (Faraday 1857) and stated that these suspensions contained 
metallic particles in a “highly divided state”. The Austrian Nobel laureate Zsigmondy 
said that “A colloidal mixture may sometimes behave like a chemical compound and has 
frequently simulated one” (Zsigmondy 1926). Initially, Zsigmondy described about the 
colloidal gold synthesis methods with different particle size using H2O2, formalin 
and white phosphorus as the reducing agents. 
 
Among the various methods described, the trisodium citrate reduction method at 
elevated temperatures, initiated by Turkevich and co-workers (Turkevich, Stevenson 
et al. 1951), is the most widely method. They have proposed the mechanism of 
synthesis of monodisperse colloidal gold hydrosols by the controlled reduction of an 
aqueous solution of tetrachloroauric acid. The Au3+ ions are reduced by the 
multidentate chelating agent (trisodium citrate) to produce clusters of supersaturated 
Au0 nuclei. As the Au0 concentration increases, they form seeds of nuclei and the 
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particle growth occurs by further deposition of metallic gold upon the nuclei. Small 
metal particles with a negative charge are formed in which case; the negative charge 
is believed to arise from dichlorogold (I) ions on their outer surface. Here, the citrate 
anion acts both as a capping as well as reducing agent. This technique leads to gold 
nanoparticles of an average core size of 20 nm.  
 
The paticle size obtained by this method is inversely proportional to the ratio 
between citrate: tetrachloroauric acid, resulting in particles in the range, 20 to 100 nm 
(Englebienne 1999). In 1973, Frens reported that, pre-selected size between 16 and 147 
nm were obtained via controlled formation, by varying the ratio between the 
reducing/stabilising agents (the trisodium citrate-to gold ratio) (Frens 1973). The 
sodium citrate reduction method produces a uniform size distribution of 
nanoparticles but with a slightly different mean size with every synthesis (Link, 
Wang et al. 1999). 
 
Synthesis of smaller particles requires the use of strong reductants such as white 
phosphorus or sodium borohydride. They produce a great number of nuclei and 
hence the small particles with average diameter of 2 to 10 nm are produced 
depending on the synthetic conditions (Hyning and Zukoski 1998). Gold, silver and 
platinum nanoparticles have been prepared using this method (Turkevich, Stevenson 
et al. 1951; Frens 1973; Lewis 1993; Chow and Zukoski 1994; Henglein 1997). 
Additives, such as tannic acid, may be used to stabilise and to control their size. 
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1.2.1.2.2. Two-Phase Synthesis and Stabilisation by Thiols 
The two-phase procedure that has revolutionised the field of nanoparticle synthesis 
involves the phase transfer of metal ions from water into an organic toluene medium 
using phase transfer reagents such as tetraoctyl ammonium bromide (TOABr) (Brust, 
Walker et al. 1994). Subsequently, the metal ions are reduced using reducing agents 
such as NaBH4, in the presence of capping agents such as dodecanethiols (Brust, 
Walker et al. 1994) and amines (Leff, Brandt et al. 1996) that have great affinity for 
noble metal surfaces. Once the organic phase changes colour from orange to deep 
brown, the solvent is evaporated to yield particles. These particles can be made 
soluble in different solvents depending on the polarity of the capping agent. The 
advantage of this procedure is that the method yields highly stable and capped 
nanoparticles which can be repeatedly isolated and re-dissolved in common organic 
solvents without irreversible aggregation or decomposition. 
  
The above synthesis technique was inspired by Faraday’s two-phase system and uses 
the thiol ligands as capping agents that strongly bind gold due to the soft character of 
both Au and S (Faraday 1857; Brust, Fink et al. 1995). Brust et al.. extended this 
synthesis to p-mercaptophenol-stabilised gold nanoparticles in a single phase system, 
which opened an avenue to the synthesis of monolayer protected clusters (MPCs) of 
gold nanoparticles stabilised by a variety of functional thiol ligands (Brust, Fink et al. 
1995; Kang and Kim 1998; Chen 1999). The synthetic procedures have been further 
refined to obtain highly monodisperse nanoparticles (Hicks, Miles et al. 2002).  
 
Nanoparticles are generally better dispersed in organic solvents than aqueous 
solvents. Giersig and Mulvaney converted the citrate- capped gold nanoparticle sols 
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into thiol- capped particles by substitution in a phase transfer experiment from 
aqueous to organic phase (Giersig and Mulvaney 1993). These thiol- capped particles 
were subsequently redispersed in non-polar solvents. Schmid and co- workers 
(Schmid, Lehnert et al. 1991) have prepared Au clusters capped with 
triphenylphosphine derivatives and due to the polar nature of the capping agent, 
these particles can be redispersed in aqueous solutions. Methods to transfer the 
nanoparticles from organic to aqueous media were also reported which is of 
particular interest for biological applications (Gittins and Caruso 2002). Superhydride 
and hexadecylaniline have been used as alternative reagents to NaBH4 for the 
reduction of gold (III) in the synthesis of thiol-stabilised gold nanoparticles (Yee, 
Jordan et al. 1999; Selvakannan, Mandal et al. 2002). 
 
1.2.1.2.3. Seeding Growth and Other methods 
Although the seeding-growth procedure is an age old technique, recent studies have 
successfully led to control of the particle size distribution, by manipulating the ratio 
of seed to metal salt (Jana, Gearheart et al. 2001; Meltzer, Resch et al. 2001). 
Nanoparticles in the size range of 5-40 nm were successfully prepared using this 
method. It was reported that, step-by-step particle enlargement is more effective than 
a one-step seeding method since it avoids secondary nucleation (Carrot, Valmalette et 
al. 1998). 
 
The use of microemulsions (Aliotta, Arcoleo et al. 1995; Chen, Xu et al. 2003) 
copolymer micelles (Carrot, Valmalette et al. 1998; Bronstein, Chernyshov et al. 1999) 
reverse micelles (Lisiecki and Piled 1995), surfactants adsorbed (Markowitz, Dunn et 
al. 1999; Aslan and Perez-Luna 2002), membranes and other amphiphile based 
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techniques for the synthesis of stabilised nanoparticles in the presence or in the 
absence of thiol ligands has been reported. The syntheses involve a two-phase system 
with a surfactant that causes the formation of the microemulsion or the micelle 
maintaining a favorable microenvironment, and the thiols that interact with 
nanoparticles surface and stabilise the particles. This provides an advantage over the 
conventional two-phase systems that control both the growth and stabilisation of the 
gold nanoparticles. 
 
Common surfactants such as cetyl trimethylammoniumbromide (CTAB) and sodium 
bis (2-ethylhexyl) sulphosuccinate (NaAOT) are used to form reverse micelles (Chen, 
Xu et al. 2003). The metal salts are dissolved in the water and volume of the water 
pool inside a reverse micelle can be carefully controlled. The addition of a second 
reverse micelle containing a suitable reducing agent causes the reduction of metal 
ions to nanoparticles and their size is predetermined by the micellar core where the 
water is trapped. Phospholipids were also used in particular as dispersants, for the 
preparation of gold nanoparticles (Chow, Markowitz et al. 1996; Bhattacharya and 
Srivastava 2003). 
 
Colloidal dispersions of noble metals have been prepared by reducing the metal ions 
under reflux conditions in methanol/water in the presence of polyvinyl pyrollidine 
(Hirai, Nakao et al. 1978). The sol- gel processing of materials, where the metallic 
particles can be stabilised in both liquid and solid matrices (Epifani, Giannini et al. 
2000), is a versatile method for making particles at room temperatures. Very stable 
dispersions of the Au, Ag, Pd and Pt nanoparticles were synthesised in the form of 
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sols, gels and monoliths in a single step by a sol-gel process (Bharathi, Fishelson et al. 
1999). 
 
Spontaneous formation of gold nanoparticles have been observed in aqueous 
suspensions of sugar-persubstituted PAMAM dendrimers without the addition of 
additional reductant (Esumi, Hosoya et al. 2000). Gold nanoparticles were prepared 
in both aqueous and organic systems by reducing HAuCl4 with o-anisidine in the 
presence of 1:1 N-methyl-2-pyrrolidone/toluene (Dai, Tan et al. 2002).  
 
Metal nanoparticles have also been synthesised by techniques such as sonochemical 
(Pol, Gedanken et al. 2003), radiolytic, UV irradiation, Near-IR laser irradiation 
(Mallick, Wang et al. 2001), ϒ-irradiation  (Dawson and Kamat 2000), laser photolysis 
(Sau, Pal et al. 2001), electrochemistry and microwave reduction methods in the 
presence of suitable stabilisers. Radiolysis has been used to synthesise and to control 
the size of gold nanoparticle. Irradiation by UV light in conjuction with seed growth 
method was shown to improve the quality of the gold nanoparticles (Meltzer, Resch 
et al. 2001; Sau, Pal et al. 2001). Sonochemistry has also been also used for the 
synthesis of gold nanoparticles and Au/Pd bimetallic particles within the pores of 
silica substrate. Laser ablation is another technique of gold nanoparticle synthesis, 
wherein size can be controlled by the laser (Mafune, Kohno et al. 2002).  
 
1.2.1.2.4. Gold nanoparticle biosynthesis 
Since there is a growing need to develop non-toxic, environment friendly synthetic 
procedures, biochemical preparation methods of gold nanoparticles have been 
reported whereby biological organisms play the roles of reductant, protecting agent, 
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and precipitating agent (Li, Chung et al. 2003). Microorganisms like bacteria and 
fungi as well as plant extracts, have been successfully employed to stabilise Au 
nanoparticles (Torresdey, Tiemann et al. 1999; Hillyer and Albrecht 2001; Mukherjee, 
Ahmad et al. 2001; Torresdey, Parsons et al. 2002). 
 
Reaction of AuCl4– ions with the extract of geranium leaves and an endophytic 
fungus, Colletotrichum sp., present in the leaves, leads to the formation of gold 
nanoparticles (Ascencio, Mejia et al. 2003; ShivShankar, Ahmad et al. 2003). This is 
described as sort of biomineralisation process, in which protein components control 
the formation of nanoparticles by specifically interacting with the growing particles. 
 
1.2.1.2.5. Bimetallic Nanoparticles 
Bimetallic nanoparticles containing gold as one of the elements have been 
synthesised in a variety of ways. Bimetallic gold nanoparticles have been reported 
with Ag, Pd, Pt, Ti, Fe, Zn, Cu, Zr, CdS and Eu (Schmid, Lehnert et al. 1991; Vacassy, 
Valmalette et al. 1998; Cao, Jin et al. 2001; Kolny, Kornowski et al. 2002; Moskovits, 
Sloufova et al. 2002; Ravel, Carpenter et al. 2002; Schierhorn and Marzan 2002; 
Shibata, Bunker et al. 2002; Shon, Dawson et al. 2002; Mandal, Selvakannan et al. 2003; 
Yang, Shi et al. 2003). The molar ratios of metals both in and on the surface of the 
bimetallic cores differed significantly from the metal: salt ratio used in the bimetallic 
particle synthesis (Hunter 1993).  
 
1.2.2. Control of size of metal nanoparticles 
Almost all properties of nanoparticles are dependent on shape and size (Burda, Chen 
et al. 2005) and nucleation and growth are two closely inter-linked processes that 
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manage the size and shape of controlled synthesis of metal nanoparticles (Turkevich, 
Stevenson et al. 1951; Toshima and Yonezawab 1998) The size of the nanoparticles is 
generally governed by factors such as the ratio of the capping agent to the reductant 
(Frens 1973; Brust, Fink et al. 1995), the nature of the reducing and capping agents 
(Chow and Zukoski 1994), temperature (Hostetler, Wingate et al. 1998) and the rate of 
addition of the reducing agent (Tsai and Dye 1991). Strong reducing agents such as 
alkali metal anions (alkalides) (Brust, Walker et al. 1994; Brust, Fink et al. 1995), 
borohydrides and superhydrides (Yee, Jordan et al. 1999) induce the formation of 
nucleation centres which then grow into small clusters whose final size is determined 
by the nature of the capping agent. In the case of weak reducing agents such as 
hydrazine (Nickel, Castell et al. 2000), ascorbic acid (Sau, Pal et al. 2001), tartarate 
(Tan, Dai et al. 2003) and trisodium citrate (Turkevich, Stevenson et al. 1951), the rate 
of reduction is slow. Hence, it is growth of the particle and not the nucleation process 
that dominates, resulting in large-sized particles. Methods used to prepare large 
particles of size 50 nm and above directly, result in high polydispersity and varied 
shapes (Brown, Walter et al. 2000). Methods such as ‘seed growth’ have  the 
advantage of eliminating nucleation and promoting only the growth process and is 
used to increase particle size in a uniform manner (Brown, Walter et al. 2000).  
 
1.2.3. Stability of gold nanoparticles 
As noted, nanoparticles prepared by aqueous chemistry techniques, are often formed 
in the presence of a surface-capping/stabilising ligand that also control the final 
dimensions of the nanoparticles. In the absence of suitable stabilising agents, 
colloidal particles would be attracted to each other by van der Waals forces, 
ultimately resulting in the aggregation and precipitation of the particles (Brust, Fink 
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et al. 1995). This is prevented by this use of a stabiliser/ capping agent, (Templeton, 
Chen et al. 1999; Yao, Momozawa et al. 2001) which establishes a repulsive barrier 
between the approaching particles. Many capping systems are available which 
includes, hydrophobic monolayers, (Miyazaki and Nakano 2000), hydrophilic 
monolayers (Bradley 1994), which provide electrostatic stabilisation and polymer 
layers which provide steric stabilisation (Figure 1.2) (Bradley 1994).  
 
 
C  
Figure 1.1. Schematic representation of the stabilisation forces in colloidal particles 
(A) Electrostatic (B) Steric (Bradley 1994) and (C) Citrate reduced colloidal gold 
particle ("Inorganic Colloid Chemistry;" by Weiser, H. B) (Reyerson 1939). 
 
 
 
The electrostatic stabilisation involves the use of charged capping agents such as 
sodium citrate, where the negatively charged citrate-capped nanoparticles attract 
positively charged counter-cations from the surrounding solution. This results in the 
formation of a diffuse electrical double layer, which creates a Coulombic repulsion 
between the particles. This electrostatic repulsion between the particles will prevent 
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aggregation, as long as the electric potential associated with the double layer is 
sufficiently high (Figure 1.1.). However, the double layer is very sensitive to changes 
in ionic strength of the solution. An increase in the ionic strength by the addition of a 
salt which causes a compression of the double layer and displacement of the 
adsorbed citrate anions on the colloid by the addition of a strongly binding 
adsorbate, would result in aggregation (Brust, Walker et al. 1994; Brust, Fink et al. 
1995).  
 
Large molecules or ligands like polymers (Schmid 1992; Bradley 1994) and long chain 
thiols (Schmid 1992; Bradley 1994) provides steric stabilisation to the nanoparticles. 
When particles adsorbed with such molecules approach each other, a reduction in 
the conformational freedom of the adsorbate molecules occurs due to the 
interpenetration of the ligand chains. As the local concentration of the the adsorbate 
increases, the solvent tries to counteract this effect by diluting the concentration of 
the adsorbate and thereby causes the particles to move apart (Bradley 1994). This is 
especially useful in organic solvents, where electrostatic effects are small. Thus, a 
highly monodisperse and uniform sized particles can be synthesised in organic 
solvents and can be stabilised at relatively high concentrations. 
 
1.2.3.1. Stabilisation by Sulfur and Non-Sulfur Ligands 
Sulphur-containing ligands, such as xanthates (Tzhayik, Sawant et al. 2002), 
disulphides (Porter, Ji et al. 1998; Tan, Li et al. 2002), di- and trithiols (Tan, Li et al. 
2002) and resorcinarene tetrathiols (Balasubramanian, Kim et al. 2002), have also been 
used to stabilise gold nanoparticles. Thiols are better stabilising agents than 
disulfides and thioethers (Shelley, Ryan et al. 2002), whereas the use of polythioethers 
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circumvented this problem (Maye, Chun et al. 2002). Other gold complexes, in 
particular gold(I) amine complexes, have been used as precursors for the synthesis of 
amine-stabilised gold nanoparticles (Leff, Brandt et al. 1996). Microemulsions, 
micelles and reverse micelles have been used to trap and stabilise the nanoparticles 
(Niemeyer 2001; Sohn, Choi et al. 2003).  
 
1.2.3.2. Stabilisation by using Polymers 
In 1718, Hans Heinrich Helcher, stated that the use of boiled starch in drinkable gold 
preparations noticeably enhanced its stability (Helcher 1718). Two centuries later, 
such materials were recognised as polymers, since then there has been a revival of 
activity in the field of polymer-stabilised gold nanoparticles (Napper 1983; Hayat 
1991; Tuzar and Kratochvil 1993; Schulz, Schulz et al. 2002). Poly (N-vinyl-2-
pyrrolidone) (PVP) is one of the most commonly used polymers for the stabilisation 
of gold nanoparticles in water. The greatest stability is obtained with polymers 
possessing hydrophobic backbones and side groups, allowing interactions with the 
AuCl4- ion (Mayer and Mark 1998).  
 
Functionalised polymers such as poly(ethylene glycol)-based polymer have also been 
used as stabilisers (Otsuka, Akiyama et al. 2001). Hollow polymer spheres have been 
synthesised with movable gold nanoparticles at their core interiors (Kamata, Lu et al. 
2003). An amine functionalised polymer was used to simultaneously assemble 
carboxylic acid functionalised gold and silica naoparticles into extended aggregates 
(Chechik and Crooks 1999; Wang, Neoh et al. 2001). Mangeney et al.. reported that, 
disulphide-bearing polymers have shown only a slightly larger affinity for the gold 
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surface than those that do not have the disulphide groups (Mangeney, Ferrage et al. 
2002).  
 
1.2.3.3. Stabilisation by using Dendrimers 
Gold nanoparticles have been stabilised in the presence of excess polyamidoamine 
(PAMAM) dendrimers in solution. Thiol functionalized PAMAM dendrimers acted 
as both a stabiliser and a ligand (Chechik and Crooks 1999). PAMAM dendrimers 
were also functionalised with hydrophobic groups for solubilisation of the gold 
nanoparticles in organic solvents (Esumi, Hosoya et al. 2000). These dendrimer-gold 
nanoparticle assemblies have been deposited as films on sensor surfaces (Krasteva, 
Krustev et al. 2003). Another important observation was the use of that PAMAM 
dendrimers to stabilise  gold nanoparticles allowed the control of the interparticle 
distance (Frankamp, Boal et al. 2002). 
 
1.2.4. Characterisation of gold nanoparticles 
The most common technique for characterisation of gold nanoparticles is high-
resolution transmission electron microscopy (HRTEM), which generates a 
photomicrograph of the gold core of the gold nanoparticles, providing the size 
distribution and dispersity of the sample. The mean number of gold atoms can be 
calculated form the mean diameter, d, of the cores. The core dimensions of the 
metallic nanoparticles have also been characterised using alternative techniques 
based on microscopy (scanning electron microscopy-SEM, scanning tunneling 
microscopy-STM, atomic force microscopy-AFM), X-ray methods (small-angle X-ray 
scattering-SAXS, Extended X-ray absorption fine structure-EXAFS, X-ray 
photoelectron spectroscopy- XPS, X-ray diffraction- XRD), optical spectroscopy (UV-
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Visible spectroscopy), electrochemistry, infrared (IR), Raman and nuclear magnetic 
resonance (NMR), thermogravimetric analysis (TGA),  laser desorption ionisation 
mass spectrometry (LDI-MS), or high-resolution time-of-flight mass spectroscopy 
analysis. (Toshima and Yonezawab 1998). 
  
The localised elemental composition on the nanoparticles can be obtained from 
Energy Dispersive X- ray microanalysis (EDX) in conjunction with TEM. However, 
the disadvantage associated with TEM, is that the high energy of the beam can cause 
phase transitions and desorption of the protective ligands (Bovin and Malm 1991). 
Scanning tunneling microscopy (STM) is a useful technique for determining particle 
size, which also includes the size of the ligand shell as well (Reetz, Helbig et al. 1995).  
 
UV-Visible spectroscopy is used for analysis of the intensely coloured colloidal 
dispersions having characteristic surface plasmon absorption. In a given preparation 
of gold nanoparticles, there is usually a mixture of different size nanoparticles. 
Different size nanoparticles have characteristic surface plasmon resonance peaks and 
thus the UV-Visible spectra of the different nanoparticles are also usually 
significantly different, which may also helps in determining the particle size. The 
UV-Visible together with infrared (IR) spectra provides an identification of the ligand 
that is also confirmed by nuclear magnetic resonance (NMR) spectroscopy. The 
detection of order-disorder transitions in gold nanoparticles in the solid state has ben 
achieved using by IR and NMR spectroscopy techniques together with differential 
scanning calorimetry (DSC). The results suggested that the energetic states and the 
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dimensions of the gold nanoparticles are influenced by both the radii and 
concentrations of the stabilising groups. 
 
The information on the inter-atomic distances and coordination numbers of the metal 
atom in colloids can be obtained using Extended X-ray Absorption Fine Structure 
(EXAFS) sprecroscopy and thus allowing investigation of the size-dependent 
distance contraction in thiol-stabilised gold nanoparticles. X- ray diffraction is used 
to investigate the structure and size of metal nanoparticles. Surface-enhanced Raman 
scattering (SERS) and X-ray photoelectron spectroscopy (XPS) are used to determine 
the chemisorptive properties of tetrathiol ligands and the oxidation states of metallic 
nanoparticles. The oxidation state of the gold atoms and the interaction of thiols with 
gold have been studied by Brust et al.. and confirmed using 1H NMR measurements 
(Brust, Walker et al. 1994). Capillary zone electrophoresis has also been used to 
determine the core radius and size of the nanoparticles based on the mobility of gold 
nanoparticles in acetate buffer (Hwang, Lee et al. 2003). 
 
1.2.5. Optical Properties of gold nanoparticles 
Gold nanoparticles have a remarkably low melting temperature (300 - 400°C), 
compared to that of bulk gold (1064 °C). During the reduction process, the properties 
of the bulk metal begin to change dramatically because more of inner atoms move to 
the surface and the electrons begin to suffer the quantum effects. The resulting 
physical properties are neither those of bulk metal nor those of molecular 
compounds, but they strongly depend on the factors such as particle size, shape, 
interparticle distance and nature of the protecting group. This makes nanoparticles 
different from bulk gold as well as the atomic state of the metal (Katz and Willner 
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2004). Thus the properties of nanoparticles such as optical, electronic, chemical, 
magnetic and mechanical are affected by these factors (Hövel, Fritz et al. 1993). The 
optical properties of nanoparticles such as surface plasmon resonance, are strikingly 
different from that of bulk gold. This section details only about the surface plasmon 
resonance (SPR) property (Underwood and Mulvaney 1994; Link and El-Sayed 1999) 
since it is relevant to the present study. 
 
1.2.5.1. Surface Plasmon Resonance 
Certain metal colloids like Au, Ag and Cu, exhibit strong absorption bands in the 
visible region and are therefore intensely coloured. Gustav Mie (Mie 1908) 
determined that these intense colours associated with metal colloids is a consequence 
of the absorption and scattering of light and described a theoretical explanation for 
the colour of the colloidal gold. He solved Maxwell’s equations for the absorption 
and scattering of electromagnetic radiation by spherical particles and proposed an 
equation (Mie 1908) to calculate the extinction spectra of the particles. Later, Mie’s 
theory was extended by Gans to prolate and oblate spheroidal particles averaged 
over all orientations (Gans 1915). However, all subsequent reports that describe the 
spectroscopic behavior of gold nanoparticles continued to correlate with the Mie 
theory. 
 
An absorption band of metallic nanoparticles induced by an interacting 
electromagnetic field, is referred as the “surface plasmon band”, (Kreibig and 
Vollmer 1995). This phenomenon appears in the absorption spectrum of the 
nanoparticles due to the collective coherent oscillation of the free conduction band 
electrons occupying energy states just above the Fermi level. In the case of gold 
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nanoparticles, it is due to plasmon oscillation of 6s electrons of the conduction band. 
The deep-red colour of gold nanoparticles in water and glasses reflects the surface 
plasmon band (SPB), a broad absorption band in the visible region around 520 nm. In 
general, the surface plasmon values of gold, silver and copper nanoparticles with a 
diameter below 20 nm, lie close to 520 nm, 400 nm and 570 nm respectively 
(Creighton and Eadon 1991) and for larger particles, the peak shifts to longer 
wavelength (e.g., 529 nm for 50 nm nanoparticles). Thus, the SPB provides 
information on the development of the band structure in specific metals and has been 
the subject of extensive study. 
 
The position of the surface plasmon depends on and is sensitive to several factors 
such as particle size, shape, stabilising agent and temperature as well as nature of the 
surrounding medium (Hövel, Fritz et al. 1993; Underwood and Mulvaney 1994; 
Kreibig and Vollmer 1995; Link, Wang et al. 1999). Kreibig and Fragstein (Kreibig and 
Fragstein 1969) and several other groups have shown, that the plasmon bandwidth is 
proportional to 1/R, where R refers to the radius of the particle. When the diameter 
of the particle becomes smaller than the mean free path of the conduction electrons 
(approximately 3 nm) electron scattering occurs at the particle boundaries resulting 
in broadening and damping of the surface plasmons. That is the reason why SPB is 
absent for gold nanoparticles with core diameter less than 2 nm, as well as for bulk 
gold.  
 
The plasmon bandwidth increases with decreasing size in the intrinsic size region 
(mean diameter smaller than 25 nm) (Link, Wang et al. 1999), and also increases with 
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increasing size in the extrinsic size region (mean diameter larger than 25 nm) (Link, 
Wang et al. 1999) and is found to follow the predicted behavior of quantum size 
effects. The surface plasmon resonance shows a red- shift in the extrinsic size region 
and as the particle size increases, the gold nanoparticles colour changes from ruby 
red to purple and finally blue. However, in the intrinsic size region, the changes in 
surface plasmon position are not very clear (Link, Wang et al. 1999). It has been found 
that the plasmon resonance absorption obtained often deviate from the predictions of 
the Mie theory, and the discrepancies are attributed to the complex physical and 
chemical influences of the capping agent. 
 
As the particle shape changes from a sphere to a spheroid, ellipse or a rod, a 
significant change in the absorption spectrum is observed (Link, Wang et al. 1999). 
With elliptical particles, the SPB is shifted to higher wavelength as the spacing 
between particles is reduced, and this shift is well described as an exponential 
function of the gap between the two particles (Blatchford, Campbell et al. 1982). A 
similar phenomenon is observed in the case of particles that are in close contact with 
each other. This is due to coupling between the plasmon modes of the individual 
particles (Blatchford, Campbell et al. 1982). Gans (Gans 1915; Link, Wang et al. 1999) 
has calculated the extinction coefficient of nanorods and good agreement between 
theoretical and experimental data has been observed. For rod like particles, the 
extinction maximum polarised along the long axis occurs at a longer wavelength 
than the SPB maximum for polarisation along the particle radius.  
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The presence of a ligand shell or group alters the refractive index and causes either a 
red or blue shift, so that the spectroscopic data obtained often deviate from the 
prediction of Mie theory that deals with naked nanoparticles. The agreement with 
Mie theory is obtained only when the shift induced by this ligand shell is taken into 
account. Another influential parameter is the core charge. Excess electronic charge 
causes shifts to higher energies, whereas electron deficiency causes a corresponding 
shift to lower energy. The effect of temperature was also found to have a smaller 
effect.  
 
The refractive index of the solvent has been shown to induce a shift of the SPB, as 
predicted by the Mie theory. For instance, suspensions of dodecanethiolate capped 
gold nanoparticles of 5.2 nm average diameter reveal an 8-nm shift in SPB as the 
solvent refractive index is varied from 1.33 to 1.55. Therefore, impurities in the 
system can be easily detected since the refractive index of gold nanoparticles greatly 
differs from that of gold oxide or gold chloride. The SPR wavelength and width of 
nanoparticles also depend on the dielectric constant of the surrounding medium and 
hence on their average diameter. Underwood and Mulvaney (Underwood and 
Mulvaney 1994) have demonstrated that, an increase in the refractive index of the 
gold nanoparticle suspension leads to a corresponding red-shift of the surface 
plasmon peak. A red shift was also observed with an increase of the solvent dielectric 
constant with solvents that do not coordinate the gold core, but the SPB is unaffected 
in polar solvents that do not bind to the core. 
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The SPB was used to study the degree of dispersion of gold nanoparticles in a variety 
of solvents. Formation of large aggregates caused a reversible change in colour of the 
gold nanoparticle suspension from red to violet due to coupling to surface plasmons 
in aggregated colloids. Apart from colloidal suspensions of Au, Ag and Cu, alkali 
and alkaline earth metals such as, cadmium and thallium also exhibit distinct 
absorption bands. Most other metal colloidal suspensions are usually brown in 
colour, do not show strong absorption bands in the visible region, and the absorption 
spectra appear flat and featureless (Creighton and Eadon 1991). 
 
 
1.2.6. Biological Applications of gold nanoparticles 
 
1.2.6.1. Biomolecule-directed nanoparticle organisation - Nanoparticles as 
biolabels 
The dimensions of the metal nanoparticles are similar to those of biomolecules such 
as proteins (enzymes, antigens, antibodies) or DNA whose dimensions are in the 
range of 2-20 nm (Service 1997; Mirkin and Taton 2000; Niemeyer 2001). 
Immibilisation of biomolecules onto nanoparticles to yield novel hybrid nano-
biomolecules, has been achieved by a variety of techniques including physical 
adsorption, electrostatic binding, specific recognition, and covalent coupling (Katz 
and Willner 2004). Under appropriate conditions, noncovalent bonding is a general 
strategy to bind colloidal gold and macromolecules, with little or no change in the 
specific activity of the bound macromolecule. This interaction is influenced by a 
number of factors including ionic concentration, pH conditions (in correlation with 
the protein pI values) and protein/DNA stabilising levels. 
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In the case of citrate capped nanoparticles, biomolecules can be linked directly by 
exchange reactions with stronger binding ligands (Niemeyer 2001). For example, the 
coating of colloidal gold with proteins such as immunoglobulins and serum albumin, 
which have cysteine residues. If the native proteins doesn’t have the cysteine 
residues, thiol groups can be incorporated by chemical modification (Tarentino, 
Phelan et al. 1993) or by genetic engineering. DNA molecules can also be synthesised 
with alkylthiol groups at either the 3'- or 5'-end to facilitate binding to gold 
nanoparticles (Tarentino, Phelan et al. 1993).  
 
By utilising the advantage of specific receptor-ligand ineractions, various 
nanoparticle assemblies have been generated. Analogous to the interactions between 
the amino acid side chains and the metal atoms in many reaction centres of enzymes, 
the interaction between biomelcules and the surface of an inorganic nanoparticle 
provides the way for the coupling of biomolecular recognition systems to generate 
novel materials. The two sets of nanoparticles are functionalised with individual 
recognition groups that are either directly complementary to each other, or else are 
complementary to a molecular linker (Niemeyer 2001). The bio-recognition elements 
such as proteins/enzymes, antigens/antibodies, and DNA/oligonucleotides, in 
conjunction with nanoparticles, have been used for various biotechnological 
applications including, affinity separations, biosensing, bioreactors, and the 
construction of biofuel cells.  
 
1.2.6.2. DNA-gold nanoparticles assemblies and sensors  
Negatively charged DNA was found to substitute citrate ions around gold 
nanoparticles to form a DNA-nanoparticle probe, which was confirmed by 
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electrophoresis and fluorescence (Cushing, Kolesnichenko et al. 2004). DNA 
functionalised gold and semiconductor nanoparticles have been prepared using the 
n-alkylthiolated DNA and also using DNA containing several adenosyl 
phosphothioate residues at their ends (Niemeyer 2001). Nucleic acids are superior for 
the functionalisation of nanoparticles, since the possible programmability of DNA 
base-pairing to organise nanoparticles in space and the range of techniques available 
for the detection of precise DNA sequences (Castaneda, Merkoci et al. 2007). 
 
DNA conjugated to the nanoparticles is able to hybridise with complementary DNA 
and is thermally reversible (Mirkin, Letsinger et al. 1996). In the presence of 
complementary strands, the coupled nanoparticles are released at high temperatures 
due to the “melting” transition of the complementary DNA strand (Qin and Yung 
2007).  
 
In recent times, the fabrications of DNA-driven assemblies of two-dimensional arrays 
and three-dimensional networks of gold and silver nanoparticles have indeed 
attracted considerable interest. The Mirkin group have used DNA as a linker to form 
macroscopic assemblies of 13-nm gold nanoparticles (Mirkin, Letsinger et al. 1996). 
Alivisatos et al.. have used DNA as a template to prepare nanocrystal chains 
consisting of two or three 1.4 nm particles on a single oligonucleotides strand 
(Alivisatos, Johnsson et al. 1996). 
 
Conjugates of gold nanoparticles-oligonucleotides are of great interest for detection 
of DNA hybridisation, because of its application in the diagnosis of pathogenic and 
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genetic diseases (Castaneda, Merkoci et al. 2007). Most of the DNA hybridisation 
techniques utilize fluorescent, chemiluminescent, or radioactively labelled probes or 
requiring special instrumentation or both (Kim, Rajamohan et al. 2006). A significant 
enhancement of the shift (40 nm) of the transmission surface plasmon resonance (T-
SPR) absorption band of the gold nanoislands, was observed, when a self assembled 
monolayer of a single-stranded DNA deposited onto a glass microscopic slide is 
hybridised by its complementary DNA functionalised to gold nanoparticles (Garcia 
and Garcia 2000; Hutter and Pileni 2003). The sensitivity of SPR biosensing of DNA 
hybridisation on continuous Au film was greatly enhanced by using Au 
nanoparticles (Hutter and Pileni 2003). Indeed, conductivity changes in gold 
nanoparticle labelled DNA arrays have recently been employed for selective 
molecular recognition of targets present in low concentration (Tirelli 2006). 
 
The SPB phenomenon has led to the development of a highly selective diagnostic 
method for DNA, based on the distance-related properties of gold nanoparticles. 
Aggregation of gold nanoparticles linked by the oligonucleotides mediates a red-to-
blue colour change (red shift from 520 to 620 nm of the SPB) and this property is 
utilised in the DNA-sensing method. The effect of the length of the DNA strands that 
control the interparticle distance has been studied, and it was found that the SPB 
frequency changes are inversely dependent on the oligonucleotides linker length 
(Fischler and Simon 2007). A new colorimetric technique based on the sensitivity of 
the surface plasmon band (SPB) has been designed to monitor the sequence specific 
DNA modifications (Li, Chu et al. 2005). 
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Stable, water-soluble, hydroxycapped quantum dots-oligonucleotide conjugates have 
been used as labels in fluorescence in situ hybridization (FISH) studies (Wu, Zhao et 
al. 2006). Biosensors based on gold nanoparticle-DNA interactions have enabled 
detection within minutes, and quantitative data obtained (Yáñez-Sedeño and 
Pingarrón 2005). Thus, applications in the fields of biosensors, disease diagnosis, and 
gene expression using gold nanoparticle-DNA conjugate probes are clearly called for.   
 
1.2.6.3. Protein-based recognition systems: Enhanced immuno sensing 
Biomolecules and inorganic nanoparticles are conjugated by means of various 
conjugation methods that allow the preparation of well-defined bioconjugate hybrid 
nanoparticles (Niemeyer 2001). Though, a large number of complementary binding 
pairs are available, nucleic acid based conjugation might offer advantages over 
protein based assembly, since the physicochemical properties of a single 20-mer 
oligonucleotide represents 420 (=1012) different recognition elements (Mann, Shenton 
et al. 2000). However, it was suggested that extensive use of protein-based assembly 
may lead to a ”factory of the future”, directed by multiple highly specific 
biomolecular recognition elements such as, antibodies that are specific against 
various antigens (Mann, Shenton et al. 2000). These biomolecule based coupling 
systems were useful in various diagnostic applications and for generating inorganic 
nanoparticle networks (Niemeyer 2001). 
 
The conjugation of proteins on colloidal gold nanoparticles is achieved by the 
electrostatic interactions between negatively charged citrate on surfaces of gold 
nanoparticles and positively charged groups of the proteins (Xiao, Ju et al. 1999). The 
strong interaction between the protein and the colloidal gold nanoparticle surface 
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may increase the surface density of the adsorbed protein, and small size of the 
colloidal gold particles gives the protein molecules more freedom in orientation (Liu, 
Leech et al. 2003). Enzymatic activity of fungal protease-gold nanoparticle 
bioconjugates was reported (Phadtare, Kausik et al. 2004). Assembly of gold 
nanoparticles on polyurethane spheres were used to immobilise enzymes such as 
pepsin and these bioconjugate catalysts were reused as free enzymes (Phadtare, 
Kumar et al. 2003). 
 
The conjugation of antigens and antibodies on colloidal gold has been used for the 
development of immunological detection methods (Lin, Sabri et al. 2005). The 
experimental gold nanoparticle-protein conjugate architectures involves either direct 
binding of antigen-gold nanoparticle bioconjugates to an antibody modified surface 
or the exposure of an antibody derived surface to free antigen and then to a 
secondary antibody-gold nanoparticle conjugate. Recently, a unique, sensitive and 
highly specific immunoassay system for antibodies using gold nanoparticles has 
been developed (Thanh and Rosenzweig 2002). 
 
Biosensors for immunoassays in human serum have been developed (Jianrong, 
Yuqing et al. 2004). An electrochemical method to monitor biotin-streptavidin (STV) 
interactions has been established using colloidal gold as an electrochemical label 
(Garci, Sanchez et al. 2000). The Biotin-STV system is a versatile system for 
developing novel strategies for assembling nanoparticles in suspension or on a 
substrate and the conjugates form the basis of many diagnostic and analytical tests 
(Niemeyer 2001). The STV - biotin interaction was also used to organise gold colloids 
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that were functionalised by chemisorptive coupling to a disulphide biotin analogue 
(Connolly and Fitzmaurice 1999). Niemeyer and Ceyhan prepared biofunctionalised 
nanoparticles by DNA-directed conjugation of proteins (Niemeyer and Ceyhan 
2001). These studies demonstrate the emergence of a new field of application for 
colloidal gold in protein immobilisation and biosensing. 
 
The specific interaction between antibodies and low molecular weight organic 
compounds, the so-called hapten groups, has been used to cross-link nanoparticles 
(Shenton, Davis et al. 1999). Shenton et al. functionalised gold and silver nanoparticles 
with the immunoglobulins IgG and IgE, which had a specificity directed against 
either the d-biotin or the dinitrophenyl (DNP) group respectively (Shenton, Davis et 
al. 1999). 
 
Gold nanoparticles have been immobilised in the gaps of microelectrodes through 
biospecific interactions and then the silver enhancement of gold nanoparticles has 
been applied for the electrical sensing of biological binding events (Velev and Kaler 
1999). These gold colloids serve as catalytic cores for the reductive deposition of a 
conducting layer of silver, which short circuits the two electrodes. This ultimately 
resulted in decrease in ohmic resistance which is used as a positive signal for the 
sensing of the biospecific interactions (Velev and Kaler 1999). Biosensors for the 
electrocatalytic detection of hydrogen peroxide were prepared by adsorption of the 
horse-radish peroxidase enzyme onto electrode-immobilised layers of gold colloids 
(Patolsky, Gabriel et al. 1999; Xiao, Ju et al. 1999).  
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In another example, conjugates of nanocrystals with IgG molecules were prepared 
and subjected to immuno-precipitation by using a complementary antibody with 
binding specificity for the particle-bound proteins. The widespread aggregation 
observed in this experiment clearly indicated that the nanocrystals were suitable for 
the sensitive immunoassays and the attachment of nanocrystals does not interfere 
with the intrinsic functionality of the biomolecule (Chan and Nie 1998). In 
continuation to this work, Han et al.. tagged the micrometre-sized polymer particles 
with various quantum dots to achieve an optical barcode for biomolecules (Han, Gao 
et al. 2001). 
 
The great sensitivity of the surface plasmon band (SPB) by gold nanoparticle 
adsorption has also led to their use in bioassay applications (Daniel and Astruc 2004). 
Gold nanoparticles were also applied to enhance the detection limits in SPR-based 
biospecific interaction analysis (Lyon, Musick et al. 1998). The dramatic enhancement 
of SPR biosensing with colloidal Au was observed in a sandwich immunoassay in 
which Au nanoparticles were coupled to a secondary antibody , thereby allowing 
picomolar detection of the antigen (Lyon, Musick et al. 1998).  
 
1.2.6.4. Drug delivery 
Nanoparticles can easily enter cells although the mechanism(s) involved are not well 
understood. Dai and co-workers (2005) suggested that the nanoparticle influx occurs 
by endocytosis (Shi Kam, O'Connell et al. 2005).  In contrast, Bianco et al.. suggested 
that the particles are inserted and diffused through the lipid bilayer of the cell 
membrane (Bianco, Kostarelos et al. 2005).   Furthermore, these nanoparticles were 
shown to be able to enter the cells even after linkage to proteins such as antibodies 
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(Shi Kam, O'Connell et al. 2005). Nanoparticles conjugated with antibodies against 
exclusive cancer cell surface receptors have been used to specifically bind with 
cancerous cells (Shi Kam, O'Connell et al. 2005). 
 
The functionalised nanoparticles have also been used for targeted entry into cells 
(Jiang, Kim et al. 2007). Phthalocyanine-stabilised gold nanoparticles have ben shown 
to be a potential delivery vehicle for photodynamic therapy (Hone, Walker et al. 
2002). gold nanoparticles with a size of 20 nm have been conjugated to various 
cellular targeting peptides to provide functional nanoparticles that penetrate the 
biological membrane and target the nucleus (Katz and Willner 2004). Various 
nanoparticles have also applied as targeted biomarkers and drug-delivery agents for 
diagnosis and medical treatment of cancers (Katz and Willner 2004). 
 
1.2.6.5. Cytochemical labels and other applications 
Colloidal gold nanoparticles prepared in sizes from 1 to 25 nm, are electron dense 
due to the high atomic number of the gold atoms and, this makes them ideal for 
electron microscopy. Specific sites in a biological specimen may be visualised by 
introducing antibody conjugated colloidal gold particles (Hainfeld 1992; Takizawa, 
Suzuki et al. 1998). Small gold clusters with a diameter of 0.8 or 1.4 nm, stabilised 
with arylphosphanes have been routeinly used as probes for the site-specific labeling 
of biological macromolecules in histological applications (Hainfeld and Furuya 1992).   
 
Colloidal gold nanoparticles are also used as cytochemical labels for the study of 
macromolecules with transmission and scanning electron microscopy (Garcia and 
Garcia 2000), light microscopy (Csaki, Moller et al. 2002) and freeze-etch electron 
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microscopy (Garcia and Garcia 2000) and to enhance the signals of both surface 
enhanced Raman spectroscopy (Manimaran and Jana 2007) and surface plasmon 
resonance (Lyon, Musick et al. 1999).  
 
Specific binding of mannose-encapsulated gold nanoparticles to FimH adhesin of 
bacterial type 1 pili in Escherichia coli, have been shown by TEM (Lin, Yeh et al. 2002). 
The method used in these studies labelled specific proteins on the cell surface using 
carbohydrate-conjugated gold nanoparticles, and the visualisation of the target 
receptor was easily accomplished with an electron microscope. 
 
Colloidal gold, with an indirect digoxigenin-tagged nucleotide and an anti-
digoxigenin probe, was used for in situ hybridisation studies using an electron 
microscope (Jin and Lloyd 1997). Both a gold nanoparticle label and a fluorescein tag 
are attached to an antibody to yield a single probe for imaging a specimen both by 
fluorescence and electron microscopy (Thompson and Swanson 1998).  A further 
advantage of using the colloidal gold marker is that the colloidal gold nanoparticles 
can be easily be counted and thus the cytochemical signal may be evaluated 
quantitatively. Several procedures such as silver enhancement have been developed 
to amplify the final signal which makes the techniques more sensitive. 
 
Separation of acidic and basic proteins was achieved by nanoparticle-filled capillary 
electrophoresis (Yu, Su et al. 2006). gold nanoparticles have been used to manipulate 
the selectivity between solutes in capillary electrophoresis (Neiman, Grushka et al. 
2001). Thus, gold nanoparticles serve as large surface area platforms for organo-
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functional groups that interact with the capillary surface, the analytes, or both. The 
use of gold nanoparticles in conjunction with chip-based capillary electrophoresis to 
improve the selectivities between solutes and to increase the efficiency of the 
separation has been reported (Pumera, Wang et al. 2001). In summary, gold 
nanoparticles that are functionalised with proteins have long been used as tools in 
the biosciences. Moreover, the synthesis of well defined nanoparticle-biomolecule 
complexes is particularly important to generate well defined nanoarchitectures. 
 
The primary aim of this project is to design and develop a rapid, specific and highly 
sensitive diagnostic assay for Neisseria meningitidis using OMP85 and anti-OMP85 
antibody as a model system. In the following chapters, details about the preparation 
of different target antigens including expression and purification of the recombinant 
OMP85 antigen are discussed. Polyclonal antibodies were raised against these 
antigens. Methods were optimised for successful conjugation of both antigens and 
antibodies to gold nanoparticles. Gold nanoparticles were utilised both as colour 
reporting agents and also as the signal amplification probes for the detection of the 
antigen. 
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Chapter 2 
 
 
The detection system - Potential biomarker targets and 
receptors 
 
 
 
2.1. Potential biomarkers and target antigens 
There are several target antigen molecules on the surface of Neisseria meningitidis 
including the bacterial outer membrane proteins (OMP’s) such as OMP85, anti-
phagocytic polysaccharide capsule and lipo-oligosaccharides, which are being used 
for immunodiagnostic and therapeutic purposes (Figure 2.1. and 2.2.) (Granoff, 
Bartoloni et al. 1998; Vipond, Suker et al. 2006). 
 
 
Figure 2.1. Cross-sectional view of the Meningococcal Cell Membrane (Rosenstein, 
Perkins et al. 2001) 
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Figure 2.2. Structural representation of meningococcal cell envelope (Morley and 
Pollard 2001). 
 
 
2.1.1. Neisseria meningitidis OMP85 
The cell membrane of Gram negative bacteria consists of an outer membrane and an 
inner membrane, separated by the periplasm. The inner membrane is a phospholipid 
bilayer, whereas the outer membrane is an asymmetric structure which consists of 
phospholipids and lipopolysaccharides (LPS) in its inner and outer leaflets, 
respectively (Voulhoux, Bos et al. 2003). Even though the integral proteins are present 
in both the outer and inner membranes, the main structural difference between the 
two membranes is that the integral proteins of inner membrane are mostly α-helical 
and that of outer membrane proteins (OMPs) are the β-barrel proteins. 
 
OMPs with an NH2-terminal signal sequence are synthesised in the cytoplasm. After 
inner membrane translocation (Voulhoux, Bos et al. 2003), the signal sequence is 
cleaved off, releasing the mature OMP protein into the periplasm. In the periplasm, 
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LPS stimulates the OMP’s to fold into their native tertiary conformation and then 
inserted into the outer membrane (Voulhoux and Tommassen 2004). There have been 
reports that describe other factors which also mediate OMP folding, such as the 
periplasmic chaperones SurA and Skp proteins (Voulhoux, Bos et al. 2003). Very little 
information is available about the subsequent steps in OMP biogenesis (Gentle, 
Gabriel et al. 2004).  
 
Meningococcal OMP85 which fulfill the above criteria to some extent, is a highly 
conserved protein amongst Gram-negative bacteria, and sequence analysis reveals 
that it has close similarities with other OMP’s from other bacteria including OMP 85 
protein of Neisseria gonorrhoeae (95% sequence identity), Haemophilus influenzae D-15-
Ag (31.5% sequence identity) and Pasteurella multocida Oma87 (31.6% sequence 
identity) (Manning, Reschke et al. 1998). Several hypothetical proteins similar to 
OMP85 have also been identified  (Fitzpatrick and McInerney 2005). Southern blot 
analysis has shown that omp85 is present as a single copy both in N. gonorrhoeae and 
N. meningitidis (Bronska, Kalmusova et al. 2006). The gene in N. meningitidis encodes a 
797 amino acid OMP85 protein with a predicted molecular weight. of 88.5 kDa and 
NH2- terminal signal peptide. After cleaving the signal peptide, it yields a mature 
protein with 85.8 kDa predicted molecular weight. A carboxy-terminal phenylalanine 
residue  is also present in the mature protein, which is characteristic of Gram 
negative bacterial outer membrane proteins (Judd and Manning 2003). 
 
 OMP85 of N. meningitidis is an essential protein for growth and also for various 
other functions such as outer membrane protein assembly (Gentle, Gabriel et al. 
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2004), host-pathogen interactions and lipid transport from the inner membrane to the 
outer membrane (Genevrois, Steeghs et al. 2003). Unsuccessful attempts by Voulhoux 
et al.. to delete the structural gene for the homologous protein in Haemophilus ducreyi 
and Synechocystis sp., indicates that OMP85 is an essential protein (Voulhoux, Bos et 
al. 2003). The same authors reported that deletion of the omp85 homologoue gene 
resulted in the accumulation of various outer membrane proteins in the periplasm, 
suggesting that OMP85 is also essential for translocation into the outer membrane 
(Voulhoux, Bos et al. 2003).  
 
To demonstrate that the presence of OMP85 is essential for viability, Gentle et al.. 
constructed a meningococcal strain in which OMP85 expression could be switched 
on or off through a tac promoter-controlled OMP85 gene, (Gentle, Gabriel et al. 2004). 
This experiment also proved that the absence of OMP85 expression leads to the 
accumulation of electron-dense amorphous material and some vesicular structures in 
the periplasm. 
  
Another essential function of the OMP85 protein is the lipid transport from the inner 
membrane to the outer membrane (Genevrois, Steeghs et al. 2003). However, it is still 
not clear how the lipopolysaccharides and phospholipids synthesised at the inner 
membrane are subsequently transported to the outer membrane. A possible 
explanation for the role of OMP85 in this regard is that both the omp85 gene and the 
genes involved in lipid biosynthesis are co-transcribed and thus may be involved in 
the lipid transport (Genevrois, Steeghs et al. 2003). Another interesting observation was 
that upon depletion of OMP85 expression, the lipopolysaccharide and phospholipids 
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mostly disappeared from the outer membrane and they were not transported from 
the inner membrane (Genevrois, Steeghs et al. 2003). These results explain the role for 
OMP85 in lipid transport to the outer membrane and thus in outer membrane 
protein assembly. 
 
 Sequence analysis reveals that proteins homologous to OMP85 are found in other 
Gram negative bacteria and also in the outer membrane of mitochondria in 
eukaryotes from plants to humans (Gentle, Gabriel et al. 2004). The outer membrane 
protein, Toc75, a plastid protein translocator of the chloroplast protein-import 
machinery is a plant homologue of the OMP85 protein (Gentle, Burri et al. 2005). 
Toc75 is involved in protein transportation into chloroplasts and this suggests a 
common evolutionary origin (Surana, Grass et al. 2004). 
 
 In eukaryotes, OMP85 is present in the mitochondrial outer membrane is essential 
for outer membrane biogenesis (Gentle, Gabriel et al. 2004) including protein 
transport and mitochondrial fission. In metazoans, OMP85 is also involved in 
mitochondrial aspects of programmed cell death (Leuenberger, Curran et al. 2005). 
Antibodies against yeast recombinant OMP85 were conjugated to gold nanoparticles 
and used to decorate thin sections of cryo-preserved yeast cells (Gentle, Burri et al. 
2005). Accumulation of the gold nanoparticles indicate the presence of OMP85 on the 
surface of mitochondria (Gentle, Burri et al. 2005). 
 
Bacterial outer membrane proteins (OMP’s) can be used as targets for 
immunodiagnostic and therapeutic purposes because of their easy access and they 
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perform a variety of different functions. Antibodies to these outer membrane 
proteins (D-15-Ag and Oma87) have been shown to be protective against infectious 
challenge in animal models (Manning, Reschke et al. 1998), which in turn suggests 
that these proteins play an important role in host-pathogen interactions and thus in 
pathogenesis (Judd and Manning 2003). Thus OMP85 protein has been selected as 
the initial target antigen in the first phase of this project. 
 
 
2.1.2. Identification of a specific peptide sequence in OMP85 
The meningococcal omp85 gene was found to encode a 797 amino acid polypeptide 
(Figure 2.3.) with a predicted molecular weight of 88.5 kDa (Judd and Manning 
2002). Meningococcal OMP85 is a highly conserved protein in Gram-negative 
bacteria and specially the regions between residues 360-395 and 643-662 of the 
protein sequence (OMP85 2002). Though it is a conserved protein, it can serve as a 
useful marker since the predicted antigenic sequence between residues 720 and 745 is 
unique to this organism (Judd and Manning 2003).  Also, there are five additional 
amino acids at the N-terminus which distinguishes it from other related outer 
membrane proteins (Judd and Manning 2003). A useful approach will be to target 
these specific sequences as selective epitopes for immunodiagnosis of Neisseria 
meningitidis. 
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MKLKQIASALMMLGISPLAFADFTIQDIRVEGLQRTEPSTVFNYLPVKVGDTYNDTHGSAIIKSLYAT
GFFDDVRVETADGQLLLTVIERPTIGSLNITGAKMLQNDAIKKNLESFGLAQSQYFNQATLNQAVA
GLKEEYLGRGKLNIQITPKVTKLARNRVDIDITIDEGKSAKITDIEFEGNQVYSDRKLMRQMSLTEGGI
WTWLTRSNQFNEQKFAQDMEKVTDFYQNNGYFDFRILDTDIQTNEDKTKQTIKITVHEGGRFRWG
KVSIEGDTNEVPKAELEKLLTMKPGKWYERQQMTAVLGEIQNRMGSAGYAYSEISVQPLPNAETKT
VDFVLHIEPGRKIYVNEIHITGNNKTRDEVVRRELRQMESAPYDTSKLQRSKERVELLGYFDNVQFD
AVPLAGTPDKVDLNMSLTERSTGSLDLSAGWVQDTGLVMSAGVSQDNLFGTGKSAALRASRSKTT
LNGSLSFTDPYFTADGVSLGYDVYGKAFDPRKASTSIKQYKTTTAGAGIRMSVPVTEYDRVNFGLVA
EHLTVNTYNKAPKHYADFIKKYGKTDGTDGSFKGWLYKGTVGWGRNKTDSALWPTRGYLTGVN
AEIALPGSKLQYYSATHNQTWFFPLSKTFTLMLGGEVGIAGGYGRTKEIPFFENFYGGGLGSVRGYES
GTLGPKVYDEYGEKISYGGNKKANVSAELLFPMPGAKDARTVRLSLFADAGSVWDGKTYDDNSSS
ATGGRVQNIYGAGNTHKSTFTNELRYSAGGAVTWLSPLGPMKFRYAYPLKKKPEDEIQRFQFQLGT
TF 
Figure 2.3. OMP85 protein sequence of Neisseria meningitidis with the highlighted 
specific peptide sequence 
 
 
According to the topology predictions (Voulhoux and Tommassen 2004), the OMP85 
protein consist of two domains, the N-terminal periplasmic domain until residue 483 
and the C-terminal β-barrel domain, with 12 β-strands in the outer membrane. The 
specific region between residues, 720-745 is a surface exposed domain which makes 
it easily accessible (Figure 2.4.).  
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Figure 2.4. Topology prediction of Neisserial OMP85 (Voulhoux, Bos et al. 2003; 
Voulhoux and Tommassen 2004). Periplasmic domains are represented by dashed 
lines. Exposed domains are represented by solid lines. The first and last amino acids 
of each β-strand are indicated. The specific peptide region between 720-745 amino 
acid residues are shown as a surface exposed domain. The amino (N) and carboxy 
(C) termini of the protein are indicated. 
 
In order to develop Neisseria meningitidis specific anti-peptide antibody, the specific 
region between 720-745 amino acid residues designated as SR1 was synthesized 
using t-Boc chemistry. 
 
2.1.2A. Peptide Synthesis and Analysis 
The first peptide was synthesised by Fischer in the early 1900’s by the use of solution 
phase peptide synthesis (Fischer and Fourneau 1901). Peptide synthesis was 
revolutionised by Merrifield who introduced solid phase peptide synthesis (SPPS) in 
1963 (Merrifield 1963). This technique is less labour intensive, allows the synthesis of 
much longer peptides and is suitable for automation, considerably reducing the time 
required for synthesis.  
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Two main methods are used in which either the acid-labile Nα-t-butyloxy carbonyl 
group (t-Boc) (Merrifield 1963) or the base-labile 9-fluorenylmethoxycarbonyl group 
(Fmoc) (Atherton, Gait et al. 1979) is the protecting group on the α-amino group of 
the amino acids (Figure 2. 5). 
  
 
 
 
 
Figure 2.5. Structure of α-amino protecting groups. (a) t-Boc (b) Fmoc 
 
Kent et al.. developed a highly optimised form of the t-Boc chemistry (Kent and 
Clark-Lewis 1985; Schnolzer and Kent 1992). This method increases the coupling of 
amino acids and reduces the time each cycle takes and later this has been adapted for 
automation by (Fecondo 1996). 
 
SPPS involves the covalent attachment of the C-terminal amino acid to a solid 
support and the addition of the following amino acids to assemble the sequence. The 
main advantage of SPPS is that reactants can be used in excess to drive the reactions 
forward and can then be separated by simple filtration and washing with respective 
solvents.  
 
A mBHA resin containing 1% divinyl benzene such as 4-methylbenzhydrylamine 
(mBHA-HCl) (Figure 2.6) has been used as the solid phase support in t-Boc synthesis. 
O
C
O
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The synthetic cycle (Figure 2.7) involves the anchorage of the first amino acid to the 
resin by activating it as an active ester using a reagent such as 2-(1H-benzotriazol-1-
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) or a mixture of HBTU 
and 1-hydroxybenzotriazole (HOBT). The bond is very stable and can only be 
cleaved using a strong acid such as hydrogen fluoride (HF) or 
trifluromethanesulphonic acid (TFMSA). The amino acids used have a t-Boc 
protecting group on the α-amino group, which can be removed with an acid such as 
trifluoroacetic acid (TFA) and may have side chain protecting groups that are more 
stable and are removed by only a strong acid. After deprotection by TFA, the peptide 
resin needs to be neutralised using a tertiary amine, usually N, N-
diisopropylethylamine (DIEA). Alternatively, the next activated amino acid can be 
coupled in the presence of DIEA (in situ neutralisation) (Schnolzer 1992).  
 
 
 
 
 
Figure 2.6. Structure of linker on mBHA-HCl resin 
 
This reduces the time required for each cycle of the synthesis. After all the amino 
acids have been added, the peptide is completely deprotected and cleaved from the 
resin using anhydrous HF. 
 
The purity of the final product is usually evaluated using reverse-phase high 
performance liquid chromatography (RP-HPLC) with a C8 or C18 column and with an 
C
H
NH2
CH3
Resin 
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acetonitrile gradient. The composition can be analysed using mass spectrometry. 
Usually analysis by matrix assisted laser desorption/ionisation-time of flight 
(MALDI-TOF), provides the monoisotopic mass which is sufficient to determine 
whether the desired peptide has been synthesised. 
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Figure 2.7. Overview of cycle used for peptide synthesis (S. Thoduka, Unpublished). 
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2.1.3. The Capsule of Neisseria meningitidis 
In case of certain infectious diseases, especially those caused by some invasive Gram-
negative bacteria (Frosch, Gorgen et al. 1985), poorly immunogenic bacterial capsules 
are responsible for the weak humoral immune response. This occurs mainly either 
because they interfere with cellular events that results in induction of an antibody 
response (Taylor, Stashak et al. 1983) or because of their chemical resemblance to 
those of host determinants (antigenic mimicry) and as a result they are not 
recognised as foreign (Mauel 1982). This mechanism results in the ability of bacteria 
to evade host defences. 
 
The capsular polysaccharide of meningococci is a major virulence factor, consisting 
of sialic acid derivatives of mono, di, or trisaccharide repeating units as a 
homopolymer (serogroup B and C) or a heteropolymer (serogroup Y and W135) 
units (Tone 2005). The serogroup B capsule is composed of (α2→8)-linked N-acetyl 
neuraminic acid (NANA), whereas the serogroup C capsule composed of partly O-
acetylated repeating units of sialic acid, linked with 2-->9 glycosidic bonds, mostly 
over 100,000 Dalton (100 kDa) in weight (Henriques, Jessouroun et al. 2006). The 
serogroup Y consists of partly O-acetylated alternating units of D-glucose and 
NANA, linked with 2-->6 and 1-->4 glycosidic bonds and the serogroup W-135 
capsule consists of partly O-acetylated alternating units of sialic acid and D-
galactose, linked with 2-->6 and 1-->4 glycosidic bonds (Spinosa, Progida et al. 2007).  
 
Apart from serogroup A, other serogroup capsules are composed of sialic acid (N- 
acetyl neuraminic acid, NANA) derivatives (Figure 2.8.). The serogroup A capsule 
consists of repeating units of N -acetyl- O-acetyl mannosamine-1-phosphate (O-
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acetylated repeating units of N-acetylmannosamine, linked with 1-->6 
phosphodiester bonds) and is encoded by a four gene biosynthesis cassette unique to 
this group (Spinosa, Progida et al. 2007). The differences in sialic acid capsule 
composition are due to the distinct polysialyl transferases encoded by the fourth 
gene of the capsule biosynthesis operon and which also forms the basis for capsule 
specific PCR (Hammerschmidt, Muller et al. 1996). 
 
Figure 2.8. N-acetyl neuraminic acid (NANA) 
 
An enzyme, sialic acid synthase NeuB in N. meningitidis directly converts 
phosphoenolpyruvate (PEP) and N-acetylmannosamine (Man- NAc) into N-
acetylneuraminic acid (NeuNAc, or sialic acid) (Masson and Holbein 1983; Gunawan, 
Simard et al. 2005). These nine carbon 3-deoxy-2-keto sugars are found as a series of 
repeating units on the boundary of the secreted and cell surface glycoproteins and 
glycolipids on bacterial organisms. The gene siaD is responsible for polymerisation of 
monomers into the homopolymer or heteropolymer to form the capsule (Frosch and 
Vogel 2006). Several species of pathogenic bacteria, such as Escherichia coli and 
Neisseria meningitidis, produce sialylated capsular polysaccharides to avert host 
defenses and thereby leading to poor antibody responses (Gunawan, Simard et al. 
2005).  
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Meningococcal polysaccharide vaccines contain cultured, inactivated, and purified 
capsular polysaccharides from N. meningitidis groups A, C, Y and W-135, 
respectively, either alone or in combination (Fisseha, Chen et al. 2005). The bacterial 
polysaccharide components, together with calcium ions and residual moisture, 
account for nearly all of the mass of these vaccines. Immunogenicity of the 
polysaccharide polymers increases with their molecular weight (Stephens, 
Gudlavalleti et al. 2006). Meningococci also have the capacity to exchange the genetic 
material responsible for capsule production and thereby switch from serogroup B to 
C or vice versa (Swartley, Marfin et al. 1997). Capsule switching may become an 
important mechanism of virulence with the widespread use of vaccines that provide 
serogroup-specific protection (Swartley, Marfin et al. 1997). Serotyping is very 
important for the development of vaccination strategies and the current methods 
involving the serotyping of meningococcal infection utilise the capsule specific 
monoclonal antibodies (Popovic, Ajello et al. 1999).  
 
 
2.2. Development of receptors against target antigens 
 
2.2.1. Monoclonal and polyclonal antibodies against target antigens 
A range of receptors targeted against the selected antigens from the surface of 
Neisseria meningitidis were developed including polyclonal antibodies against the 
whole organism, purified OMP85, a ‘unique’ peptide sequence derived from OMP85 
and a polysaccharide capsule component together with commercially available 
monoclonal antibodies that recognise capsule epitopes on the bacterial cell surface.  
Rabbit anti-OMP 85 polyclonal antibodies (RMIT University), sheep anti-SR1 peptide 
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and anti-N. meningitidis polyclonal antibodies were made (Institute of Medical and 
Veterinary Science (IMVS), Australia). Mouse anti-NM type B monoclonal antibodies 
were purchased from the National Institute for Biological Standards and Control 
(NIBSC), UK. In addition, attempts were made to define novel and specific receptors 
known as IgNAR’s (immunoglobulin-like new antigen receptors) by screening 
recombinant antibody fragment libraries in collaboration with Dr Stewart Nuttall’s 
group at CSIRO Molecular and Health Technologies in Parkville.  These IgNAR 
receptors were considered to be the smallest antibody fragment capable of full 
antigen-binding capacity and specificity but with greater thermal stability and 
production efficiency. 
 
 
2.2.2. Immunoglobulin New Antigen Receptors (IgNAR’s) as novel 
receptors 
In the adaptive immune system, the antigen receptors, Immunoglobulins (Igs) and T 
cell receptors (TCRs) are generated for the recognition of pathogens (Roux, 
Greenberg et al. 1998). The typical immunoglobulin receptor is composed of two 
heavy (H) and two light (L) polypeptide chains. Each chain, in turn, is composed of a 
single, variable (V) domain at the N-terminal end followed by one to seven constant 
(C) domains (Roux, Greenberg et al. 1998). Normally, constant domains define the 
effector functions characteristic of a given class of Ig whereas V domains each display 
a unique sequence and structure defining antigen specificity. Igs can be subdivided 
further into Fab and Fc fragments, responsible for antigen binding and effector 
functions (Roux, Greenberg et al. 1998). The V region contains frame work (FR) 
regions and hypervariable sequences known as complimentarity-determining 
regions (CDR’s). FR’s are responsible for protein folding and CDR’s are responsible 
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for antigen interactions. The evolutionary origin of antigen receptors is unknown, 
but the first indication of their emergence phylogenetically is in cartilaginous fish 
(sharks, skates, and rays), where at least three types of Ig (Greenberg, Avila et al. 
1995) and four TCR isotypes are found (Rast and Litman 1994; Rast, Anderson et al. 
1997).  
 
One of the goals of antibody engineering has been to reduce the size of the minimum 
antibody fragment whilst retaining binding affinity and specificity (Nuttall, Krishnan 
et al. 2001).  Until recently Fv fragments, composed of only the heavy and light chain 
variable (VH and VL) domains were considered to be the smallest antibody fragment 
capable of full antigen-binding capacity. Recently, an alternate type of antigen 
receptor in nurse sharks (Orectolobus maculates and Ginglymostoma cirratum), called 
IgNAR (Immunoglobulin-like New Antigen Receptor) (Roux, Greenberg et al. 1998; 
Nuttall, Krishnan et al. 2001) that is secreted by splenocytes but does not associate 
with Ig light (L) chains had been identified (Greenberg, Avila et al. 1995).  
 
The IgNAR protein has been shown to be a homodimeric heavy-chain complex with 
each chain composed of one V and five C domains (Greenberg, Avila et al. 1995). 
IgNAR’s V region undergoes high levels of somatic mutation and is equally 
divergent from both Ig and T cell receptors and thus may be an evolutionary 
intermediate (Diaz, Greenberg et al. 1998). The NAR V region conforms to the model 
of prototypic Ig super family domains with an exceptionally small CDR2  region 
(Williams and Barclay 1988; Greenberg, Avila et al. 1995). By electron microscopy, it 
was shown that NAR V regions, unlike those of conventional Ig and TCR, do not 
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form dimers but rather are independent, flexible domains function as a bivalent 
antigen-binding site (Roux, Greenberg et al. 1998). This unusual feature is analogous 
to bona fide camelid IgG in which modifications of Ig heavy chain V (VH) sequences 
prevent dimer formation with L chains (Roux, Greenberg et al. 1998). In camelid 
species (camels and llamas), a significant proportion of the serum immunoglobulin 
consists of antibodies naturally devoid of light chains (Casterman, Atarhouch et al. 
1993) and the unassociated VH domains interact with antigen as monomers (Spinelli, 
Frenken et al. 1996).  
 
The development of phage display has allowed the generation of libraries of Fv 
fragments and engineered derivatives such as scFv, dsFv from which many antigen 
specific binders have been isolated (Winter, Griffiths et al. 1994; Hoogenboom and 
Chames 2000). To decrease the size of the minimal binding unit below that of the Fv, 
it was generally accepted that the antibody fragment must be composed of a single 
domain.  
 
Based on this IgNAR variable domain region, a single domain library has been 
created by the successful cloning and generation of a bacterial phage-display library 
in E. coli (Nuttall, Krishnan et al. 2001). This library was based upon the antibody 
fragments V region sequence from the wobbegong shark (Orectolobus maculates) 
which, like the nurse shark, is a member of the shark family Orectolobidae. The 
library was constructed so as to incorporate a randomised, synthetic CDR3 of either 
16 or 18 aa. Selection on a number of proteinaceous antigens resulted in the selection 
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of anti-Kgp protease clones which were able to bind both specifically and with good 
affinity (Nuttall, Krishnan et al. 2001; Nuttall, Krishnan et al. 2002). 
 
Screening of such a library generated from nurse sharks (Ginglymostoma cirratum) 
immunised with the model antigen hen egg-white lysozyme (HEL) facilitated the 
successful isolation of intact antigen-specific binders matured in vivo (Dooley, Flajnik 
et al. 2003). The selected variable domains were shown to be functionally expressed 
in Escherichia coli, selection from this library resulted in the isolation of clones highly 
specific for antigen, binding with nanomolar affinity and showing great resistance to 
irreversible thermal denaturation (Dooley, Flajnik et al. 2003). This approach can 
therefore be considered as an alternative route for the isolation of minimal antigen-
binding fragments with favourable characteristics.  
 
This chapter mainly delas with the preparation of various Neisseria meningitidis cell 
surface antigens and generation respective monoclonal and polyclonal antibodies. 
These reagents were utilized for designing a model immuassay for N. meningitidis.  
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2.3. Materials and Methods 
All chemicals used were of analytical grade laboratory reagents. All solutions were 
prepared with deionised water obtained from a Millipore Milli-Q water system 
excluding media, which was prepared with distilled water (dH2O). All glassware 
was washed with Proneg detergent (Diversey-Lever, Pty. Ltd., Australia), rinsed in 
tap water and then in deionised water.  
 
Finnpipette pipetters (Thermo Labsystems) were used for dispensing all solutions. 
Volumes of 1.5 mL or less were centrifuged with the Eppendorf microcentrifuge 
5415C. Larger volumes upto 50 mL were centrifuged in the Beckman J2-21 M/E 
centrifuge. For high-speed centrifugation, Beckman Allgra 21R and Beckman J2-21 
M/E Super model centrifuges, both from Beckman Coulter, USA were used. 
Sartorius analytical top-loading balance was used for weighing the reagents.  
 
Materials 
Neisseria meningitides, Escherichia coli and other bacteria were obtained from RMIT 
microorganisms stock. E. coli TG1 bacteria were obtained from Stratagene, USA. 
Luria-Bertani (LB) media, 2 YT (Yeast extract-tryptone) media, 
ampicillin/glucose/yeast extract-tryptone (Amp/glc/YT) plates were prepared 
according to the standard microbiology protocols. Nickel-nitrilotriacetic acid (Ni-
NTA) sepharose resin, protein A sepharose and protein G Sepharose Fast Flow resin 
were obtained from Amersham Biosciences Ltd. UK. Sodium dodecyl sulphate (SDS) 
and dithiothreitol were purchased from Bio-Rad, USA. Also, 0.22 µm and 0.45 µm 
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pore size polypropylene membrane filters and Centricon 4.0 mL 30 kDa cut-off 
concentrators were purchased from Millipore, USA.  
 
Isopropyl β-D-1-thiogalactopyranoside (IPTG), phenylmethanesulphonylfluoride 
(PMSF), sulfosuccinimidyl 4-N-maleimidomethyl cyclohexane-1-carboxylate 
(SMCC), polyethylene glycol 8000, triton X 100, tween-20, DNAse, RNAse, reduced 
glutathione, oxidised glutathione, glycerol, lysozyme, tricine, thimerosal, proteinase 
K, cyanuric chloride, phenolphthalein indicator, poly-L-lysine (type VIII; mol. Wt. 
30,000-70,000), ampicillin, kanamycin, chloramphenicol, Freund’s 
complete/incomplete adjuvant, Keyhole limpet haemocyanin, urea, p-cresol, p-
thiocresol and triethylamine were purchased from Sigma-Aldrich Ltd., USA. Anti-
rabbit, anti-mice and anti-sheep IgG-HRP (horsh raddish peroxidase) antibodies was 
obtained from Millipore, USA, where as HRP substrate, BD OPTia TMB substrate 
reagent was purchased from BD Biosciences, USA. India ink stain was purchased 
from Pro Art, USA. 
 
The resin used for the synthesis of the peptides was 4-methylbenzylhydrylamine (p-
mBHA), with a substitution level of 0. 89 meq/g and was obtained from Peptide 
Institute Inc, Osaka, Japan. All the amino acids used were Boc protected with benzyl-
based side chain protection. The aspartic acid (Boc-Butyloxycarbonyl- L- Aspartic 
Acid b- Benzyl Ester), arginine (Nα- Boc- Ng- Tosyl- L- Arginine), glutamic acid (Boc- 
L- Glutamic Acid g- Benzyl Ester) and cysteine (t- Boc- S- Benzyl- L- Cysteine) were 
obtained from Peptide Institute Inc, Osaka, Japan. The histidine (Boc-L-His (Dnp)-
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OH.isopropanol) was obtained from Auspep, Melbourne. All other amino acids used 
were obtained from Bachem Inc, California. 
 
Solvents including N,N-dimethyl formamide (DMF), trifluoroacetic acid (TFA), 
ninhydrin reagent, O-benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate (HBTU), N-hydroxybenzotriazole (HOBT) and (N, N-
diisopropylethylamine (DIEA), which were peptide synthesis grade, were obtained 
together with HBTU from Auspep. Hydrogen fluoride (HF) was obtained from 
Matheson Gases, USA. HPLC grade dicholoromethane (DCM) and far UV grade 
acetonitrile (ACN), were obtained from Mallickrodt. Other reagents were analytical 
grade unless otherwise stated. 
 
Equipment: 
HF manifold reaction vessel    Peptide Institute Inc, Japan 
Heto cold trap      Thermo Electron Corporation, 
        USA  
Javac DDL 300 vacuum pump     Javac, Australia  
Perkin Elmer Series 200 HPLC pump    PerkinElmer, USA 
C18 column 4.6x30 mm      Applied Biosystems, USA  
785A Programmable Absorbance Detector  
with a PE Nelson 900 Series Interface   Applied Biosystems, USA  
Voyager-DE RP mass spectrometer    Applied Biosystems, USA 
Ultrasonicator      Branson Sonic Power Co., USA 
Rotary shaker      Ratek, Australia  
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Analytical Balance      Sartorius, Germany 
Bio-Rad Model 680XR Microplate reader  Bio-Rad Laboratories, USA 
Eppendorf 5414C bench top centrifuge   Eppendorf, Germany 
Beckman Allegra 21R centrifuge    Beckman Coulter, USA 
Beckman J2-21 M/E Super centrifuge   Beckman Coulter, USA 
Electrophoresis PowerPac 300    Bio-Rad Laboratories, USA 
Bio-Rad mini-PROTEAN III system    Bio-Rad Laboratories, USA 
Bio-Rad PROTEAN II xi cell apparatus    Bio-Rad Laboratories, USA 
Electro elution chamber      Bio-Rad Laboratories, USA 
Western blot module     Bio-Rad Laboratories, USA 
Hitachi U2000 UV-visible absorption spectrophotometer    
        Hitachi Ltd., Japan 
PhilipsEM400 Transmission electron microscopy Philips, Netherlands 
 
 
 
2.3.1. Expression and purification of the recombinant OMP85 antigen 
in E. Coli 
 
Recombinant OMP85 was expressed and extracted from E. coli, and purified by Ni-
NTA chromatography and sonic extraction (Takahashi, Sandberg et al. 1997; Qiagen 
2000).  
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Figure 2.9. Map of pRSNMO85-2 
 
 
2.3.1A. Recombinant OMP 85 protein expression 
A single colony of E. coli cells containing pRSNMO87 plasmid with omp85 gene and 
hexa histidine tag gene inserts (Figure 2.9.) was inoculated in 10 mL LB medium 
containing 100 µg/mL ampicillin in a 50 mL flask. Cultures were grown overnight at 
37°C with shaking. 200 mL of pre-warmed media (with antibiotics) was inoculated 
with 10.0 mL of the overnight cultures and incubated at 37°C, with vigorous shaking 
(300 rpm). Incubation was continued until the OD at 600nm reached 0.5-0.7 
(approximately 4 hours). To induce protein expression, IPTG to a final concentration 
of 1 mM was added. Cultures were grown for an additional 4 hours at 37°C. Then the 
cells were harvested by centrifuging at 5,000 x g for 15 min and the pellet was 
weighed. The cell pellet was stored at -20°C overnight. 
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2.3.1B. Protein Extraction and purification 
Cell pellet was subjected to freeze/thaw cycles 4 times to improve the lysis 
efficiency. Then the cell pellet was resuspended in 10 mL of chilled lysis buffer (20 
mM Tris-HCl pH 8.0 containing 200 mM NaCl, 5mM DTT, 5% (v/v) Glycerol, 
0.35mg/mL lysozyme and 1% (w/v) Triton X-100). 1mM PMSF was added just 
before experiment.  
 
The cell lysis suspension was incubated for 15 minutes at room temperature, with 
gentle shaking. It was then subjected to ultrasonication at 250 W with 6X10s with 
intervals of 30 sec for cooling. The suspension was then cooled on ice for 10 minutes 
Then, 5 µl of 1M MgCl2 and 1 µl DNase solution (1 mg/mL) per mL of the lysate was 
added and incubated for 30 min at room temperature. 
 
The cell debris was removed by centrifugation at 30,000 xg for 25 minutes at 4 °C. 
The supernatant fluid was removed and then 5 µl of 2x SDS-PAGE sample buffer 
was added to 20 µl supernatant and stored at –20°C for SDS-PAGE analysis. The 
pellet was retained and thoroughly washed twice by spinning at 30 000 xg for 30min 
at 4°C with TBS or PBS containing 1% triton X 100. 
 
The pellet was then solubilized in 2 mL of solubilisation/extraction buffer (50 mM 
Tris-HCl pH 7.5 containing 8 M urea, 1 mM DTT, 2 mM reduced glutathione, 0.2 mM 
oxidised glutathione, 1 mM PMSF) by incubating for 1h at room temperature. Once 
the pellet was dissolved, an equal amount of sterile deionised water was added, and 
mixed gently by vortexing.  
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Insoluble material that may clog the Ni-NTA column (45-165 µm) was removed by 
centrifugation at 100,000g for 30 minutes. Then the protein sample was filtered 
through a 0.45 µm filter). The protein concentration was determined by Bradford 
assay and adjusted to 1mg/mL using solubilisation buffer. It was followed by Ni-
NTA column (45-165 µm) purification. Alternatively, the supernatant was stored at 
4°C overnight. 
 
2.3.1C. Ni-NTA Chromatography 
Extracted recombinant OMP85 protein was loaded on to a Ni-NTA column for 
purification. After a number of trials, protein elution conditions were optimised to 
achieve a >70% reasonable purity. Aliquots (1.0 mL) were collected and the aliquots 
containing the desired His-tagged protein were determined by using Bradford assay 
(Bradford 1976).  
 
For analysis of the protein profile, 5.0 µl of SDS-PAGE sample buffer was added to 20 
µl of purified OMP85 protein and heated for 10 min at 95°C, followed by loading of 
the protein samples onto an 8% SDS-PAGE gel (0.75 mm and 1.0 mm thick gels).  
Electrophoresis was performed using Bio-Rad mini-PROTEAN III electrophoresis 
system at 80/120 V for 3 hours. It was followed by Coomassie blue staining to check 
the purity of the protein of interest. 
 
2.3.2. Extraction of protein bands from polyacrylamide gels 
As the protein purified by Ni-NTA column chromatography was not pure, two 
different approaches (1) sonic gel extraction and (2) electro elution were used to 
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further increase the purity the OMP 85 protein. A slightly modified sonic extraction 
method was followed (Takahashi, Sandberg et al. 1997).  
 
2.3.2.1. Identifying and excising the band of interest 
Maxi-gels (16 x 16 cm) were made and run using Bio-Rad PROTEAN II xi cell 
apparatus to maximise the yield of pure protein. After gel electrophoresis (at 120 V 
overnight with central cooling core's recirculation ports connected to a refrigerated 
water bath), a strip containing the protein band was excised from the gel using a 
scalpel. The cut strip of gel was stained using Coomassie Blue R-250 to identify the 
portion of the protein band.  
 
The stained gel strip was aligned with the unstained gel portion and the band of gel 
just above and below the region presumed to contain the protein of interest was also 
excised and processed. The remaining portion of the gel after excising the protein 
band was stained with Coomassie blue staining to determine the accuracy of 
excision. Then the protein of interest was eluted from the gel matrix either by sonic 
extraction or electro elution methods. 
 
2.3.2.2. Elution of the protein from the gel matrix 
 
2.3.2.2A. Passive elution of proteins by sonic extraction 
The excised gel pieces were placed in a clean screw-cap culture or microcentrifuge 
tube and washed three times for 5 mins with 2.0 mL of 250 mM Tris buffer 
containing 250 mM EDTA, pH 7.4, followed by three washes for 5 minutes each with 
distilled water. 
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After removing the distilled water with a pasteur pipette, elution buffer (50 mM Tris-
HCl, 150 mM NaCl and 0.1 mM EDTA; pH 7.5) containing 0.1% (v/v) SDS was 
added, so that the gel pieces were completely immersed (approx. 2:1 ratio of buffer 
and gel pieces) .  
 
The sample was then kept in an ice bath and sonicated for 3 min (6 passes of 30 secs) 
with a 3.0 mm probe sonicator (high-intensity ultrasonic processor, 50-W model). It 
was followed by mixing of the sample overnight, on a rotary shaker at room 
temperature. 
 
The extract was centrifuged at 7,500 Xg for 10 minutes and the supernatant fluid was 
pipetted into a new microcentrifuge tube. An aliquot of the supernatant was tested 
for the presence of protein by SDS-PAGE (Tris buffer with or without SDS) and for 
quantitation. Finally, the purified protein samples were stored at -20 °C.  
 
2.3.2.2B. Electro elution of proteins from polyacrylamide gel pieces 
In this technique, protein containing gel pieces were placed in an electro elution 
chamber (Bio-Rad), where the proteins were eluted from the gel matrix into a buffer 
solution using an electrical field and captured against a dialysis membrane with a 12 
kDa molecular weight cut off. 
 
2.3.3. Rabbit anti-OMP85 polyclonal antibodies 
To assess the immunogenicity of the purified OMP85 antigen, polyclonal antibodies 
were raised in rabbit. Antigen was injected at regular intervals (Table 1) and 
antibody titre was estimated using ELISA method. 
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The Rabbit antiserum was produced as follows. Two New Zealand white rabbits 
were injected with four doses of antigen at 2 week intervals subcutaneously with 
purified OMP85 antigen (100 µg/0.35 mL), emulsified with an equal volume of 
Freund’s complete adjuvant for the initial dose and with Freund’s incomplete 
adjuvant for the booster doses. At the end of week 12, terminal bleeds were 
performed on the rabbits (Table 2.1.). Antiserum was separated from the collected 
blood by centrifugation at 2000 x g for 20 min and stored at -20 °C. 
 
Standard Protocol  
Prebleed Week 0 
Primary Inoculation Week 0 
1st Booster Week 3 
2nd Booster Week 6 
Test Bleed Week 7.5 
3rd Booster Week 9 
Bleed out  Week 12 
    
Table 2.1. Rabbit immunisation schedule for raising polyclonal antibodies 
 
 
2.3.4. Western blot analysis of anti-OMP85 polyclonal antibodies 
The immunogenic specificity of the rabbit anti-OMP85 antibodies against both crude 
and purified OMP85 antigen were assessed by the western blot analysis. SDS-PAGE 
gel electrophoresis was performed with purified OMP85 antigen and then 
transferred onto a nitrocellulose membrane. The membranes were blocked overnight 
in phosphate-buffered saline (PBS, pH 7.6), 1% (w/v) non-fat dried milk, 0.01% (v/v) 
Tween-20-PBS. It was followed by incubation for 1 hour with primary antibodies 
against OMP85 antigen in blocking buffer. The antibody was removed and the 
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membrane was washed three times with 0.01% (v/v) Tween PBS. The membrane was 
probed by incubating with anti-Rabbit IgG-HRP (horsh raddish peroxidase) 
antibodies (1 in 5,000) in blocking buffer, for one hour. Finally, the blot was 
developed using HRP substrate reagent (BD Biosciences, USA). 
 
2.3.5. Synthesis of SR1 peptide specific to N. meningitidis type B 
 
 
2.3.5A. Resin preparation 
The peptides were synthesised at a 0.5 m mol scale. Approximately 0.5 mmol of the 
p-mBHA-HCl resin with a substitution level of 0. 89 meq/g, was weighed out and 
placed in the reaction vessel. The resin was prepared by flow washing with DMF for 
20 seconds. It was neutralised with 1 mL DIEA for 1 minute and flow washed again 
with DMF. The neutralisation and the resin flow wash steps were repeated. 
 
2.3.5B. Synthetic cycles 
The 2 mmol of the Boc-protected amino acid derivatives were weighed out into clean, 
glass scintillation vials. It was activated using 4 mL of 0.5 M HBTU dissolved in DMF 
or, in the case of R, N or Q, 4 mL of 0.5M HBTU and 4 mL of 0.5M HOBT dissolved in 
DMF. Immediately after addition of the activation agent(s), 470 µL of DIEA was 
added for in situ neutralisation.  
 
The activated amino acid was added to the resin and allowed to couple by mixing for 
10-15 minutes. After coupling, ninhydrin analysis was performed to calculate the 
coupling effeciency. Where the coupling percentage was below 99.0%, a double 
coupling was done, in which a second 2 mmol aliquot of the same protected amino 
acid was activated, neutralised and coupled. After double coupling, a ninhydrin 
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analysis was repeated. The solution was then drained and flow-washed with DMF 
for 30 sec prior to starting a new synthesis cycle.  
 
While the amino acid was activated, the previous amino acid on resin was 
deprotected by mixing with 10 mL of anhydrous TFA for 1 minute. The TFA was 
drained and the deprotection step was repeated for a further minute. After removal 
of TFA, the reaction vessel was filled with DMF and drained. The resin was 
vigorously flow washed with DMF for 30 seconds after which the activated amino 
acid was added for next coupling. 
 
The cycle of deprotection, activation, neutralisation and coupling were followed for 
each amino acid that was added (GKTYDDNSSSATGGRVQNIYGAGNTH). Double 
couplings were carried out when required. 
 
2.3.5C. Ninhydrin Analysis 
Approximately 5 mg of resin was removed at the end of each coupling to calculate 
the coupling percentage according to the procedure described by Sarin et al.. (Sarin, 
Kent et al. 1981). The resin was washed three times with 50:50 DCM : Methanol 
mixture and then dried under vacuum. The dried resin was placed in a culture tube 
and weighed. 2 drops of phenol solution, 4 drops of 20 mM KCN solution and 2 
drops of ninhydrin solution were added to the resin prior to heating at 100 °C for 5 
minutes together with a reagent blank tube.  
 
After 5 minutes, the tubes were removed from the heating block and 3 mL of 60% 
ethanol was added. After the resin was allowed to settle at the bottom of the tube, the 
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absorbance of the solution was measured against the blank at 570 nm. The weight of 
the resin and absorbance of the solution were entered into Pepmate (Fecondo, 
unpublished) to determine the coupling percentage.  
 
2.3.5D. Deprotection prior to HF cleavage 
Approximately 360 mg of the resin-peptide was weighed out to be deprotected and 
cleaved. The protecting group on the side chain of Histidine, 2,4-Dinitrophenol 
(DNP), was removed using 10mL of 20% (v/v) 2-mercaptoethanol : 10% (v/v) DIEA 
in DMF, which was mixed for 30 minutes. This was repeated three times until the 
solution was clear. The resin was then washed with DMF. 
 
The N α-terminal Boc protecting group was removed by the addition of 10 mL 
anhydrous TFA and mixed for 1 minute. The resin was then flow washed with DCM 
for 30 seconds, followed by a second 10 mL anhydrous TFA deprotection step for 1 
minute. Following a further 30 sec flow wash with DMF, the resin was neutralised 
with approximately 10 mL of 10% (v/v) DIEA in DCM for 1 minute, followed by 1 
minute DCM flow wash. The resin was dried under vacuum. 
 
2.3.5E. Hydrogen Fluoride cleavage of the peptide-resin 
Aliquots (0.5 mL) of the scavengers’ p-cresol and p-thiocresol were melted and added 
to the dried peptide-resin in the small reaction vessels of the HF manifold (Peptide 
Institute Inc) reaction vessel. Vacuum pressure was maintained in the apparatus at -
330 mm Hg and about 25 mL of anhydrous HF was released from the cylinder and 
condensed into the reservoir using liquid nitrogen. Water heated to about 50 oC was 
used to evaporate the HF collected, which was allowed to condense into the reaction 
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vessels. The peptide was completely deprotected and cleaved from the resin by 
reacting with anhydrous HF, for 1 hour at 0 oC under vacuum. HF was then removed 
by aspiration. 
 
2.3.5F. Extraction of the cleaved peptide 
The peptide-resin mixture was washed twice with 40 mL of anhydrous ethyl ether to 
remove the scavengers and all traces of HF. The peptide was extracted with a 
minimal volume of 10-20% acetic acid (Sigma) and collected into round-bottomed 
flasks under vacuum. The peptide was lyophilised overnight with a Heto cold trap 
fitted with a Javac DDL 300 vacuum pump (Javac, Australia). The freeze-dried 
peptides were stored at –20oC. 
 
2.3.6. Analysis of peptides 
 
2.3.6A. High Performance Liquid Chromatography (HPLC) 
Approximately 100 µg of the SR1 peptide was dissolved in 0.5 ml of 0.1% TFA in 
Milli Q water. A Perkin Elmer Series 200 HPLC pump was used with a C18 column 
4.6x30 mm (Brownlee Labs, Applied Biosystems, USA) and 20 µl of the peptide 
solution was injected.  
 
The mobile phase gradient used was 0-60% ACN / 0.1% TFA over 30 minutes with a 
flow rate of 1 mL/minutes The absorbance was monitored at 214 nm using an 
Applied Biosystems 785A Programmable Absorbance Detector. The data was 
acquired using Turbochrom software (Perkin Elmer) with a PE Nelson 900 Series 
Interface.  
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2.3.6B. Mass spectrometry 
MALDI-TOF was performed in reflector mode using a Voyager-DE RP mass 
spectrometer with a horizontal tube of 2 m in length. The matrix used was α-cyano-4-
hydroxycinnamic acid (10 mg/mL in 60% ACN / 0.3% TFA). Samples were 
irradiated at 337 nm with 2 nsec pulses from a nitrogen laser at a frequency of 20 Hz. 
The resultant ions were then accelerated to 20 kV, recorded at a digitisation rate of 
500 MHz and reflected to a dual micro channel plate detector. The signal from a 
minimum of 200 shots was then summed to achieve the reported intensities. The data 
was examined on Data Explorer 4.0 software. 
 
2.3.7. Keyhole limpet haemocyanin (KLH) – SR1 peptide conjugation 
To assess the immunogenic specificity of the SR1 peptide, polyclonal antibodies were 
raised in sheep. The SR1 peptide was conjugated to keyhole limpet haemocyanin 
(KLH) prior to immunisation given the relatively low molecular weight of the 
peptide. 
 
2.3.7A. Column Pre-swelling and Equilibration 
Approximately 300mg of Sephadex G10 gel filtration media was weighed out into a 
small eppendorf tube and added an excess of 2M Gu.HCl in PBS, pH 7.4 for pre-
swelling.  It was allowed to equilibrate with three buffer changes. 
 
2.3.7B. KLH/SMCC Preparation 
While allowing time for the column media to equilibrate in the eppendorf tube, the 
entire contents of 1 vial of KLH (20mg) was reconstituted in 2mL of milliQ H2O to 
obtain a 10 mg/mL solution. An aliquot (600 µL) of this mixture was transferred into 
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an eppendorf tube. In another eppendorf tube, 0.8mg of SMCC was weighed out and 
dissolved in 30µL of DMF solvent. Then 400 µL of PBS, pH 7.3 was added to this 
eppendorf tube and mixed thoroughly. Later, 600mL aliquot of KLH was added to 
the eppendorf tube containing the SMCC cross linker and mixed gently for 30 min at 
room temperature.  
 
2.3.7C. Peptide Preparation 
Approximately 12 mg of peptide was dissolved in 300 µl of 2 M Gu. HCl in PBS, pH 
3-4 solution. Once the crude peptide material was dissolved, an equimolar amount of 
solid dithiothreitol (7-7.5 mg of DTT) was added and mixed gently until solubilised 
and allowed to stand for 10 minutes. 
 
2.3.7D. Column arrangement 
The top of Bio-rad mini prep column was cut so that the column could fit into a 15mL 
centrifuge tube and filled with pre-swelled 300mg of Sephadex G10 gel filtration 
media. 
 
An empty eppendorf tube was wedged (with lid removed and hole pierced on the 
side) to the tip of the column and placed this apparatus in a 15mL centrifuge tube. 
Then the column was spun in a centrifuge at 1000 x g for 2 min in order to remove 
excess buffer. 
 
2.3.7E. Peptide Conjugation to KLH/SMCC Carrier Complex  
Once excess buffer had been removed, the wedged eppendorf tube at the tip of the 
column was replaced with the eppendorf tube containing the KLH/SMCC mixture. 
A one step gel filtration and coupling was performed by placing the KLH-SMCC 
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solution to a receiving bottom tube with the peptide solution applied to G-10 
centrifuge column (i.e. spin column). The entire column setup was placed in a 15mL 
centrifuge tube and spun at 4000xg for 3min to allow for the peptide to elute from the 
column into the receiving bottom tube. 
 
The spin column was rinsed twice with 300 µl 2M PBS-Gu.HCl (pH 3.5) and 
centrifuged for 3 minutes at 4000 x g in order to recover as much of the peptide as 
possible. The peptide-KLH conjugate mixture was transferred the entire contents into 
another sealable eppendorf tube. The pH of the contents was adjusted to 7.5 with 2 M 
NaOH. The conjugate sample was allowed to mix i.e. end over end mixing for 3 
hours at room temperature for complete conjugation. Finally 30 µL of 1% Thimerosal 
in PBS was added to the conjugate sample and stored at 4 °C until required. 
 
2.3.8. Sheep anti-SR1 and anti-NM serotype B polyclonal antibodies 
SR1 peptide conjugated with Keyhole Limpet Haemocyanine (KLH) was used to 
raise the sheep polyclonal antibodies (Institute of Medical and Veterinary Science 
(IMVS), Australia). Antibodies were also raised in sheep against the formaldehyde 
treated whole cell N. meningitidis bacteria.  A standard immunisation protocol was 
followed, antigens were injected at regular intervals and antibody titre was estimated 
as described in table 2.2. 
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Antigen ID Amount 
mg/dose/animal 
Details  Number of 
animals 
Species 
SR-1 Peptide 2.5 mg (in 0.5 mL KLH-
peptide solution) / dose mixed 
this dose with 0.5 mL CFA/IFA 
KLH conjugated Peptide (2.8kD) via 
SMCC, in PBS 
 1 Sheep 
NM-B 
 
109 cells / 0.5 mL of PBS 
mix this dose with 0.5 mL 
CFA/IFA 
Neisseria meningitidis Serogroup 
B Inactivated by treatment with 
2% Formaldehyde , in PBS at 2 
x109 cfu/mL 
 1 Sheep 
 
Table 2.2. Sheep immunisation details for raising polyclonal antibodies against the 
SR1 peptide and N. meningitidis bacteria. 
  
2.3.9. Preparation of capsular polysaccharide (CPS) from Neisseria 
meningitidis serotype B 
The following steps were followed in the preparation of the capsular polysaccharide 
from Neisseria meningitidis bacteria. A bacterial culture grown overnight was chilled 
rapidly on ice. The cells were harvested by centrifugation at 13,600 x g for 15 minutes 
and the pellet was washed 3 times with sterile ice cold saline (pH 7.2).  
 
The supernatant liquid containing the released soft fibrillar capsular material was 
collected and stored on ice. The bacterial pellet was then suspended in 0.01% (w/v) 
SDS in PBS at room temperature until the capsule was released as monitored by 
India ink staining. Bacteria were then pelleted by centrifugation at 13,600 x g for 15 
minutes at 4°C. The supernatant was collected and mixed with the initial supernatant 
collected. The whole supernatant mixture was then filtered through a 0.22 µm pore 
size membrane filter and kept on ice. 
 
The bacterial pellet from the above separation was resuspended in 500 µl of lysis 
buffer containing 31.25 mM Tris-HCl (pH 6.8), 4% (w/v) SDS, 20% (v/v) glycerol. 
Samples were then heated at 100 °C for 5 minutes. The cell debris along with the 
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remaining capsular material was pelleted by centrifugation at 13, 600 x g for 30 
minutes at 4°C. 
 
Proteinase K (15 units/mL) was then added to the filtered capsular material and 
incubated at 56 °C for 1 hour, followed by addition of 2 volumes of ice cold ethanol 
to precipitate the carbohydrates. The precipitated capsular material was 
subsequently washed with a mixture of cold ethanol-saline (3:1). The purified 
capsule was solubilised in sterile distilled water and NaCl was added to a final 
concentration of 0.9 % (w/v). Finally, the capsule was treated with DNase and RNase 
(10 µg/mL) for 2 hours at 37 °C, and the absorbance was measured at 260 and 280 
nm. The polysaccharide capsule was then lyophilised and resuspended in Tris buffer 
(0.01M Tris-HCl, pH 7.5). This solution was lyophilised again and stored at -20 0C 
until required. 
 
 
2.3.10. Analysis of the purity of N. meningitidis type B specific 
capsular polysaccharide 
 
2.3.10A. Gels 
The purity of the capsular polysaccharide preparation was visualised by loading 
onto a Tricine SDS-PAGE gel.  A sample of the polysaccharide preparation was 
dissolved in 2 ml of sample buffer (0.125 M Tris base, 10% (v/v) glycerol, pH 6.8), 
loaded onto the gel. A running buffer containing 0.1 M Tris, 0.1 M tricine, 0.1% (w/v) 
SDS, pH 8.25 was used and run at a constant voltage of 120 V. Siver staining was 
performed to visualise the capsule. 
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2.3.10B. High Performance Liquid Chromatography (HPLC) 
Approximately 100 µg of the polysaccharide capsule was dissolved in 200 µl milli Q 
water. A Perkin Elmer Series 200 HPLC pump was used with a C8 column 4.6x30 mm 
(Applied Biosystems) and 20 µl of the capsule solution was injected.  
 
Analysis was performed using the elution conditions, 0-60% ACN / 0.1% (v/v) TFA 
over 30 minutes with a flow rate of 1 mL/minutes The absorbance was read at 214 
nm using an Applied Biosystems 785A Programmable Absorbance Detector. The 
data was acquired using Turbochrom software (Perkin Elmer) with a PE Nelson 900 
Series Interface.  
 
 
2.3.11. Anti-NM serotype B capsular monoclonal antibodies 
Anti-NM serogroup B Capsular monoclonal antibodies were purchased from 
National Institute for Biological Standards and Control (NIBSC), UK. These 
antibodies were tested for the specificity and titre against the whole cell bacteria and 
the purified capsular preparation by ELISA method. 
 
2.3.12. BLAST search to identify related organisms-cross reactivity 
A BLAST search of OMP 85 protein antigen sequence using NCBI/ BLAST/ blastp 
program (protein-protein BLAST) against 5,815,196 sequences, produced a broad list 
of different Gram negative bacteria with varying similarity (Table 2.3.). From the list, 
the bacteria which are more likely to be associated with human infections were short 
listed. Out of that list, 21 bacteria were available from the RMIT microbiology stocks 
(Table 2.3.). Cross reactivity experiment was done with the panel of antibodies 
against the 21 bacteria. 
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     Sequence  Percentage  
     Identities  of identity 
 Neisseria meningitidis   797/797  100% 
 Neisseria meningitidis MC58   795/797                  99% 
 Neisseria gonorrhoeae   758/797   95% 
 Chromobacterium violaceum ATCC 12472  404/800    50% 
 Bordetella pertussis    285/783  36% 
 Acinetobacter sp.     283/816   34% 
 Escherichia coli    273/830   33% 
 Pseudomonas fluorescens    263/790  33% 
 Pseudomonas aeruginosa    266/799  33% 
 Salmonella Paratyphi    276/824   33% 
 Salmonella Typhi    276/824   33% 
 Vibrio alginolyticus     275/826   33% 
 Vibrio vulnificus     273/817   33% 
 Shigella dysenteriae     273/830   32% 
 Vibrio cholerae    265/817   32% 
 Vibrio parahaemolyticus    265/817   32% 
 Vibrio sp.      267/817   32% 
 Haemophilus influenzae   261/823   31% 
 Legionella pneumophila    244/783   31% 
 Pasteurella multocida    257/813   31% 
 Brucella abortus    217/821   26% 
 
Table 2.3. List of Bacteria used for cros reactivity study against the panel of prepared 
antibodies. The sequence identities varied from 26% to 100%. 
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2.3.13. Purification of polyclonal antibodies 
 
 
2.3.13.A. Protein A sepharose antibody purification procedure 
A five mL column was packed with 1.0 mL of Protein A (Protein G in case of sheep 
antibodies) Sepharose Fast Flow (Amersham Biosciences) resin. The column was 
washed 10 column volumes with PBS (binding buffer). An aliquot of anti-serum (1.0 
mL) obtained from rabbits was filtered using syringe through a 0.45 µm filter and 
centrifuged for 5 minutes at 5000 x g. Then the serum was diluted into 5.0 mL PBS 
and this was then filtered through a 0.45 µ filter. 
 
The diluted anti-serum was loaded onto the column and the flow through was 
collected. Unbound protein was washed out with 10 column volumes of PBS or until 
the UV absorption at 280 nm measured reached to near zero. After a flat base line 
was achieved with binding buffer, antibodies were eluted with 0.1 M glycine pH 3.0 
(elution buffer). Eluted antibody was collected in 500 µl aliquots into 1.0 mL 
eppendorf tubes containing 500 µL of 1.0M Tris-HCl, pH 7.0, to neutralise the acidic 
elution buffer. All fractions were mixed and kept on ice. The fractions were pooled 
and concentrated into 0.1 M PBS, pH 7.4, using a Millipore Centricon 4.0 mL 30 kDa 
cut-off concentrator according to the manufacturer’s instructions. Then, UV 
absorption of each aliquot at 280 nm was measured and the IgG concentration was 
determined using an absorptivity constant of 1.4 mg-1. mL. cm-1. 
 
The Protein A sepharose was regenerated by washing with additional 3-4 column 
volumes of elution buffer followed by re-equilibration with 3-4 column volumes of 
PBS. 
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2.3.13.B. Protein G sepharose antibody purification procedure-Isolation of 
sheep antibody 
Polyclonal antibody was purified from sheep serum using Protein G sepharose beads 
(Amersham Biosciences, USA). The pH of the 500µl fractions eluted using 0.1M 
Glycine (pH 3.0) was raised to 7.4 by mixing each of the fractions with 500µl of 1.0 M 
Tris-HCl buffer (pH 7.4). All 1.0 mL fractions were pooled together and the protein 
quantity was estimated. 
 
2.3.14. Monospecificity of anti-SR1 antibodies 
The protein G purified sheep anti-SR1 antibody was further purified by affinity 
purification and then tested for cross reactivity against the previously tested panel of 
bacteria by ELISA method. 
 
 
2.3.15. ELISA analysis of bacterial polysaccharide antigens 
ELISA with the purified capsule was performed according to the published 
procedure (Gray 1979). Three glass vails containing, 0.5 mL of 0.01N NaOH with 
0.001% phenolphthalein indicator, 0.5 mg of Cyanuric chloride crystals and 0.1 mL of 
0.1% poly-L-lysine (type VIII; mol. Wt. 30,000-70,000) were taken. Alkalinisation of 
polysaccharide antigen was done by adding 0.1mL of capsule antigen (1.0 mg/mL) 
in distilled water, to the tube containing 0.5 mL of 0.01N NaOH with 0.001% 
phenolphthalein indicator and mixed for 10 sec (solution was pink at this stage). 
 
The contents of the above vial were pipetted into the vail containg 0.5 mg of cyanuric 
chloride crystals and mixed for approximately 10 sec, and the solution became 
colourless as the pH dropped to 8.0 – 8.2 (mixed gently as the vigorous mixing could 
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release more HCl into solution and pH might drop below 8.0). Then to couple the the 
polysaccharide antigen to poly-L-lysine, the entire solution was transferred into a 
vial containing 0.1 mL of 0.1% poly-L-lysine (type VIII; mol. Wt. 30,000-70,000), 
mixed and refrigerated at 4 °C for 2 hrs. 
 
The protein coujugated polysaccharide antigen was then diluted in 0.01M PBS pH 7.4 
to approximately 1.0 µg/mL and coated the ELISA wells overnight. Then, the normal 
ELISA procedure was followed. 
 
2.3.16. IgNAR’s as novel receptors- protocol for phage rescue and 
panning 
Selection from IgNAR library resulted in the isolation of clones highly specific for a 
range of antigens, binding with nanomolar affinity and showing great resistance to 
irreversible thermal denaturation.  In this project, OMP85 protein (0.156 mg/mL of 
purified OMP85), SR1 paptide (0.05 mg/mL crude peptide) and 10.0 µg/mL capsular 
polysaccharide antigens were screened against the IgNAR library to identify suitable 
IgNAR receptor molecules and to characterise them in terms of binding specificity 
and affinity for their cognate antigen. 
 
 
DAY 1  
2.3.16.1. Phage rescue from library glycerol stock 
All 2 YT media was prewarmed to 37 °C. Each 1mL of library stock (~109 cells), was 
inoculated into 20mL of prewarmed 2YT in a small flask, followed by incubation 
with shaking at 37°C for 30 minutes Then, another 20mL of 2YT/Amp100 (to a final 
conc. of Ampicillin 50 µg/mL) was added and incubated with shaking at 37°C for 1 
hour.  
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It was then transferred to a 500mL baffled flask, and added another 40mL of 
2YT/Amp 100 and incubated with shaking at 37 °C for 45 minutes. It was followed 
by further incubated at 37 °C for 15 min without shaking to allow formation of F pili. 
At this stage, helper phage (MOI phage/E. coli = 20:1) was added and incubated the 
culture for 15 min at 37 °C without shaking. Then, another 90 mL of 2YT/Amp100 
was added and incubated with shaking at 37 °C for 2 hours. Finally, Kanamycin (25 
µg/mL) was added and incubated overnight at 28 °C with shaking. 
 
2.3.16.2. Coating immunotubes 
For each antigen prepared, a pre-absorption of immunotubes was carried out to 
eliminate non-specific high affinity binders present in the library, which may bind to 
either the modified polystyrene surface (Maxisorp) of the immunotube or to the 
blocking reagent. 
 
Approximately 10 µg of each antigen was diluted in appropriate coating buffer (1 x 
PBS, 0.1 M sodium carbonate) and added to individual immunotubes. Pre-absorption 
tubes were coated with 2% (w/v) MPBS solution and incubated the tubes at 4°C 
overnight. 
 
DAY 2  
2.3.16.3. Washing and blocking immunotubes 
Each immunotube was washed 3 times with 1 x PBS. The tubes were filled with 2% 
MPBS, capped and then incubated at RT for 2 h to block. Prior to adding precipitated 
phage, each tube was washed 3 times with 1 x PBS. 
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2.3.16.4. Rescue and Panning 
Overnight cultures were centrifuged at 6500 x g for 10 minutes The supernatant fluid 
(containing phage) was transferred into an ice-cold 250 mL centrifuge bottle and 1/5 
volume of ice cold 20 % (w/v) PEG 8000/15% (w/v) NaCl was added. The phage 
was incubated on ice for 1 h with intermittent shaking. 
 
The cell pellet was resuspended in a small volume of 2YT and prepared 2-3 glycerol 
stocks to recover the library at a later stage if necessary.  Alternatively, the phagemid 
was purified and transformed into competent cells for future use.   
 
The phage was centrifuged in 20 % PEG (w/v) 8000 / 15% (w/v) NaCl at 9500 x g for 
45 minutes. Supernatant was discarded and the bottle was drained upside down on a 
tray lined with a Teri wipe.  Phage was visible on the side of flasks as a white smear. 
Then the phage was resuspended in 3 mL of 1 x PBS and transferred to 1.5 mL tubes. 
It was followed by a centrifugation at 14000 x g for 10 min at 4°C. The phage was 
filtered through a 0.22 µm filter and then stored at 4°C. This phage stock was used 
for polyclonal phage ELISAs after the 3rd - 4th panning rounds.  
 
To titre amplified phage, 990 µL of TG1 cells were infected with 10 µL of precipitated 
phage then incubated at 37 °C without shaking for 15-20 minutes  The infected cells 
were diluted to 10-3, 10-5, 10-7 and 10-9 then 100 µL of each dilution was plated on 
YT/Amp/glucose plates.   
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2.3.16.5. Panning 
Two millilitres of precipitated phage was transferred to each (washed) pre-
absorption immunotube, then added 2.0 mL of 4 % (w/v) MPBS and incubated for 
15-30 min at RT. Following pre-absorption, phage was transferred into immunotubes 
coated with antigen, then incubated for 30 min at room temperature rotating 
continuously, and then stood for at least 90 min at room temperature. The pre-
absorption tubes were discarded. The immunotubes were washed 3 times with 1 x 
PBS/ 0.1% (v/v) Tween-20 and then same number of times with 1 x PBS. For second 
and subsequent panning rounds the number of washes were increased to 4 times. 
 
Excess PBS was drained from immunotubes. The phage was eluted with 1 mL of 
freshly prepared 100 mM triethylamine by rotating continuously for 10 min, then 
neutralised with 0.5 mL Tris-HCl pH 7.4 buffer.  Aliquotes (100 µL) of Tris-HCl 
buffer (pH 7.4) was added to each immunotube and all phage samples were stored at 
4°C for using in next round of panning. An overnight culture of TG1 from a minimal 
media plate was set up for the next round of rescue and panning. 
 
DAY 3. 
2.3.16.6. Phage rescue 
An overnight TG1 culture (1/100) was inoculated into 100 mL of 2YT media and 
grown until mid log phase.  TG1 cells (5.0 mL) along with half of the eluted phage 
from the previous pan were added to a sterile 50 mL tube. 4.0 mL of the TG1 cells 
were added to each immunotube (from the previous panning round). Both were 
incubated at 37°C for 15-20 min without shaking.  
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Both the cultures from the 50 mL tube and the immunotube were pooled into a 0.5 L 
flask. 100 µL from this was taken for titration and plated 100 µL of 10-1, 10-3, 10-5, 10-7 
dilutions on Amp/glc/YT plates and next day, colony count was performed. 
  
Next, 15 mL of 2YT, Amp 40 µg/mL was added into the above flask and incubated 
for 1 h at 37 °C with shaking. It was followed by addition of 30 mL 2YT, Amp 100 
µg/mL into the flask and incubated for 1 h at 37 °C with shaking. Helper phage 
(MOI = 20:1; phage: E. coli) was added, swirled to mix and left in the incubator at 37 
°C for 15 min without shaking. Then, 110 mL of 2YT and Amp to 100 µg/mL was 
added and incubated for 2 h at 30 °C with shaking. Finally, 25 µg/mL of Kanamycin 
was added and incubated overnight at 28°C. 
 
2.3.16.7. Preparation of DNA for cloning 
An overnight TG1 culture was grown and inoculated with a single colony taken from 
a minimal media plate of less than 1 week old. Then, the overnight TG1 culture was 
diluted 1/100 into 50 mL of 2YT and grown until mid log growth phase (A595 OD 0.2-
0.5). This step was followed by incubation at 37 °C for 15-20 min without shaking to 
allow the formation of F pili. The, 10.0 mL TG1 cells were inoculated with 1 mL 
eluted phage in a 0.5 L flask and incubated at 37 °C for 15 - 20 min without shaking. 
100 µL from this for titration was taken: plated 100 µL each of 10-1, 10-3, and 10-5 
dilutions on Amp/glc/YT plates.  Colonies on these titration plates could be used for 
monoclonal phage ELISAs.  
 
Then, 10.0 mL of 2YT with Amp 40 µg/mL (8 µL of 100 mg/mL stock) and glucose 2 
% (w/v) were added and incubated for 1 h at 37°C with shaking. Then, 100 mL of 
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2YT and 100 µg/mL Amp and 2 % (w/v) glucose was added and incubated at 37 °C 
until the end of the day. To prepare glycerol stocks, 20 mL of the culture was 
separated and incubated overnight at 28°C. To the remaining culture, 
chloramphenicol was added to a final concentration of 170 µg/mL and the growth 
continued overnight at 28°C. This latter culture was used for isolation of amplified 
phagemid.   
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2.4. Results 
2.4.1. Purification of recombinant OMP85 protein 
Recombinant OMP85 was expressed and purified to raise anti-OMP85 polyclonal 
antibodies. Overexpression of recombinant hexa-his tagged OMP85 in bulk 
quantities in E. coli, was achieved. It was difficult to purify the protein using Ni-NTA 
column chromatography. Many other proteins were eluted along with the OMP85 
protein. Electro elution as an additional purification step yielded very low quantities 
(70% loss) of the protein. Then, the modified sonic extraction method from maxi gels 
(16 x 16 cm) using Bio-Rad PROTEAN II xi cell apparatus was adopted (Figure 2.10.). 
The protein was purified to apparent homogeneity as indicated by a single band on 
the gel by Coomassie blue R-250 staining with increased yield (Figure 2. 11). 
 
 
 
Figure 2.10. A Coomassie blue R-250 stained maxi-gel image showing the excised OMP85 
protein band.  
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                                                    a               b                c                d                 f 
          
 
Figure 2.11. OMP85 Protein purified by sonic extraction Method. (a). Crude OMP85 
protein (b). OMP85 by Ni-NTA chromatography, (c). OMP85 by electro elution (d). 
OMP85 by sonic gel extraction, and (f) Protein marker.  
 
  
 
2.4.2. Titration of rabbit anti-OMP 85 polyclonal antibodies 
Rabbit polyclonal antibodies were raised against OMP-85 antigen in the RMIT 
animal facility. A standard procedure for polyclonal antibody production was 
followed (Section 2.2.2A.). By serial dilution of serum, between 1/10 and 1/1032, a 
sigmoidal curve was plotted with the absorbance on the y-axis against the related 
titre on the x-axis. The antibody titre for rabbit anti-OMP 85 polyclonal antiserum 
was determined 1 in 10-4 (Figure 2.12. (a)). In ELISA, the anti-OMP85 antiserum 
recognised the N. meningitidis bacteria equally as like sheep anti-NM antisera (Figure 
2.12. (b)).    
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   (a)      (b) 
Figure 2.12. Rabbit anti-OMP85 antisera-Terminal bleed (a). Assay to determine the 
anti-OMP85 antibody titre (b). Comparison between anti-OMP Ab and anti-NM 
antibody against whole cells.  
 
2.4.3. Western blot analysis of anti_OMP85 antibodies   
The rabbit anti-OMP85 antiserum was used to probe western blots containing protein 
extracts of from cell lysates of E. coli DH5a, E. coli DH5a/pOMP85 and the purified 
OMP85 protein (Figure 2.13.). The anti-OMP85 serum reacted with the recombinant 
OMP85 protein produced by E. coli DH5a/pOMP85 as well as with other proteins 
due to the polyclonal specificity. The purified protein was equally reactive with the 
antibodies suggesting that OMP 85 was expressed in its active conformation. These 
results also suggest that OMP85 is a highly conserved protein. Pre-clearing of the 
antiserum with E. coli removed the majority of cross-reactive antibodies, but 
complete removal of all reactive antibodies was not possible. 
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Figure 2.13. Western Blot: Rabbit polyclonal antibodies against crude and purified 
OMP 85 Protein antigen 
 
 
2.4.4. Synthesis of the SR1 peptide specific to N. meningitidis type B 
 
2.4.4.1. Coupling 
The ninhydrin analysis results are shown in Figure 2. 14. The average coupling 
achieved per residue was 99.33%. The overall theoretical yield was calculated to be 
99.34%, which indicates a theoretical yield 719.91 mg of deprotected peptide for each 
gram of dried peptide-resin used.  
 
Given that the sequence was relatively long (29 aa’s), the coupling of a number of 
residues required double or triple couplings to achieve a coupling efficiency of 
>99.5%. Out of the 29 amino acids in the complete sequence (including the gly-gly-
cys spacer sequence), 15 residues required double coupling. However, as can be seen 
in Figure 2.14. , the coupling percentage of a number of amino acid residues did not 
reach the 99.5% coupling. The triple couplings were required for residues 7 (N), 15 
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(R) and 18 (N) which had a final coupling percentages of 97.83, 98.96 and 97.90% 
respectively. Although the first cysteine and the two glycine residues were not part 
of the original sequence, they were added to facilitate binding of the peptide to the 
gold nanoparticles via the thiol group and also to act as a spacer arm.  
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Figure 2.14. Coupling efficiency of the synthesis of the SR1 peptide sequence. 
Ninhydrin analysis data was used to quantify the coupling using the Pepmate 
program (J. Fecondo, unpublished). 
 
2.4.4.2. Peptide-resin yield 
 
Resin used 559.24 mg 
Peptide-resin 2183 mg 
Table 2.4. Peptide-resin yield 
 
Peptide-resin used 359.20 mg 
Peptide extracted 130.14 mg 
Table 2.5. Crude peptide yield from second cleavage 
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2.4.4.3. HPLC analysis 
Figure 2.15. shows the crude peptide chromatogram developed on the analytical 
HPLC system. The highest peak that is eluted at 13 minutes is the expected peptide.  
 
From the chromatogram, it can be seen that there are impurities in the crude peptide. 
But this is expected because of the deletion peptides that are formed due to 
incomplete coupling and also truncated peptides. During extraction of the peptide, 
not all the scavengers and the protecting groups can be removed and these will also 
appear on the chromatogram.  Although HPLC analysis indicates the purity of the 
peptide, mass spectrometry is needed to verify if the desired peptide has been 
synthesised. 
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2.4.4.4. Mass Spectrometry 
Figure 2.16. shows the MALDI-TOF analysis of SR1. One of the highest peaks is 
the most abundant compound the crude peptide and it had a mass, m/z of 2887. 
The calculated monoisotopic mass of SR1 (Peptide Mass Calculator, 
PeptideSynthetics, UK) is 2886.248. A second major peak with an m/z of 2993 
(+106) was also observed. This peptide derivative is most likely due to a 
combination of oxidation and formation of a thiocresyl adduct during HF 
cleavage (ABRF) (Fields, Angeletti et al. 1994). It was reported that, during the 
cleavage and side-chain deprotection of peptide-resins, oxidation and scavenger 
alkylation of the peptide were primary causes of poor quality products and this 
can be minimized by optimizing HF concentration and/or temperature during 
peptide resin cleavage (Feinberg and Merrifield 1975). 
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2.4.5. Characterisation of sheep anti-SR1 and anti-NM 
polyclonal antibodies 
Sheep polyclonal antibodies were raised against SR1 peptide antigen and the 
whole cell N. meningitidis bacteria. Formalin (2% v/v) treated whole cells and 
SR1-peptide-KLH conjugate were injected into sheep to raise antibodies against 
N. meningitidis serogroup B bacteria and SR1 peptide respectively. By serial 
dilution of serum, between 1 in 10 and 1 in 1032, a sigmoidal curve was plotted 
with the absorbance on the y-axis against the related titre on the x-axis. The 
antibody titres for both the anti-SR1 and anti-NM polyclonal antisera were 
turned out to be 1 in 10-4. 
 
Both anti-NM and anti-SR1 polyclonal antisera were tested against SR1 peptide 
and the whole cell bacteria (Figure 2. 17). Anti-NM and anti-SR1 antisera 
recognised their respective antigens at a high titre value (1 in 10-4). Interestingly, 
anti-SR1 antibodies recognised the bacteria (Figure 2. 17. a) more strongly than 
the anti-NM antibodies with SR1 peptide (Figure 2. 17. b). Rabbit anti-OMP85 
antiserum reacted with the SR1 peptide (Figure 2.17. c). Another interesting 
observation is the anti-SR1 and anti-NM antibodies purified by protein G column 
chromatography recognised the whole cell bacteria equa
  122
SR1 coated plates
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
0.00
0.25
0.50
0.75
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
Anti NM on SR1
Anti SR1 on SR1
-Log10[Serum]
Ab
s
o
rb
an
c
e 
@
 
45
0n
m
 
Sera Reactivity to Whole Cells
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
anti-SR1 on NM
anti-NM on NM
-Log10[Serum]
Ab
so
rb
an
ce
 
@
 
45
0n
m
 
   (a)       (b) 
Rabbit anti-OMP Serum on SR-1
0 1 2 3 4 5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
-Log10[Rabbit Serum]
A
bs
o
rb
an
ce
 
@
 
45
0 
n
m
  
Protein A purified antibodies
0 1 2 3 4 5
0.0
0.5
1.0
1.5
2.0
2.5
Anti-NM on NM
Anti SR-1 on NM
-Log10[Serum]
Ab
so
rb
an
ce
 
@
 
45
0n
m
 
(c) (d) 
Figure 2.17. Reaction of antisera against the SR1 peptide and the whole cell 
Neisseria bacteria. (a). anti-SR1 and anti-NM antisera against the SR1 peptide (b). 
anti-SR1 and anti-NM antisera against the whole cell bacteria antiserum (c). 
Rabbit anti-OMP85 antiserum against SR1 peptide (d). protein G purified anti-
NM and anti-SR1 antibodies against NM.  
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2.4.6. Capsule purification and Tricine SDS-PAGE 
analysis 
Analysis of the polysaccharide capsule extract from Neisseria meningitidis using a 
Tricine-SDS PAGE gel revealed diffuse bands, commonly observed with 
polysaccharide analysis in SDS-PAGE gels (Figure 2.18.). 
 
 
Figure 2.18. Capsular preparation on Tricine SDS-PAGE gel. All of the lanes in 
the gel were loaded with the same capsular polysaccharide. 
 
2.4.6.1. HPLC analysis of Polysaccharide analysis 
Figure 2.19. shows the extracted and purified polysaccharide capsule 
chromatogram developed on the analytical HPLC system. The highest peak that 
is eluted at 21 minutes is the expected peak, which indicates that the capsule 
preparation was pure.  
Polysaccharide 
capsule 
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Figure 2.19. HPLC chromatogram of the capsular polysaccharide. The peak 
eluted at 21 minutes is the extracted capsule. 
 
2.4.7. Anti-NM serotype B capsular specific monoclonal 
antibodies 
N. meningitidis serogroup B capsule specific monoclonal antibodies (MAbs) were 
purchased from National Institue for Biological Standards and Control (NIBSC), 
UK. These MAbs were evaluated for their specificity and sensitivity against the 
whole cell bacteria as well as against the purified capsular preparation by ELISA 
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method (Figure 2.20.). The monoclonal antibodies recognised the whole cell 
bacteria with a titre of 1 in 10-4 and to a lesser extent with the poly-L-lysine 
conjugated purified capsular polysaccharide. By serial dilution of the antibody 
solution, between 1/10 and 1/1032, a sigmoidal curve was plotted with the 
absorbance on the y-axis against the related titre on the x-axis.  
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Figure 2.20. Reaction of anti-NM serogroup B capsule specific monoclonal 
antibodies with the whole cell bacteria and the purified capsule. 
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2.4.8. Cross reactivity assay against different Gram 
negative bacteria 
The panel of antibodies against the different Gram negative bacteria examined 
showed varying degree of cross reactivity (Figure 2.21.). Anti-NM capsular 
monoclonal antibody was highly specific against the Neisseria meningitidis 
serogroup B bacteria. All other polyclonal antibodies including rabbit anti-
OMP85 antibody, sheep anti-SR1 antibody and sheep anti-NM antibody were 
highly cross-reactive against different analysed bacteria. All bacteria except 
Legionella pneumophila, Pasteurella multocida, Brucella abortus had shown varying 
degree of cross reactivity. The results are summarised in table 2.6., where 4+ 
indicates the highest reactivity and + indicates least or no reactivity. 
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Figure 2.21. Cross reactivity with different closely related bacteria against the 
panel of antibodies. 
 
 
 
 
 
 
 
 
 
 
  133
 
 Identity 
With 
OMP 85 
Anti-
OMP85 
Anti-
SR1 
Peptide 
Anti-
NM poly 
Anti-
NM 
mono 
Neisseria meningitidis  100% 3+ 2+ 4+ 4+ 
Neisseria meningitidis MC 
58 
99% 3+ 2+ 4+ 4+ 
Neisseria gonorrhoeae 95% 2+ 2+ 3+ + 
Chromobacterium 
violaceum HB Agar 
50% 2+ 1+ 2+ + 
Chromobacterium 
violaceum LB Agar 
50% 1+ 1+ 2+ + 
Bordetella pertussis 36% 3+ 3+ 3+ + 
Acinetobactor Sp. 34% + 1+ 1+ + 
Escherichia coli 33% 1+ 3+ 2+ + 
Pseudomonas flourescens 33% 3+ 2+ 2+ + 
Pseudomonas aeruginosa 33% 3+ 2+ 3+ + 
Salmonella typhi 33% 3+ 2+ 3+ + 
Salmonella paratyphi 33% 3+ 2+ 3+ + 
Vibrio vulnificus 33% 2+ 2+ 2+ + 
Vibrio alginolyticus 33% 2+ 1+ 2+ + 
Vibrio cholerae 32% 3+ 2+ 4+ + 
Vibrio parahaemolyticus 32% 2+ 1+ 2+ + 
Vibrio Sp. 32% 2+ 1+ 3+ + 
Shigella dysenteriae 32% 1+ 1+ 2+ + 
Haemophilus influnzae 31% 1+ 1+ 2+ + 
Legionella pneumophila 31% + + + + 
Pasteurella multocida 31% + + + + 
Brucella abortus HB agar 26% + + + + 
Brucella abortus Chocolate 
agar 
26% + + + + 
 
Table 2.6. Summary of data from cross-reactivity studies: A panel of different 
antibodies were assessed for their cross reactivity against different bacteria. In 
this summary, 4+ indicates highest reactivity and + indicates least or no 
reactivity. 
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2.4.9. Protein A / Protein G sepharose purification of 
polyclonal antisera 
All of the antibody preparations were purified by affinity column 
chromatography. Rabbit IgG antibodies were purified by using protein A 
sepharose column and the sheep IgG antibodies were purified by using protein 
G sepharose column using the method described in section 2.3.13. Figure 2. 22. 
represents the typical antibody purification experiment by immunoaffinity 
chromatography. 
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Figure 2.22. Protein G sepharose purification of sheep anti-SR1 polyclonal 
antiserum 
 
2.4.10. Monospecificity of anti-SR1 antibodies 
As expected, the affinity purification of SR1 specific antibodies removed the 
cross-reactive antibodies to make the antibody monospecific (Figure 2.23.). The 
purified antibody showed no cross reactive response against all of the bacteria 
examined except vibrio sp. (Figure 2.24.).  
Elution buffer 
added 
Binding buffer 
added 
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Figure 2.23. Cross-reactivity studies of anti-SR1 monospecific antibody on 
different species, showing no cross reactivity with bacteria which was positive 
before with the anti-SR1 polyclonal antisera.  
 
 
Figure 2.24. Reactivity of mono-specific anti-SR1 antibody towards different 
Vibrio bacteria. 
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2.4.11. Shark IgNAR phagemid library panning 
After completing 4 rounds of panning the IgNAR library against the different 
target antigens, positive clones were picked from the ELISA experiment (Table 
2.7.). IgNAR specific PCR was positive for the selected clones (Figure 2.25.). After 
DNA sequencing, all clones selected were identified as either non-specific or 
“sticky” clones. 
  
 1      2      3     4            5     6     7            8     9     10           11   12  13                  14 
 
Figure 2.25. PCR reaction showing the IgNAR positive gene (non-specific clone). 
Lane 1: 100 bp DNA ladder, lanes 2-4: semi-pure OMP85 specific IgNAR clones, 
lanes 5-7: pure OMP85 specific IgNAR clones, lanes 8-10: SR1 specific IgNAR 
clones, lanes 11-12: capsule specific clones and lane 14 is the positive control. 
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Antigens 
Screened 
Round 1  
No. of 
Colonies 
Round 2  
No. of 
Colonies 
Round 3  
No. of 
Colonies 
Round 4  
No. of 
Colonies 
IgNAR 
PCR 
+ves 
Tth 
PCR 
+ves 
No. of 
possible 
clones 
picked from 
ELISA 
DNA 
Sequencing 
results                 
OMP85 0 0 2.5 X 104 2.6 X 102 100% 100% 6 Sticky and 
non-specific 
clones 
SR-1 
peptide 
0 0 4.8 X 105 2.6 X 102 100% 100% 4 Sticky and 
non-specific 
clones 
Capsule 2.4X 105 0 4.0 X 105 5.2 X 102 100% 100% 2 Sticky and 
non-specific 
clones 
Table 2.7. Shark IgNAR phagemid library panning. After 4 round of panning, 
different clones which appeared positive from PCR were selected for ELISA. 
After DNA sequencing, all of the selected clones were proved to be non-specific 
clones. 
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2.5. Discussion 
The recombinant OMP 85 protein, polysaccharide capsule component of the 
bacteria and whole bacteria were selected as target antigens. A peptide unique to 
N. meningitidis serogroup B was also synthesised using optimised t-boc 
chemistry. All of the antigens were prepared and their respective antibodies 
were purified using either protein A or protein G-sepharose affinity 
chromatography. 
 
2.5.1. OMP85 and rabbit anti-OMP85 polyclonal antibodies 
The recombinant OMP85 expressed with hexa-His tag was cloned, transformed 
and expressed in E. coli successfully. With Ni-NTA affinity column 
chromatography, other proteins were eluted along with prominent OMP85 
protein. This might be due to the partial affinity of other proteins towards the Ni-
NTA resin because hexa histidine does not exhibit the highest level of specificity. 
The use of transition metal complexes of iminodiacetic and nitrilotriacetic acid 
(NTA) has become commonly used for the efficient purification of hexa-His 
tagged proteins. NTA forms a tetravalent chelate with Ni(II) that subsequently is 
coordinated by basic amino acids such as histidine (Nallamsetty, Austin et al. 
2005). Even after optimising the imidazole concentration to elute more of OMP85 
and less of other proteins, the protein isolated was not homogeneous. 
Accordingly, modified sonic gel extraction procedure from SDS-PAGE maxi gels 
(16X16 cm) was followed, through which pure protein was obtained and the 
yield was much higher than the electro elution technique. Positive western blot 
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results with both crude and purified OMP85 antigen confirmed that the protein 
was expressed in its immunoreactive conformation. 
  
A BLAST search revealed the presence of OMP85 homologues in the complete 
genome sequences of all Gram negative bacteria examined (Surana, Grass et al. 
2004). Manning et al.. (Manning, Reschke et al. 1998) described surface cross-
linking experiments that suggested as OMP85 is surface exposed and interacts 
with other proteins on the bacterial surface. Conservation in the amino acid 
sequences is observed throughout the OMP85 protein. Two highly conserved 
motifs are located between amino acid residues 360-395 and 643-662 of neisserial 
OMP85 protein (OMP85 2002). OMP85 has been suggested as a possible vaccine 
target, as it is highly conserved among the Gram negative bacteria and elicits an 
immune response (Surana, Grass et al. 2004). Information regarding the possible 
binding sites of anti OMP85-antibodies is not available but it may be postulated 
that the two membrane-exposed loops are targets for host antibodies (Surana, 
Grass et al. 2004).  
 
Secondary structure prediction methods, such as PsiPred (Jones 1999) and PHD 
(Rost and Sander 1993), predicted the presence of at least two extracellular 
domains in OMP85 protein. A two-domain model for OMP85 was proposed, 
with a highly conserved NH2-terminal α/β periplasmic domain that includes the 
sequences required for secretion from the bacteria (Manning, Reschke et al. 1998; 
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Voulhoux, Bos et al. 2003) and a 12 stranded β–barrel domain at the COOH 
terminus domain consisting of β-strands and terminal phenyl alanine residue 
and could form a β-barrel for anchorage in the OM (Bredemeier, Schlegel et al. 
2006). The COOH-terminal domain is referred as “surface antigen”, because 
antibodies against this domain are protective against Haemophilus influenzae 
infection in animal models (Loosmore, Yang et al. 1997). 
 
The rabbit anti-OMP 85 polyclonal antibodies showed a higher degree of cross 
reactivity against the range of closely related bacteria. Given that OMP85 is a 
conserved protein amongst Gram negative bacteria (Surana, Grass et al. 2004) 
and that the protein is expressed in E. coli, it would be expected that anti-OMP85 
polyclonal antiserum would have high cross reactivity. There are no known 
commercial monoclonal antibodies available against OMP85 because of its 
conserved nature. Pre clearing the anti-OMP85 polyclonal antibodies with E.coli 
and other bacteria may be utilised to make them more specific to Neisseria 
meningitidis and may be useful as a capture system in ELISA or in quartz crystal 
microbalance (QCM) experiments. 
 
It has been postulated that OMP 85 could be used as an alternate vaccine 
candidate for serogroup B (Romero and Outschoorn 1994). Being a highly 
conserved protein among Gram negative bacteria, the greatest limitation of OMP 
vaccines is the specificity (subtype and serotype) of the protection that they 
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induce. Consequently, they cannot be used worldwide as prevalent 
meningococcal strains vary from region to region (Porritt, Mercer et al. 2000). 
 
2.5.2. SR1 peptide and sheep anti-SR1 polyclonal 
antibodies 
Sequence analysis of the surface antigen domain of OMP85 from N. meningitidis 
suggests it would form a 12- stranded β-barrel structure (Voulhoux, Bos et al. 
2003). Across the prokaryotic and eukaryotic members of the OMP85 family 
(fungi, plants, and animals (including humans)), there is strong sequence 
conservation in the regions predicting as β-strands, with variable intervening 
sequences that might correspond to inter-strand loops (Martelli, Fariselli et al. 
2002; Surana, Grass et al. 2004). These predictors may not sufficiently be reliable 
to determine a valid structural model for OMP85 but, the overall predictions on 
the family suggest a close structural relationship that goes beyond simple 
sequence similarities. 
 
Though it is a conserved protein, it still serves as a useful diagnostic marker and 
may be a potential vaccine candidate, since the predicted antigenic sequence 
between local residues 720 and 745 is unique to this organism (Judd and 
Manning 2003). A BLAST search of this particular sequence against the database 
reveals only as the sequence present in N. meningitidis serotype B bacteria (100% 
sequence identity). Also, there are five additional amino acids at the N-terminus 
  142
which distinguishes it from other related outer membrane proteins (Judd and 
Manning 2003). A useful approach will be to target these specific sequences as 
selective epitopes for immunodiagnosis of Neisseria meningitidis. By targeting 
these specific regions, OMP85 may be utilised as a more effective diagnostic 
marker. 
 
The selected N. meningitidis specific amino acid sequence (SR1) from OMP85 
protein sequence was synthesised using t-boc chemistry and confirmed by HPLC 
and mass spectrometry. After the synthesis, the SR1 peptide was conjugated to 
Keyhole Limpet Haemocyanine (KLH) as a carrier protein using SMCC as a 
linker molecule. Polyclonal antibodies were raised in sheep against this SR1-KLH 
conjugate. The antiserum was tested for high titre and specificity for the peptide, 
OMP85 protein and the whole cell bacteria. 
  
Anti-SR1 peptide antibodies reacted with the peptide, the OMP85 protein and 
the N. meningitidis bacteria itself. It proved that not only the OMP85 protein, but 
also the peptide sequence itself also is highly immunogenic and the anti-SR1 
peptide antibodies are able to identify whole bacteria. Unfortunately, in initial 
cross reactivity experiments, the anti-SR1 polyclonal antiserum was highly cross 
reactive with other closely associated Gram negative bacteria. The high degree of 
cross-reactivity of sheep anti-SR1 peptide antiserum might be due to the 
background of polyclonal antiserum and may be due to previous environmental 
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exposure to any of the tested organisms. Being a highly specific target against 
Neisseria meningitidis, anti-SR1 antiserum has potential to become a useful 
specific diagnostic marker for this organism.  
 
Purification of monospecific anti-SR1 antibodies by the immuno-affinity 
chromatography removed all cross-reactivity of the anti-SR1 antibodies except 
the Vibrio species. This should not be a limiting factor as the Vibrio sp. is not 
present in the cerebrospinal fluid of the infected person (Blake, Weaver et al. 
1980). In light of the specificity of these antibodies, it may be useful to raise 
monoclonal antibodies against the peptide for commercial application as a 
diagnostic tool for NM serogroup B. 
 
OMP85 is an outer membrane protein that is located beneath a polysaccharide 
capsule (Rosenstein, Perkins et al. 2001).  This may be a limiting factor that would 
affect the accessibility of diagnostic and/or therapeutic reagents that are specific 
to OMP85 or the SR1 peptide. During the life cycle of the N. meningitidis, bacteria 
shreds capsule and thus both capsulate and non-capsulate forms exist at different 
stages. Anti-SR1 antibodies against the non-capsulate bacteria form the potential 
base for the specific and rapid diagnosis of meningitis. Like many other virulence 
factors, the expression of capsular PS is phase variable (Hammerschmidt, Muller 
et al. 1996), allowing the bacteria to vary from adherent, serum sensitive, un-
encapsulated phenotype to a less-adherent, serum resistant encapsulated 
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phenotype. Colonisation is favored by the absence of the capsule, 
unencapsulated mutants adhering to human buccal epithelial cells or 
nasopharyngeal organ cultures in greater numbers than the encapsulated parent 
(Stephens, Spellman et al. 1993). This is in strict contrast to systematic spread: 
encapsulation is a pre-requisite for bacterial survival in the blood. In contrast to 
case isolates that are frequently encapsulated, approximately 40-50% of the 
strains isolated from carrier patients lack the capsule and hence are not grouped 
serologically (Caugant, Kristiansen et al. 1988; Ala'Aldeen, Neal et al. 2000). 
Alternatively, when the patient sample is subjected to treatment with detergents 
such as SDS, NM bacteria shred the capsule under stress conditions which 
exposes the outer membrane proteins.  
 
2.5.3. Capsule and anti-capsular monoclonal antibodies 
With the exception of serogroup A meningococci, all disease associated 
serogroup B, C, Y and W135 have sialic acids in their capsular polysaccharide 
structures (Vogel, Hammerschmidt et al. 1996) and the capsule is the major 
virulence factor of meningococcus bacteria. The poor immunogenicity of the 
Neisseria meningitidis group B polysaccharide capsule, a homopolymer of a sialic 
acid, has been attributed to immunologic tolerance induced by prenatal exposure 
to host polysialyated glycoproteins, such as the neural cell adhesion molecules 
expressed in a variety of host tissues (Orskov, Orskov et al. 1979; Beuvery, van 
Rossum et al. 1982). 
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The capsular polysaccharide of N. meningitidis serogroup B bacteria was purified 
by a simple and slightly modified procedure (Section 2.3.9. ). The purity was 
assessed by Tricine-SDS PAGE gel electrophoresis.  Using Reversed phase HPLC, 
the capsule preparation was observed as a single peak without any impurities. 
Commercial anti-capsular monoclonal antibodies were equally reactive both 
with the bacteria and the purified capsule. The capsule was purified as an 
alternate target antigen for future experiments for the gold nanoparticle based 
experiments as described in chapter 4 and 5.       
 
2.5.4. Cross reactivity assay and monospecificity of anti-
SR1 antibodies 
A panel of different antibodies were examined for cross reactivity against the 
range of closely associated bacteria. The anti-OMP 85 and anti-NM polyclonal 
antibodies showed a higher degree of cross reactivity relative to the anti-SR1 
polyclonal antibodies. It is mainy that the cross-reactivity is due to the nature of 
polyclonal antibodies which contain a multitude of reactive antibodies against a 
broad range of epitopes. Being a highly conserved protein among Gram negative 
bacteria and that the protein was expressed in E. coli, explains why anti-OMP85 
polyclonal antiserum showed high cross reactivity. Pre clearing the anti-OMPP85 
polyclonal antibodies with E.coli and other bacteria may be an idea to make them 
more specific to Neisseria meningitidis and it could be used as in capture system in 
an ELISA or in a QCM immunosensor. 
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2.5.5. Shark IgNAR phagemid library panning 
Screening of IgNAR library to identify OMP85 protein and other antigen specific 
IgNAR’s (at CSIRO Health Sciences and Nutrition, Parkville) was not successful. 
All the psuedopositive clones were finally proven as either non-specific or sticky 
clones. 
 
These target antigens and their antibodies and in particular OMP85 antigen and 
anti-OMP85 antibody were utilized to conjugate to the gold nanoparticles and 
ultimately to develop a model diagnostic assay for the rapid diagnosis of N. 
meningitidis. 
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Chapter 3 
 
 
Gold Nanoparticles: conjugation with proteins 
 
 
3.1. Introduction                                                
For the past few decades, colloidal gold nanoparticles and their attractive and 
unusual solution properties have led to the development of a range of useful 
applications, especially in the biotechnology and nanotechnology fields (Gittins, 
Bethell et al. 2000; Bachtold, Hadley et al. 2001). Nano-scale particles are also 
referred with other names such as, clusters, colloids, hydrosols, nanoparticles 
and nanocrystals. 
 
Attention was drawn to colloidal gold particles because their unique properties 
are very different from the bulk or the atomic state. Despite all the promise about 
the nanotechnology, the control of nanostructures and ordered assemblies of 
nanoparticles to develop a proper nanodiagnostic assay has so far been limited. 
This chapter describes the synthesis of gold nanoparticles and the conjugation of 
biomolecules to the nanoparticles.  
 
For many different biotechnological applications, colloidal gold nanoparticles are 
conjugated with biomolecules. Before proteins can be conjugated to 
nanoparticles, a preliminary titration must be performed to determine the 
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optimum conditions for conjugation to favour protein binding to the gold 
particles. The optimal conjugation ratio can be determined by means of a 
flocculation assay. 
 
Under normal circumstances, the monodisperse gold nanoparticles suspended in 
water are surrounded by a predominantly anionic double layer. This anionic 
coating, which is also referred to as the plane of shear, is usually measured in 
terms of zeta-potential (mV). This helps to stabilise the particles by the repulsive 
forces and can be considered as a direct measure of the stability of the colloid 
(Xie, Tkachenko et al. 2003).  
 
However, due to induced changes in the charges by the addition of millimolar 
concentrations of various electrolytes, the particles can become aggregated as a 
result of the shielding of the repulsive double-layer charges which normally 
stabilise them (Xie, Tkachenko et al. 2003). This irreversible process changes the 
colour of the colloidal solution from red to blue.  
 
Aggregation can be prevented by coating the gold nanoparticles with a protein 
layer as a stabiliser. The amount of stabiliser or protein needed to prevent 
aggregation is determined by increasing the concentration of electrolyte in 
various nanoparticle preparations, previously coated with distinct amounts of 
proteins (Xie, Tkachenko et al. 2003). The aggregation can be conveniently 
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monitored photometrically by the decrease and/or red shift of the plasmon 
absorption band at approximately 520 nm. 
 
The conjugation of a protein to the gold nanoparticle surface may originate from 
both chemical (hydrogen bonding, polarity and charge effects) (Mann 1988) and 
structural (size and morphology) recognition mechanisms (Weissbuch, Addadi et 
al. 1991). Target biomolecules such as proteins, peptides and oligonucleotides 
which usually have a positive charge in solution near neutral pH, can be electro 
statically attached to the negatively charged colloidal gold nanoparticles surface 
for detection and localisation (Sarikaya, Tamerler et al. 2003). In the case of gold 
clusters, biomolecules are attached to nanoparticles by covalent linking. 
 
Colloidal gold nanoparticles are often stabilised by anionic ligands such as 
carboxylic acid derivatives such as citrate, tartrate and lipoic acid (Keating, 
Kovaleski et al. 1998; Peng, Chen et al. 2007). Citrate reduced gold nanoparticles 
have been conjugated with immuniglobulin molececules through non-covalent 
electrostatic interactions at pH values that are slightly above the isoelectric point 
of the citrate ligand (Keating, Kovaleski et al. 1998). This helps in effective 
binding between the positively charged amino acid side chains of the protein and 
the negatively charged citrate groups of the colloids. In addition, colloidal gold 
conjugates can also be stabilised with an inert macromolecule such as bovine 
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serum albumin (BSA), gelatin, carbowax or polyethylene glycol to block the non-
specific binding sites on the nanoparticle surface.  
 
The adsorption of haem-containing redox enzymes on to citrate-stabilised silver 
nanoparticles (Broderick, Natan et al. 1993; Macdonald and Smith 1996) and the 
conjugation of basic leucine zipper proteins to lipoic acid stabilised 
semiconductor particles (Mattoussi, Mauro et al. 2000) are examples of protein 
conjugaton by electrostatic interactions. Biomolecules conjugated by this method 
may not be active and can be readily lost from the surface and thereby lose their 
biocatalytic or biorecognition properties. However, most proteins and enzymes 
have been shown to retain their native structure and activity after they were 
electrostatically conjugated to the nanoparticles and very few conjugations 
resulting in conformational changes and loss of biological activity of the protein 
involved (Keating, Kovaleski et al. 1998).  
 
The problems of non-specific binding of proteins through electrostatic 
interactions may be prevented by covalent attachment of proteins to nanoparticle 
surfaces, thus overcoming the problems of false or background labelling (Jain 
2006). Unlike conventional colloidal gold nanoparticles, gold nanocluster labels 
are coordination complexes and are neutral in nature. Nanoclusters can be 
covalently linked to specific sites or reactive group on biomolecules, for detection 
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and localisation. This gives the covalent linking, a range and versatility which is 
not available in case of ionic interaction of colloidal gold. 
 
Gold nanoparticles can be covalently cross-linked to a specific functional group 
on biomolecules (Jain 2006). For example, monomaleimido-NHS and mono-
sulpho-NHS reagents react only with thiol (sulphydryl) groups and amine groups 
of the proteins respectively (Gregori, Hainfeld et al. 1997). This site-specificity 
allows it to be conjugated at a position remote from the recognition site so that it 
does not interfere with target binding. For example, monomaleimido-gold 
nanoparticles binds antibody Fab' fragments specifically at the hinge region (Lee 
and El-Sayed 2006). The most commonly used functional targeted groups for 
covalent conjugation of the biological compounds to nanoparticles are amine, 
active ester, and maleimide groups and this is achieved by means of 
carbodiimide-mediated esterification and amidation reactions or through 
reactions with thiol groups (Niemeyer 2001). 
 
For generation of biomolecule-nanoparticle conjugates by covalent interaction, 
low-molecular weight bifunctional linkers, with an anchor group for attachment 
to nanoparticle surfaces and a functional group for conjugation to the target 
biomolecules, are used (Niemeyer 2001). A wide variety of terminal functional 
groups such as thiols, disulphides, or phosphine ligands are available in different 
bifunctional linkers for the binding to Au, Ag, CdS, and CdSe nanoparticles. The 
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chemically modified clusters with single functional groups (e.g. active ester or 
amine units) on gold nanoparticles are also available (Malecki, Hsu et al. 2002). 
These structures are helpful for the covalent binding of a single target 
biomolecule per nanoparticle. 
 
 
3.1.1. Reactions of Thiolate-stabilised gold nanoparticles 
The binding of functionalised thiolated molecules, such as oligopeptides to 
nanoparticles is achieved by means of covalent linking (Parak, Pellegrino et al. 
2003). In the case of proteins, thiol groups from cysteine residues that exist in the 
proteins can bind with the nanoparticle surface (Hayat 1991). If thiolated 
residues are not present in the native protein sequence, thiol groups can be 
incorporated by chemical means, for example, with 2-iminothiolane (Traut’s 
reagent) (Hayat 1991) or through genetic engineering (Hong, Jiang et al. 1994).  
 
Alkane thiolate stabilised gold nanoparticles are synthesised directly and also, 
various functional thiols could be partially incorporated into gold nanoparticles 
using a substitution reaction. Various other groups, labels and catalysts have 
been similarly introduced using this ligand-exchange reaction (Hostetler, 
Wingate et al. 1998; Li, Luk et al. 1999; Templeton, Wuelfing et al. 2000; Song and 
Murray 2002; Montalti, Prodi et al. 2003). Apart from the use of thiols and other 
linker molecules, there have been reports that describe the use of gold-binding 
peptides (for example; MHGKTQATSGTIQS) with substantially improved 
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binding compared with native protein binding even in the presence of a 
detergent and at high salt concentrations (Sarikaya, Tamerler et al. 2003). 
 
 Conjugate separation from unlabelled gold or free ligand is usually achieved by 
either centrifugation or by membrane filtration or dialysis or by gel size 
exclusion chromatography (SEC) using HPLC (Wolfe, Warrington et al. 2005). 
SEC is the best method for separating gold nanoparticle labelled conjugates, 
although membrane centrifugation is useful, especially for the labelling of very 
large proteins (Wolfe, Warrington et al. 2005). Density gradient ultracentifugation 
and other separation methods are also often used to separate colloidal gold 
conjugates from non-conjugates. Ion exchange, hydrophobic interaction, or 
reversed-phase chromatography may also be used, if the conjugate biomolecule 
is charged or has very distinct hydrophobic properties.  
 
Gold nanoparticle-biomolecule conjugates may be visualised using native gel 
electrophoresis (Wang, Wu et al. 2006). A gold nanoparticle-labelled molecule 
typically runs higher on the gel due to the added weight of the gold nanoparticle, 
although in practice the observed gel shift may be very small.  
 
Following purification of conjugates, the extent of labelling may be determined 
from analysis of the UV-Visible spectrum of the conjugate (Haiss, Thanh et al. 
2007). Gold labelling of most proteins is best calculated using the molar 
absorptivity constant at 280 nm, where proteins usually absorb strongly and their 
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molar absorptivity constant are known, and 520 nm, where gold nanoparticles 
absorb strongly but most proteins do not. Most proteins do not absorb at all in 
the visible spectrum: therefore, the absorption at 520 nm arises solely from the 
gold nanoparticle (Haiss, Thanh et al. 2007). With antibody labelling, the 
calculation is simplified because these proteins do not absorb at 520 nm. The 
molar absorptivity constant of a typical IgG is 203,000 cm-1M-1 at 280 nm. This 
value may have to be determined for individual proteins. 
 
Numerous challenges including synthesis of the nanoparticles with uniform size 
and shape, controlling their mineralogy, surface structures and chemistry, and 
predicting their spatial distribution need to be addressed before the 
nanoparticles can be successfully implemented for future technological materials 
and devices (Niemeyer 2001).  
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3.2. Materials and Methods 
 
 
Materials 
All glassware was scrupulously clean. Glass and plastic containers and stirrers 
were cleaned in aqua-regia and thoroughly washed in Milli Q water. Aqua regia 
(3:1 HCl:HNO3) was made fresh each time. 13 nm gold nanoparticles were 
prepared by citrate reduction method. The larger size gold nanoparticles (30nm, 
40nm, 50nm and 60nm) used in this chapter were purchased from the British 
Biocell Ltd., UK. 
 
Sodium citrate, aurochloric acid (HAuCl4 ·  3H2O), β-mercaptoethanol, N-acetyl 
cysteine (NAc), mercapto succinic acid (MSA), phenylalanine, Tween-20 and SDS 
were purchased from Sigma-Aldrich Ltd., USA. Bio-Rad Bradford assay reagent 
was used for protein estimation. All reagents were of high quality analytical 
grade and were filtered immediately before use. 
 
 
3.2.1. Synthesis of gold nanoparticles 
A solution of 5.0 x 10-3M HAuCl4 in water was prepared. A 1.0 mL aliquot of 5.0 
x 10-3M HAuCl4 solution was added to 18.0 mL of distilled H2O and heated until 
it began to boil. Once boiling, 1.0 mL of 0.5% (w/v) sodium citrate solution was 
added to gold solution. The reduction of the gold ions by the citrate ions was 
complete after 5 min which was evident by the solution colour change to deep 
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red solution. The boiling was continued for further 30 min (Turkevich, Stevenson 
et al. 1951).  
 
The solution was removed from the heating element and continued to stir until it 
cooled down to room temperature. The solution was topped up to 20 mL to 
account for any loss due to boiling. The colloidal suspension was stored at 4 °C 
in a bottle covered with aluminium foil. The larger size gold nanoparticles 
(30nm, 40nm, 50nm and 60nm) used in this chapter were purchased from the 
British Biocell Ltd., UK. 
 
3.2.2. Characterisation of gold nanoparticles 
 
3.2.2.1. UV-Vis Spectrophotometry   
The synthesised gold nanoparticles were analysed using a Hitachi U2000, UV-
visible absorption spectrophotometer. Each batch synthesised, including the 
commercial gold nanoparticles were analysed by spectral scan in the range of 
400-800 nm to identify the characteristic wavelength peak and for uniform size 
distribution.  
 
3.2.2.2. Transmission electron microscopy (TEM) analysis of gold 
nanoparticles 
Citrate-reduced gold nanoparticles were characterised in terms of uniform size 
distribution by TEM using Philips EM400 microscope at an accelerating voltage 
of 80 kV). Approximately, 20 µL of gold nanoparticles were coated onto a 
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Formvar coated copper EM grid (200 mesh) and dried for at least 30 minutes. The 
suspension on the grid was observed without further treatment.  
 
3.2.2.3. Particle Size - Light scattering 
The 13 nm gold nanoparticles prepared by citrate reduction method and the 
commercial gold particles were analysed by dynamic light scattering (DLS) 
method using Brookhaven 90 Plus particle size analyser and measured with 
scattered 657 nm laser light at 90°. Colloidal suspensions were diluted when 
counts/sec were greater than 600,000 to prevent multiple photon scattering. 
 
3.2.3. Preparation of antigen/antibody–gold nanoparticle conjugates 
The 13 nm lab made citrate capped gold nanoparticles and 30, 40, 50 and 60 nm 
commercial gold nanoparticles from British Biocell were used for conjugation. 
Both the antibody and antigen were affinity purified using protein A sepharose 
and Ni-NTA chromatography respectively. The OMP85 and anti-OMP85 
antibody were conjugated to the gold nanoparticles by identical procedures. 
Critical flocculation concentration (CFC) and the role of different stabilisers were 
evaluated to optimise the conditions for protein-gold nanoparticle conjugation. 
The following scheme was followed in order to determine the critical flocculation 
concentration (CFC) of OMP85 antigen and anti-OMP85 antibody for conjugation 
and stabilisation of the gold nanoparticles. 
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3.2.3.1. Determination of optimal NaCl concentration (CFC) 
Gold nanoparticle-OMP85 protein conjugates (10 mg/mL) were prepared using 
the gold nanoparticle–protein conjugation protocol which is detailed in the later 
part of the protocol. These gold nanoparticle conjugates were dispensed in a 
series (100 µl each) into 96 well ELISA plate. The gold nanoparticle conjugates 
were then exposed in duplicates to 100 µl of different sodium chloride (NaCl) 
concentrations (to a final concentration of 0.001 - 2.0 M NaCl in equal volumes). 
The solutions were agitated for 5 minutes and observed for aggregation to 
determine the maximum concentration of NaCl, after which the conjugates were 
no longer stable. Aggregation was monitored at different wavelengths (490 nm, 
595nm, 620 nm and 650 nm) in an ELISA plate reader (Bio-Rad, USA).  
 
3.2.3.2. Optimum Protein Concentration 
Gold nanoparticle-protein conjugates with varying concentrations of both 
OMP85 antigen and anti-OMP85 antibody (0.01-10 mg/mL) were prepared by 
following the gold nanoparticle – protein conjugation protocol. Having 
determined the optimum salt concentration in the previous experiment, a series 
of 100 µl aliquots of NaCl (one dilution below the optimum concentration) were 
dispensed into a 96 well ELISA plate. 
 
Followed by addition of 100 µl (in duplicates) of different concentrations of gold 
nanoparticle-protein conjugates. Then the solutions were agitated for 5 minutes 
and observed for aggregation to find the minimum amount of protein required 
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to stabilise the particles at that particular NaCl concentration. Aggregation was 
again monitored at four different wavelengths 490 nm, 595 nm, 620 nm and 650 
nm.  
 
3.2.3.3. Effect of different stabilisers 
Folowing the determination of the optimum salt concentration and the minimum 
amount of protein required for successful conjugation, the effect of different 
stabilisers were examined to observe their effect upon stability of the conjugates 
and whether the stabiliser is displacing any bound protein.  
 
3.2.3.3A. Effect of increasing concentration of stabilisers 
Gold nanoparticle-protein conjugates aliquots (100 µl) were dispensed into an 
ELISA plate as described before. Then, 60 µl of NaCl (to a final optimum 
concentration) was added to each well. At this stage, all the suspensions were red 
in colour. 
 
This step was followed by the addition of 40 µl of the different stabilisers (N-
acetyl cysteine, mercapto succinic acid (MSA), phenylalanine, Tween-20 and 
SDS) at varying concentrations. After mixing for 5 minutes, the plates were 
assessed for aggregation to determine the effect of different stabilisers on the 
stability of conjugates. The ELISA plates were centrifuged and the supernatants 
were collected for determination of free protein content using the Bradford assay.  
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3.2.3.3B. With increasing concentration of NaCl 
Gold nanoparticle-protein conjugates were prepared using the optimum 
concentration of the protein. The conjugates were distributed (100 µl aliquots) 
into an ELISA plate as described previously. Then, 40 µl of the different 
stabilisers (N-acetyl cysteine, mercapto succinic acid (MSA), phenylalanine, 
Tween-20 and SDS) of predetermined concentrations were added. Every 
combination was performed in duplicate. 
 
This step was followed by addition of 60 µl of NaCl (increasing from critical 
flocculation concentration) to each well. Following mixing for 5 minutes and 
observed for aggregation to find out whether the presence of any stabilisers 
increased/decreased the stability of conjugates. Aggregation was monitored at 
620 nm wavelength in an ELISA plate reader.  
 
3.2.3.4. Protein-gold nanoparticle Conjugation 
After determining the optimum conditions required for the successful 
conjugation and stabilisation of proteins to the gold nanoparticles, the quantities 
were scaled up. Typical experimental details are described as follows (Figure 
3.1). 
 
The OMP85 antigen and the anti-OMP85 antibody solutions (1.0 µg/µl) were 
resuspended in 5 mM sodium carbonate buffer pH 9.4, by using 30 kDa cut-off 
membrane filters. It was followed by addition of the predetermined amount of 
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antibody/antigen (to a final concentration of 0.25 mg/mL of OMP85 and 0.5 
mg/mL of anti-OMP85 antibody) solution drop wise to the gold nanoparticle 
suspension, while mixing gently. Mixing continued for 30 minutes followed by 
another 30 minutes of incubation at room temperature (without mixing).  
 
Any exposed binding sites on the surface of the gold particles were blocked to 
prevent non-specific binding by addition of 100 µl of filtered 1% (w/v) BSA in 
5mM sodium carbonate buffer pH 9.4 and stirred gently for 15 minutes.  
 
 
3.2.3.5. Purification  
The gold conjugates were purified from excess protein and nanoparticles before 
using for any experiment or storing. To separate any unbound protein and 
nanoparticles, nanoparticle conjugates were washed three times by 
centrifugation at 5000 to 20, 000 x g for 30-60 minutes, depending on the size of 
nanoparticles.  
 
These speeds and times were optimised and determined experimentally. The 
conjugates were centrifuged at different x g forces according to gold particle size:  
 
13nm      20,000 x g   for 1h @ 4 °C  
20nm      16,000 x g   for 1h @ 4 °C  
30nm      12,000 x g   for 1h @ 4 °C  
40nm        8,000 x g   for 1h @ 4 °C  
50nm        6,000 x g   for 1h @ 4 °C 
60nm        5,000 x g   for 1h @ 4 °C 
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The final product was a loose red precipitate. The clear supernatant was 
separated and used to determine the amount of protein adsorbed onto the 
nanoparticles using the Bradford protein assay. The pellet was resuspended and 
stored in 10 mM sodium phosphate buffer pH 7.4 containing 1% (w/v) BSA in 
order to shield any exposed binding sites on the gold surface. The suspensions 
were stable for several months. The conjugates prepared were examined for 
sensitivity and specificity by ELISA against the specific antigen/antibody 
molecules. 
 
Protein coated gold nanoparticle suspensions were stored in vials wrapped with 
aluminum foil and stored in the dark at 4 °C to protect the gold nanoparticles 
from oxidation and light-induced aggregation.  
 
3.2.3.6. Conjugation efficiency 
To determine the amount of OMP85 and anti-OMP85 antibody adsorbed onto 
the nanoparticles, 10 mM mercaptoethanol was added to reduce the sulphur – 
gold bond and to release all conjugated protein into solution. The amount of 
released protein was measured by absorbance at 280 nm and the gold particle 
concentration was measured by optical absorbance in the range of 520 – 535 nm 
according to the size. 
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Figure 3.1. Flow chart of Gold Nanoparticle-Protein Conjugation Protocol 
 
Added 250 µl of protein solution (in sodium carbonate 
buffer) to 6.0 ml of gold nanoparticle in scintillation vial 
and mixed them vigorously in shaker for 30 min at room 
temperature.  
Re-suspended the protein of 
interest in 5 mM Carbonate 
buffer (pH: 9.4 using 30 kDA 
molecular cut-off filters. 
(Note: Final concentration of the 
proteins used was based on CFC 
experiment. 
Transferred 6.0 mL of 50 nm 
gold nanoparticles (obtained 
from BBI, UK) into scintillation 
vials. (These nanoparticles are 
stabilised with citrate/tannic 
acid) 
Added 200 µl of BSA solution (5.0 mg/ml in 5 mM 
sodium carbonate buffer pH 9.4) to the above 
conjugated gold nanoparticle’s in scintillation vial and 
mixed them vigorously in shaker for another 30 min at 
room temperature.  
Washed the conjugation mixture by pelleting down the 
protein conjugated gold nanoparticles by centrifugation 
at 6000 x g for 45 minutes at 4 °C. Discarded the 
supernatant and resuspended the pellet in 10 mM 
sodium phosphate buffer pH: 7.4. Repeated the washing 
step twice to remove any unbound protein/BSA 
molecules. Finally, resuspend the protein conjugated 
gold nanoparticles in 5.0 ml of 10.0 mM sodium 
phosphate buffer containing 1% (w/v) BSA. Store at 4 
°C.  
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3.2.4. Detection of protein-conjugated gold nanoparticles by SDS-
PAGE 
After labelling the gold nanoparticles with proteins, unbound gold particles were 
removed by centrifugation. After separating the unbound proteins and 
nanoparticles, 20 µl of OMP85 conjugated gold nanoparticle suspension was 
mixed with 5.0 µl of modified SDS-PAGE sample buffer (appendix 2). With out 
heating, the samples were loaded in duplicates onto a 6% SDS-PAGE gel and the 
normal gel running procedure was followed (Section 2.3.1C).  
 
Silver staining was performed to develop the gold nanoparticles effectively. 
When optimal staining was reached, further development was stopped by 
rinsing in distilled water. The gel was scanned to visualise the bands pattern.  
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3.3. Results 
 
 
3.3.1. Gold nanoparticle synthesis 
The 13 nm gold nanoparticles were synthesised successfully according to 
standard wet chemical method (Turkevich, Stevenson et al. 1951) using sodium 
citrate as a reducing agent. Figure 3. 2 show the typical reaction of formation 
gold nanoparticles by citrate reduction.   
 
AuCl4-  (aq) +                H2O/100°C       
 
Figure 3.2. Reduction of HAuCl4 by sodium citrate 
                            
 
 
                                                               
3.3.2. UV-Vis spectral analysis of gold colloidal suspension 
The characteristic surface plasmon band for 13 nm gold nanoparticles at 520 nm 
peak wavelength was observed (Figure 3. 3) in the UV-Visible spectrum, 
confirming the presence of gold nanoparticles.  
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Figure 3.3. UV/Visible absorbance spectrum of 13 nm gold nanoparticles with a 
characteristic peak at 520 nm. 
 
3.3.3. Transmission Electron Microscopy (TEM) analysis 
Both laboratory synthesised 13 nm gold nanoparticles and the commercial 30, 40, 
50 and 60 nm gold nanoparticles were analysed by transmission electron 
microscopy. TEM micrographs (Figure 3. 4) showed the presence of spherical 
gold nanoparticles of approximate size (13 nm and 50 nm) with uniform size 
distribution. Although the actual value of the mean size might vary slightly from 
each preparation, the size distribution was found to be always about 10% 
standard deviation. Size distribution analysis clearly showed that nearly 90% of 
the particles reside within their size range. 
 
 
  167
                            
  (a)       (b) 
Figure 3.4. TEM images of (a) 13 nm gold nanoparticles and (b) 50 nm gold 
nanoparticles. 
 
 
3.3.4. Particle Size – Light Scattering analysis 
Dynamic light scattering measurements showed the average mean diameter of 
the particles. Figure 3. 5 show the light scattering results of the 30nm, 40 nm and 
60 nm gold nanoparticles.  
 
 
(a)     
 
60 nm 60 nm 
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(b)    
 
(c)   
Figure 3.5. Dynamic light scattering measurements of (a) 30nm, (b) 40nm and (c) 
60 nm gold nanoparticle 
 
 
3.3.5. Protein-gold nanoparticle conjugation 
 
3.3.5.1. Critical Flocculation Concentration 
The NaCl solution destabilised the colloid gold nanoparticles and caused 
aggregation. The sample containing gold nanoparticles and no protein was 
destabilised immediately upon the addition of electrolytes.  As the protein 
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concentration increased, the stability of the nanoparticles also increased which 
was reflected by a resistance to change from red to blue colour shift. During the 
flocculation assay, the aggregation was monitored photometrically by the 
decrease and/or red shift of the plasmon absorption band at different 
wavelengths of 490nm, 595 nm, 620 nm and 650 nm. 
 
3.3.5.2. Optimum NaCl Concentration 
The tube containing the minimum amount of salt to keep the particles stable was 
indicated by change from red to blue. In the case of both OMP85 and anti-
OMP85 antibody conjugation experiments, the particles were stable up to a final 
concentration of 0.512 M NaCl. Nanoparticles started to aggregate with any 
concentration of the salt above 0.512 M NaCl (Figure 3. 6).  
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(b)  
CFC using 5.0 mg/ml anti-OMP85 ab conjugated 50 nm AuNP
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Figure 3.6. Critical flocculation concentration of 50 nm gold nanoparticles 
conjugated with (a) OMP 85 protein and (b) anti-OMP85 antibody. Both were 
stable up to a final concentration of 0.512 M NaCl 
 
3.3.5.3. Optimum Protein Concentration 
Though the optimum salt concentration of 0.512 M (from the above experiment) 
was observed, one dilution below that point i.e. 0.256 M NaCl concentration was 
used for determining the optimum protein concentration. The tube containing 
the minimum amount of protein required to stabilise the gold sol was indicated 
by the one in which the colour of the gold sol did not change from red to blue 
upon the addition of NaCl. In the case of both OMP85 and anti-OMP85 antibody 
conjugation experiments, the minimum amount of protein required to keep the 
particles stable was found to be 0.4 mg/mL of final concentration (Figure 3. 7). 
Nanoparticles started to aggregate when the protein concentration used fell 
below 0.3 mg/mL.  
 
  171
(a)  
CFC on 50 nm AuNP using 0.01-10 mg/ml OMP85 at 0.256 M NaCl
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
10.24 5.12 2.56 1.28 0.64 0.32 0.16 0.08 0.04 0.02 0.01
OMP85 conc. (mg/ml)
A
bs
o
rb
an
ce
 
at
 
di
ff
er
en
t 
w
av
el
en
gt
hs
450 nm
595 nm
620 nm
650 nm
 
(b)  
CFC on 50 nm AuNP using 0.002-5.0 mg/ml anti-OMP85 ab at 0.256 M NaCl
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Figure 3.7. Critical flocculation conentration experiment to determine the 
minimum protein concentration required to stabilise the 50 nm gold nanoparticle 
in presence of 0.256 M NaCl. (a) OMP85 conjugated and (b) anti-OMP85 
conjugated.  
 
 
3.3.5.4. Effect of different stabilisers 
The effect of different stabilisers on the increasing or decreasing of stability of 
gold nanoparticle-protein conjugates did not produce any conclusive results.  
 
  172
The presence of NAc and MSA led to aggregation of the conjugates resulting in a 
colour change from ruby red to blue, despite the fact that analysis of the 
supernatants using Bradford assay showed that no protein was released or 
displaced from the aggregated conjugates (Figure 3.8). Addition of 
phenylalanine, Tween-20 and SDS resulted in no colour change of the conjugates. 
However, the Bradford assay on the supernatants revealed that, phenylalanine 
and SDS did not displace the bound protein, whereas the particle suspension 
containing Tween-20 appeared to have protein present in the supernatant 
suggesting that protein was released from the nanoparticles.    
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(b)  
Effect of increasing concentration of different stabilizers on 50 nm AuNP-
anti-OMP85 ab conjugates
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Figure 3.8. Effect of increasing concentration of different stabilisers on the 50 nm 
gold nanoparticle conjugated with (a) OMP85 protein and (b) anti-OMP85 
antibody, in presence of 0.256 M NaCl.  
 
 
 
3.3.5.5. Effect of Sodium Chloride concentration in presence of 
stabilisers 
Presence of NAc and MSA did not increase the stability of the conjugates but 
rather, the conjugates aggregated immediately. However, the stability was 
increased by two fold by the addition of SDS and Tween-20. That is the stability 
of the particles increased from 0.256 M NaCl to 0.512 M NaCl.  However, there 
was no change in the stability of the conjugates in the presence of phenylalanine.  
 
Figure 3. 9. shows the image of a typical CFC experiment of conjugating OMP85 
protein and anti-OMP85 antibody conjugated gold nanoparticles in the presence 
of increasing salt concentration.  
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Figure 3.9. Image of the critical flocculation experiment (CFC) experiment of 50 
nm gold nanoparticle conjugated with OMP 85 protein. Similar experiment was 
performed with anti-OMP85 antibody conjugated 50 nm gold nanoparticles. Both 
were stable up to a final concentration of 0.512 M NaCl. 
 
3.3.5.6. Gold nanoparticle-protein conjugation 
Despite some initial inconsistencies with the gold nanoparticles and protein 
conjugation techniques, conditions were optimised for different sized gold 
nanoparticles to achieve successful conjugation with OMP 85 and anti-OMP 85 
antibodies. Unbound proteins and nanoparticles from the nanoparticle-protein 
conjugates were separated by centrifugation and the conjugated nanoparticles 
were resuspended in 10 mM sodium phosphate buffer pH 7.4 containing 1% 
(w/v) BSA and they remained as a ruby red colour during storage.  
 
A wavelength scan of the conjugated gold nanoparticles showed slight (∼3-5 nm 
shift) or no difference from the naked gold nanoparticles (Figure 3. 10). Although 
conjugated gold nanoparticles are usually more stable, they were stored in a dark 
vial at 4°C to avoid any instability issues associated with high temperatures.   
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Wavelength shift due to conjugation of 50 nm AuNP and OMP85 protein
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Figure 3.10. UV-visible absorbance spectrum of the 50 nm naked nanoparticles 
and the OMP85 conjugated gold nanoparticles. (a) Increase in absorbance at 280 
nm indicating the successful conjugation of nanoparticles and OMP85 protein, 
(b) 5 nm red shift due to the conjugation.  
 
Once coated and properly stabilised, the colloidal gold particles in 10mM sodium 
phosphate buffer containing 0.1% (w/v) BSA and 0.05% (w/v) sodium azide, did 
not show any sign of nonspecific agglutination. This helps to prevent bacterial 
contamination and also prevents the protein from adhering to the surfaces of the 
storage vessel. 
 
 
3.3.6. Detection of protein labelled gold nanoparticles on gels  
Nanoparticles were observed as a red band passing through the gel while 
running. Native gold nanoparticles were not stained by Coomassie blue R-250.  
With silver staining, proper gel shift and the difference between conjugated and 
(a) 
(b) 
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unconjugated gold nanoparticles in the gel was noticed. Detected each 
component separately and specifically to confirm labelling. 
  
The molecular wt. of the 13 nm gold nanoparticles appeared to be around 80 
kDa. Molecular wt. of OMP 85 is normally around 85 kDa and the molecular wt. 
of OMP85 conjugated nanoparticles was appeared to be in between 130 kDa to 
170 kDa. Thus there was an observable gel shift (Figure 3. 11). Aggregates of the 
gold nanoparticles did not enter the gel and small amounts of free gold gave 
background staining. 
  
Figure 3.11. OMP85 and anti-OMP85 antibody conjugated 13 nm gold 
nanoparticle in ative polyacrylamide gel electrophoresis (M: Marker; P: OMP85 
protein; Au: 13 nm gold nanoparticle; AuP: gold nanoparticle-OMP85 conjugates; 
AuAb: gold nanoparticle-anti-OMP85 antibody conjugates. Both gels were 
stained using different silver staining methods, resulting in differences in colour.   
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3.4. Discussion 
The most simple method for the synthesis of gold nanoparticles was published 
by J. Turkevitch et al.. in 1951 and which was then refined by G. Frens in 1970s 
(Turkevich, Stevenson et al. 1951; Frens 1973). The sodium citrate initially acts as 
a reducing agent and then the negatively charged citrate ions are adsorbed onto 
the reduced gold nanoparticles surface. This introduced surface charge helps to 
repel the particles to each other and thus helps to prevent them from 
aggregating. It is believed that each particle has an Au0 core and an AuI shell as a 
result of incomplete reduction at the nanoparticle surface (Frens 1973). Citrate 
and chloride ions coordinate to the AuI shell, and thus, each gold nanoparticle 
has an overall negative charge. 
 
The citrate reduction method is generally followed to produce monodisperse 
spherical gold nanoparticles in the range of 10–20 nm in diameter. In this work, 
monodisperse gold nanoparticles with a uniform size of 13 nm were produced. 
These particles had a characteristic surface plasmon wavelength of 520 nm 
indicating that spherical particles were obtained. In general, the red colour of a 
colloidal gold nanoparticle suspension with diameters of 5–20 nm is due to a 
characteristic surface plasmon resonance peak at around 520 nm. 
 
By varying the citrate : gold chloride ratio, larger particles can be produced, but 
this comes at the cost of monodispersity and shape (Haiss, Thanh et al. 2007). For 
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this reason, larger nanoparticles (30nm, 40 nm, 50 nm and 60 nm) were 
purchased from British Biocell and these were made using citrate/tannic acid 
method instead of citrate alone. These particles were fairly uniform in size and 
had characteristic surface plasmon wavelength peaks corresponding to their size 
(Haiss, Thanh et al. 2007).  
 
TEM analysis of the 13 nm particles synthesised in the laboratory and the 
commercial larger particles confirmed the monodispersity and uniform size 
distribution of the nanoparticles (Daniel and Astruc 2004). To further establish 
the near monodispersity and sample uniformity in these materials, samples were 
also studied using dynamic light scattering (DLS) (Storhoff, Lazarides et al. 2000). 
Like TEM, this technique also has inherent limitations such as limited 
measurement range, and may not give particle diameters which are identical to 
the TEM observations. Nonetheless, a major advantage of DLS is that it gives a 
bulk measurement and thus avoids selective sampling as can occur in TEM. As 
such, DLS in combination with TEM and UV-visible measurements can serve as a 
very useful supporting technique (Mukherjee, Bhattacharya et al. 2007). Data 
obtained from DLS analysis of the larger particles supported the TEM results 
indicating that to make larger particles, reduction and stabilisation using 
citrate/tannic acid combination is better than citrate alone. 
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Stabilisation is an essential part of the nanoparticle synthesis process to avoid 
aggregation of the newly formed particles. The stability of aqueous gold 
nanodispersions is influenced by a number of variable factors such as salt 
concentration and pH (Xie, Tkachenko et al. 2003). In general, classical citrate-
stabilised particles exhibit very poor electrostatic stability and may form 
aggregates in the presence of low (10 mM) concentration of electrolyte solutions. 
The colour of colloidal gold depends on the size and the shape of particles, as 
well as the composition of the surrounding medium (Underwood and Mulvaney 
1994; Link and El-Sayed 1999). Aggregation of the nanoparticles shifts the peak 
toward longer wavelength and changes the colour of the colloidal suspension to 
purple to blue (Link and El-Sayed 1999). To prevent the particles from 
aggregating due to addition of small electrolytes, a stabilising agent that 
adsorbes to the nanoparticles surface is usually added. Protein adsorption 
stabilises the metal particles and prevents flocculation (Daniel and Astruc 2004).  
 
The coating of colloidal gold nanoparticles with proteins was performed by an 
electrostatic adsorption method (Peng, Chen et al. 2007). Colloidal gold 
nanoparticles remain negatively charged over a broad pH range. The citrate ions 
being weakly anionic, they can be easily replaced with strong anions. So, the 
OMP85 antigen and anti-OMP85 antibody dissolved in sodium carbonate buffer 
pH 9.4, bound to the gold nanoparticles by replacing the already existing citrate 
ions. 
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Conjugation of proteins to gold nanoparticles mainly depends upon different 
phenomena such as, ionic attraction between the gold nanoparticles and the 
proteins and dative binding between the gold conducting electrons and sulphur 
atoms which are present in cysteine residues (if present) in the protein (Beesley 
1989; Mukherjee, Bhattacharya et al. 2007). In some proteins the sulphydryl 
functionality may be in the form of a disulfide group and in other proteins 
sulphydryl sites may be buried within the protein structure, and therefore 
inaccessible to the gold nanoparticles (Mukherjee, Bhattacharya et al. 2007).  
 
However, studies on peptides binding to gold predicted that the mechanism of 
binding of gold binding peptide (GBP) to inorganic metal surfaces mainly 
involve the polar side chains of serine and threonine (Braun, Sarikaya et al. 2002). 
Interestingly, most of the sequences studied didn’t have cysteine, and only a few 
of them contained histidines, two residues known to bind to transition metal ions 
(Slocik, Moore et al. 2002). On the whole, binding between the protein and the 
nanoparticles may not only occur through the sulphydryl groups but also 
through hydrophobic and hydroxyl group-containing polar amino acids. 
 
Successful conjugation of proteins to gold nanoparticles was established by the 
observed increase in stability of the conjugates in the presence of high salt 
concentrations. The amount of protein needed to prevent aggregation was 
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determined by preliminary titrations in the presence of increasing concentration 
of electrolyte and utilising the red to blue colour change of the various gold 
nanoparticle preparations previously coated with defined amounts of protein. 
This was established by the increased stability (no red to blue colour change) of 
the Au colloid in the presence of a monolayer of surface-attached proteins (Xie, 
Tkachenko et al. 2003). A single monolayer of protein attached to the surface of 
the nanoparticles is often sufficient to stabilise the nanoparticles (Niemeyer 
2001). Thus, exposure of these protein-conjugated gold nanoparticles upto 0.256 
M NaCl revealed no particle growth as shown by UV-vis absorbance 
spectrophotometry (Xie, Tkachenko et al. 2003). A separate titration to determine 
the protein/colloid ratio was performed with every batch of nanoparticles used. 
 
The conjugation of biomolecules to nanoparticles is affected by several factors 
such as solvents, buffers, solubility of the proteins, pH, temperature, ratio of 
reagents etc (Sharma, Brown et al. 2006). It is necessary to determine the 
optimum pH for successful conjugation of proteins to gold nanoparticles (Peng, 
Chen et al. 2007). It is believed that pH can influence the correct orientation of the 
biomolecule on the particle for proper ligand recognition (Broderick, Natan et al. 
1993; Keating, Kovaleski et al. 1998). It has been suggested that the conjugation is 
best performed at or near isoelectric point of the protein. The theoretical 
isoelectric point for OMP85 was predicted to be 8.5 (Swiss-Prot/TrEMBL). The 
optimum pH for OMP85 conjugation was determined by performing a 
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preliminary titration at two different pH values namely, pH 7.4 and 9.2 and 
examining the extent of conjugation by Bradford assay. A pH of above 9.0 was 
found to be more effective for successful conjugation. Whilst the optimal pH for 
coating usually lies around the isoelectric point of the protein, there are no 
general rules and adsorption interaction isotherms should be conducted in each 
case (Broderick, Natan et al. 1993; Keating, Kovaleski et al. 1998). 
 
Optimising the pH also helps to target the amine group for binding (Mandal, 
Phadtare et al. 2005). The pKa of the α-amino group of proteins and peptides at 
the N-terminal region is often slightly lower than that of the side-chain amine 
groups such as ε-NH2 of lysine; therefore, under the right pH conditions, the 
proteins may be preferentially conjugated to the gold nanoparticles (Mandal, 
Phadtare et al. 2005). In order to maintain this amine group in the non-protonated 
form, the conjugation was performed in an alkaline buffer (pH above 9.0). 
 
It was also observed that conjugation of proteins to nanoparticles was higher 
with the concentrated protein solution than diluted one. Protein conjugation 
efficiencies were improved by gentle agitation of the mixture after addition of the 
protein, since generating air bubbles by vigorous agitation may denature the 
protein solution or promote oxidation of thiol groups catalysed by atmospheric 
oxygen (Hainfeld 1988). However, once the optimal conditions were identified, 
the coating process was usually reproducible and was easy to scale-up. 
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An important goal with gold nanoparticle conjugation is isolating the labelled 
conjugate from unbound gold nanoparticles or from unlabelled biomolecule. 
This was done by centrifugation at a predetermined speed (Haiss, Thanh et al. 
2007). Once after isolating gold nanoparticle conjugate, the extent of labelling 
(the number of gold nanoparticles per biomolecule) was calculated using the 
UV/visible absorption spectra of the gold nanoparticle conjugates. OMP85 and 
anti-OMP85 antibody absorb strongly at 280 nm, but have no absorbance at 520 
nm. Therefore in the conjugate spectrum, while any absorbance at 520 nm must 
be due to gold nanoparticles, the absorbance at 280 nm contained a contribution 
from the conjugated protein (Haiss, Thanh et al. 2007).  
 
After conjugation, only a modest shift in the surface plasmon band from 529 to 
534 nm was observed. The surface plasmon resonance (SPR) peak of protein 
conjugated 50 nm gold nanoparticles was about 534 nm with a red shift of 5 nm 
compared to that of original citrate/tannic acid-stabilised gold nanoparticles 
(529 nm). This shift might be due to centrifugation of the protein conjugated gold 
nanoparticles which may affect the particle size distribution due to slight 
aggregation, which in turn could affect the position of the plasmon band (Hayat 
1991). The centrifugation appears to decrease the intensity of the plasmon band 
possibly due to slight aggregation and a decrease in particle concentration. This 
red shift also denotes that protein molecules were adsorbed on to the gold 
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surface by Au–S interaction and a so-formed dielectric monolayer of protein 
around gold nanoparticles resulting in the red colour shift (Nath and Chilkoti 
2002). These assembled protein-gold nanoparticle bioconjugates in aqueous 
suspension maintained their activity with enhanced stability and similar pH 
dependence. 
 
Electrophoresis was perfomed to visualise the successful conjugation of protein 
and nanoparticles. During SDS-PAGE gel electrophoresis, gold nanoparticle 
conjugates may degrade upon exposure to thiols such as β-mercaptoethanol or 
dithiothreitol (DTT) (Beesley 1989). Based on these observations, a non-reducing 
gel was used in these studies. Samples were not heated to avoid any degradation 
of nanoparticle conjugates when heated above 50°C. 
 
Gold nanoparticle-labelled molecules may be separated using gel 
electrophoresis, but one should be cautious in interpreting the results, as gel 
shifts alone are frequently not found to be good indicators of successful 
conjugation (Beesley 1989). Two-thirds of the gold nanoparticle is comprised of 
very dense gold atoms and thus the molecule is actually smaller than a protein or 
other macromolecule of the same weight (Rao, Kulkarni et al. 2000). In gel 
electrophoresis, the gold nanoparticles travel similarly to a protein of smaller 
molecular weight. A gold nanoparticle-labelled molecule typically runs higher 
on the gel due to the added weight of the gold nanoparticle. Conjugates were 
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visualised by usual gel stains (Coomassie and gel silver stains) which detected 
protein present in the samples. 
 
From the gel electrophoresis analysis, the apparent molecular weight of the 13 
nm gold nanoparticles was found to be around 80 kDa based on the assumption 
that these particles had a shape similar to an unfolded globular protein. A band 
around around 160 kDa on the gel, suggested the successful conjugation of 
OMP85 protein (85 kDa) with the 13 nm gold nanoparticles (80 kDa). Another 
band above 200 kDa possibly suggested the presence of 13nm gold nanoparticle-
anti-OMP85 antibody conjugates. 
 
A series of five water-soluble stabiliser ligands with different solubility i.e., N-
acetyl cysteine (NAc)(Gautier and Burgi 2005), phenylalanine (Shao, Jin et al. 
2004), mercaptosuccinic acid (MSA) (Li, Chen et al. 2006) and surfactants like 
Tween-20 (Paciotti, Myer et al. 2004) and sodium dodecyl sulfate (SDS) (Mafune 
2004) were used to enhance the stability of the protein stabilised nanoparticle 
conjugates. The stability of OMP85 and anti-OMP85 antibody conjugated gold 
nanoparticles toward both salt concentration and displacement of the bound 
proteins was investigated. Addition of some of the stabilisers was found to be 
useful in particular applications, as discussed below. 
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For particles stabilised with Tween-20 and SDS, the stability of the preparations 
toward salt concentration was found to increase significantly as the surfactants 
form a monolayer around the particles. However, nanoparticles treated with 
NAc and MSA didn’t show any increase in stability but rather led to aggregation 
of the previously stabilised particles. The conjugate suspension in presence of 
MSA was aggregated which is likely due to hydrogen bonding formation 
between the carboxylic acid and amino acid group (Figure 3. 12) (Choi, Lee et al. 
2003). Presence of phenylalanine as a stabiliser made no difference to the stability 
of the particles. This may be due to the reason that phenylalanine might not be 
binding with the gold surface.  This effect may be primarily due to the end group 
rather than variations in total ligand molecular weight, even though the molar 
masses for this series of ligands were not all identical. It is not clear at this stage 
whether this difference in results is due to the mode of binding to the gold 
surface or the fact that Tween-20 and SDS form a micelle structure around the 
nanoparticles. 
    
Figure 3.12. Structure of the precipitated MSA capped Ag colloids (Choi, Lee et 
al. 2003).  
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Once stabilised, the gold nanoparticle-protein conjugates were stable to wide 
ranges of pH and ionic strength. Although gold nanoparticles are usually stable, 
under some conditions labelled conjugates may not be stable at higher 
temperatures (<50 °C) and therefore stored at 4 °C until used. 
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Chapter 4 
 
The assembly and validation of the diagnostic assay: 
A colour shift assay based on Surface plasmon 
resonance 
 
4.1. Introduction 
Colloid gold has a long history of safe use in clinical applications (Faraday 1857; 
Mulvaney 2003). The use of biomolecules such as proteins and nucleic acids with 
nanoparticles for developing nanotechnology devices has led to the development 
of hybrid nanomaterials (Sarikaya, Tamerler et al. 2003). Novel devices may 
become available by tuning the spectroscopic, fluorescence, luminescence, and 
electrochemical characteristics of gold nanoparticles with those of substrates 
including DNA, carbohydrates and other biological molecules or systems.  
 
Although bulk gold is well known for being inert, the reactivity of the gold 
nanoparticles has recently proven very useful in developing recognition systems 
based on their optical properties. Gold nanoparticles exhibit a specific optical 
property called Surface Plasmon Resonance (SPR), which is responsible for the 
deep red colour of the suspension (Mie 1908; Link and El-Sayed 2000). The 
aggregation of gold nanoparticles leads to the red shift of the absorption band 
from 520nm to longer wavelengths in the range of 600-800 nm, as a result of 
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electric dipole-dipole interaction and coupling between the plasmons of 
neighboring particles in the formed aggregates. A better understanding of the 
surface plasmon resonance properties of the gold nanoparticles can prove fruitful 
to develop the most sensitive reagents and technology for detecting biological 
molecules. 
 
Major parameters that control the formation of extended nanoparticle aggregates 
include, the size, size distribution, shape (Mock, Barbic et al. 2002), and chemical 
composition of the nanoparticle building blocks, the length and stability of the 
particle linker molecules (Mucic, Storhoff et al. 1998). Ordered or disordered 
assembly of nanoparticles in aggregates is possible by incorporating 
complementary receptor-substrate sites on the surface of the nanoparticles which 
permits the recognition-driven assembly of nanoparticles (Daniel and Astruc 
2004). The antibodies and antigens can be utilised as candidate molecules for the 
controlled assembly of nanoparticles in suspension (Mann, Shenton et al. 2000). 
By utilising the specific recognition properties of the coupling molecules, novel 
materials with controlled growth have been generated (Niemeyer 2001; Sun and 
Xia 2002; Djalali, Chen et al. 2003). Gold nanoparticles may be utilised to design 
an ideal colorimetric assay, based on the their extremely high extinction 
coefficients and the strongly distance-dependent optical properties (Liu and Lu 
2004). 
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The combination of the surface plasmon absorption property of gold 
nanoparticles with biology and medicine has already been demonstrated by 
using complementary DNA oligonucleotides attached to the surfaces of gold 
nanoparticles. Earlier work by Mirkin (Mirkin, Letsinger et al. 1996) and 
Alivisatos (Alivisatos, Johnsson et al. 1996) showed that complementary DNA 
oligonucleotides could be used to self-assemble nanoparticles. Mirkin et al.. 
(Mirkin, Letsinger et al. 1996) described a method for reversible assembly of 13 
nm colloidal gold nanoparticles into macroscopic aggregates by utilising the 
DNA specific interactions. Excellent specificity in base pairing, and its ability to 
address at the nanoscale makes DNA an ideal candidate for applications in 
biosensing and bionanotechnology. 
 
The inter-particle distance dependent colour change of colloidal gold due to 
aggregation has been used by Mirkin and co-workers to design a sensor capable 
of determining single-base mismatches in DNA hybridisation, (Elghanian, 
Storhoff et al. 1997; Storhoff, Elghanian et al. 1998). Selective colorimetric 
polynucleotide detection with the gold nanoparticle probes resulted in the 
formation of aggregates with an ultimate red to purple colour change in 
suspension (Storhoff, Elghanian et al. 1998). 
 
A highly sensitive and selective colorimetric biosensor has been designed based 
on DNAzyme-directed assembly of gold nanoparticles resulting in red to blue 
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colour shift (Liu and Lu 2003) and it has been reported that this can be used for a 
broad range of analytes. The DNAzyme catalyses specific cleavage of the 
substrate strand in the presence of lead. This ultimately disrupted the formation 
of the nanoparticle assembly, and resulted in red-coloured individual 
nanoparticles. The application of this particular sensor in lead detection in lead-
based paints was also demonstrated (Liu and Lu 2003; Liu and Lu 2004). This red 
shift based on the surface plasmon resonance of the gold nanoparticles, has been 
observed in other non–oligonucleotide-based strategies (Brust, Fink et al. 1995; 
Grabar, Smith et al. 1996; Storhoff, Mucic et al. 1997; Bao, Peng et al. 2005). 
 
However, protein-based recognition systems offer some additional advantages 
over oligonucleotides with a large number of complementary systems and a 
wide range of free energies of association (Mann, Shenton et al. 2000). To test the 
possibility of using antibody-antigen interactions in programmable nanoparticle 
self-assembly, Shenton et al.., (Shenton, Davis et al. 1999) described a study based 
on the interaction between a bivalent antigen molecule, DNP (bis-N-2,4-
dinitrophenyloctamethylenediamine) and anti-DNP IgE antibodies, conjugated 
with 12 nm gold nanoparticles. A macroscopic purple precipitate and a clear 
supernatant were evident after incubating overnight at 4 °C. TEM examination of 
the aggregates established the presence of large disordered three dimensional 
networks of discrete gold nanoparticles. The biomolecular specificity of the 
ligand-induced recognition was confirmed by a control experiment in which the 
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DNP antigen was added to a sol of Au nanoparticles conjugated with anti-biotin 
IgG antibodies. In this case, no precipitate was observed (Shenton, Davis et al. 
1999; Mann, Shenton et al. 2000).  
 
Streptavidin (STV)-biotin binding is an ideal model for studies on nanoparticle 
aggregation based on protein-ligand interactions. Being a small ligand, the 
complex is extremely stable over a wide range of temperature and pH (Mann, 
Shenton et al. 2000). Connolly and Fitzmaurice (Connolly and Fitzmaurice 1999) 
and Mann et al.. (Mann, Shenton et al. 2000) have used the STV-biotin interaction 
to organise an ordered assembly of nanoparticles. The immediate change of the 
suspension colour from red to blue was indicative of the formation of recognition 
driven assembly of nanoparticle networks. Studies by dynamic light scattering 
(DLS), showed that the average radius of all particles in suspension rapidly 
increased due to the STV-directed assembly (Niemeyer 2001). Analysing the 
aggregates by TEM revealed clusters of nanoparticles with an average of 20 
interconnected particles that were separated by about 5 nm. This inter-particle 
distance correlates with the diameter of an STV molecule. The results were also 
confirmed by Small Angle X-ray scattering (SAXS) technique. 
 
Using protein coated gold nanoparticles; a simple colorimetric sensor was also 
designed for studying the conformational changes in a protein. The 
conformational changes in the yeast iso-1-cytochrome c due to pH changes 
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caused measurable shifts in the colour of the respective protein coated gold 
nanoparticle suspensions, and it was detected by UV-Vis absorption 
spectroscopy (Chah, Hammond et al. 2005).  
 
The versatility of using gold nanoparticles in association with the antigen-
antibody recognition system should make it possible to produce a wide range of 
nanoparticle aggregates involving specific cross-linked structures, compositions 
and macroscopic architectures (Shenton, Davis et al. 1999). Such nanoparticle-
based receptors may generate novel probes for the recognition of various 
biomolecular specific ligands, and thus may provide novel tools for 
immunoassays and biosensors (Niemeyer 2001). This chapter mainly deals with 
an attempt made to utilize the surface plasmon resonance property of gold 
nanoparticles using the OMP85 antigen and anti-OMP85 antibody system.    
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4.2. Materials and Methods 
 
Materials 
All glassware was scrupulously clean. Glass and plastic containers and stirrers 
were cleaned in aqua-regia and thoroughly washed in Milli Q water. Aqua regia 
(3:1 HCl:HNO3) was made fresh each time. 13 nm gold nanoparticles were 
prepared by citrate reduction method. The larger size gold nanoparticles (30nm, 
40nm, 50nm and 60nm) used in this chapter were purchased from the British 
Biocell Ltd., UK. Molecular cut-off filters were obtained from Millipore Ltd., 
USA. Lysozyme and anti-lysozyme antibody were obtained from Sigma-Aldrich 
Ltd., USA. Bio-Rad Bradford assay reagent was used for protein estimation. All 
reagents were of high quality analytical grade and were filtered using 0.45µ 
nylon membrane filter, immediately before use. 
 
4.2.1. Conjugation of OMP85 and anti-OMP85 antibody molecules 
to different size gold nanoparticles 
 
Antibodies and antigens were attached to the surfaces of Au nanoparticles by 
identical procedures described in Chapter 3. The OMP 85 protein purified by 
sonic extraction method (Chapter 2) and protein A purified rabbit anti-OMP 85 
polyclonal antibody were re-suspended in 5 mM sodium carbonate buffer pH 
9.4, using 30 kDa molecular cut-off filters separately to achieve a final 
concentration of the protein of 5mg/mL as determined by Bradford assay. 
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To separate glass vials containing 6.0 mL of each size nanoparticles suspension 
(13, 30, 40, 50 and 60 nm) of gold nanoparticles (BBI, UK), 250 µl of protein 
solution (in carbonate buffer) was added and mixed gently on a shaker for 30 
minutes at room temperature.  To block the unbound sites on the gold 
nanoparticles surface, 250 µl of 5 mg/mL BSA in 5 mM sodium carbonate buffer 
pH 9.4, was added to the above conjugated gold nanoparticle suspensions and 
mixed gently on a shaker for another 30 minutes at room temperature.  
             
Excess protein and gold nanoparticles were removed from the individual size 
nanoparticles conjugation mixture by centrifugation at at 5000 to 20, 000 x g for 
45 minutes, at 4 °C, depending on the size of nanoparticles. The supernatant 
liquid was discarded and the pellet resuspended in low ionic strength 10 mM 
sodium phosphate buffer pH: 7.4. The washing step was repeated twice to 
remove any traces of unbound protein and BSA. Finally, the protein conjugated 
gold nanoparticles were resuspended in 5.0 mL of 10.0 mM sodium phosphate 
buffer pH 7.4.   
 
The optical absorption spectra of these systems were acquired using Hitachi U-
2000 dual-beam spectrophotometer using 1 cm path length quartz cuvettes. The 
absorbance of the supernatants was also measured in order to establish any 
presence of free protein or gold. To prevent light induced aggregation, all 
colloidal gold conjugations were stored in glass vials or polypropylene 
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centrifuge tubes in the dark at 4 °C. The suspensions were stable for several 
months.  
 
4.2.2. Coupling of nanoparticle-protein conjugates 
To verify the antigen and antibody mediated gold nanoparticle coupling of 
surface plasmons, 250 µl of anti-OMP85 antibody conjugated 13-60 nm gold 
nanoparticles in 10 mM sodium phosphate buffer pH 7.4 and 250 µl of OMP85 
conjugated 13-60 nm gold nanoparticles in 10 mM sodium phosphate buffer pH 
7.4 were added in a 48 well plate. All the combinations were carried out in 
triplicate. 
 
OMP85-conjugated gold nanoparticles (500 µl) and 500 ul of anti-OMP 85 
antibody conjugated gold nanoparticles were added to separate wells as controls. 
Native gold nanoparticles of each size (500 µl) were also added to separate wells 
as controls. They were mixed gently and then 100 µl of varying NaCl 
concentration were added (to a final concentration in the range from 2.0 mM to 
256 mM) to each combination of nanoparticles. They were mixed gently at room 
temperature. 
   
The colour shift was observed visually in specific combinations. The absorbance 
change at 620 nm was also measured within 5 minutes in a Hitachi U2000 UV-vis 
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absorption spectrophotometer. The schematic representation of the coupling 
procedure is given in the following Figure 4.1.  
 
Control system was tested using lysozyme/anti-lysozyme antibody conjugated 
13 nm gold nanoparticles without the addition of salt.     
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Figure 4.1. Schematic representation of antigen and antibody mediated gold 
nanoparticle coupling of surface plasmon resonance. 
250 µl of Ab conjugated 13-60 
nm gold nanoparticles in 5 
mM phosphate buffer pH: 
7.4. 
250 µl of Ag conjugated 13-60 
nm gold nanoparticles in 5 
mM phosphate buffer pH 
7.4. 
Mixed both of the solutions 
and 100 µl varying 
concentration of NaCl was 
added. Mixed at room 
temperature.  
Colour shift from red to blue 
was observed immediately in 
case of a specific antigen and 
antibody interaction. 
A non-specific antigen/antibody 
may be used to prove the 
concept. Absorbance at 620nm 
was measured. 
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4.3. Results 
 
4.3.1. Gold nanoparticle Conjugation 
Different size fractions of gold nanoparticles were successfully conjugated with 
OMP 85 and anti-OMP 85 antibodies. After separating the unbound proteins 
from the bound proteins, conjugated nanoparticles were resuspended in 10 mM 
sodium phosphate buffer pH 7.4 and the suspension appeared in ruby red 
colour. The absorbance at around 520 nm of the conjugated gold nanoparticles 
revealed slight or no difference in the absorbance in comparison to the native 
gold nanoparticles. After successful conjugation, the colloidal gold particles did 
not show any sign of non-specific aggregation. Reagent preparations stored at 
4°C for approximately 6 months were evaluated and shown to have no 
substantial loss in reactivity. 
 
4.3.2. Coupling of nanoparticle conjugates 
The coupling of surface plasmons of individual gold nanoparticles due to 
binding of OMP 85 and anti-OMP 85 antibodies in the presence of salt and 
subsequent colour shift from red to blue was studied. In presence of increasing 
NaCl concentration (to a final concentration in the range 2 mM to 256 mM NaCl), 
there was no observable colour shift in 13, 30, 40 and 60 nm size gold 
nanoparticles conjugated with OMP 85 and anti-OMP 85 antibodies. The 
absorbance at 620 nm of coupled nanoparticles remained below or identical to 
the individual conjugated nanoparticles. Plain gold nanoparticles of all sizes 
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aggregated immediately with salt addition and the suspension colour turned 
blue.   
 
However, in the case of coupling of 50 nm gold nanoparticles conjugated with 
OMP 85 and anti-OMP 85 antibody, the colour changed from red to blue and 
thus a change in absorbance at 620 nm as seen in Figure 4.2. Wavelength scans 
from 190-800 nm (Figure 4.3.) showed a significant difference in absorbance in 
the range 600-800 nm in case of OMP85 and anti-OMP85 antibody coupling in 
comparision to the absorbance of individual conjugated nanoparticles in the 
presence of same salt concentration. Colour changed from red to blue 
immediately in a specific antigen-antibody interaction, but no colour shift was 
observed in the controls with BSA conjugated 50 nm gold nanoparticles and anti-
OMP85 antibody conjugated 50 nm gold nanoparticles. 
 
It was found that, coupling of the 50 nm OMP85 conjugated gold nanoparticles 
with the anti-OMP85 antibody conjugated nanoparticles and subsequent spectral 
shift was not reproducible (6 out of 23 times) under identical conditions. Figure 
4.4. shows images of the colour shift experiment and their corresponding TEM 
images of the nanoparticle assemblies. 
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(a) 13 nm gold nanoparticle spectral change with variable NaCl 
concentrations. 
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(b) 30 nm gold nanoparticle spectral change with variable NaCl concentrations. 
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(c) 40 nm gold nanoparticle spectral change with variable NaCl 
concentrations. 
 
0 100 200 300 400 500 600 700 800 900 1000 1100
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
Coupling
Plain AuNP
AuNP+anti-OMP85
AuNP+OMP 85
NaCl Conc. (125-1000 mM)
Ab
so
rb
an
ce
 
a
t 6
20
 
n
m
 
(d) 50 nm gold nanoparticle spectral change with variable NaCl concentrations. 
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(e) 60 nm gold nanoparticle spectral change with variable NaCl concentrations. 
 
Figure 4.2. Red shift of gold nanoparticles and nanoparticle-protein conjugates to 
600-800 nm due to coupling of surface plasmon resonance induced by specific 
interaction of OMP85 and anti-OMP85 antibody conjugated gold nanoparticles of 
different sizes. (a) 13 nm, (b) 30 nm, (c) 40 nm, (d) 50 nm and (e) 60 nm colloidal 
gold nanoparticles. 
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Figure 4.3. Absorption spectra of the OMP85 and anti-OMP85 antibody 
conjugated 50 nm colloidal gold nanoparticles. Mixing the two conjugates 
resulted in a red shift of the wavelength to 600-800 nm which resulted in colour 
shift from red to blue. 
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Figure 4.4. Images of red to blue colour shift experiment using OMP85 antigen 
and anti-OMP85 antibody conjugated 50 nm gold nanoparticles (with 0.512M 
NaCl) and their corresponding TEM images. 
 
 
4.3.3. Lysozyme and anti-lysozyme antibody coupling 
The coupling of surface plasmons of individual gold nanoparticles (13 nm) due 
to binding of lysozyme and anti-lysozyme antibodies and subsequent colour 
shift from red to blue was also studied as a model system. The colour changed 
from red to blue indicating a change in absorbance at 620 nm. There was a 
significant difference in absorbance at 620 nm in the case of lysozyme and anti-
lysozyme antibody coupling in comparison to the absorbance of individual 
conjugated nanoparticles (Figure 4.5.). No colour shift was observed in the 
controls with BSA conjugated 13 nm gold nanoparticles and anti-lysozyme Ab 
conjugated 13 nm gold nanoparticles. 
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Figure 4.5. Proof of concept experiment using lysozyme and anti-lysozyme 
antibody conjugated 13 nm colloidal gold nanoparticles (n=0.2). 
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4.4. Discussion 
In this chapter, the distance-dependent optical properties of gold nanoparticles 
are evaluated as a novel method for detecting a N. meningitidis specific antigen as 
aggregated gold nanoparticles conjugated with specific antigens and antibodies. 
The capacity of colloidal gold to undergo a chromic transition upon aggregation 
makes possible its use as reporter agents for immunodiagnostic applications 
where it can provide a visible range of detection. Aggregation of gold 
nanoparticles by utilising OMP 85 and anti-OMP 85 antibody systems was used 
to demonstrate that gold nanoparticle aggregates could be directed by 
biomolecular recognition.  
 
The potential of a rapid diagnostic assay for N. meningitidis by utilising the 
specific interaction of OMP 85 and anti-OMP 85 antibody conjugated to gold 
nanoparticles was evaluated as a model system. It was postulated that specific 
interaction of OMP85 and anti-OMP85 antibody coated nanoparticles leads to 
coupling of surface plasmons and thus readily observable colour shift occurs. 
 
Following the detailed biochemical characterisation of both the OMP85 antigen 
and the anti-OMP85 antibody receptors, they were conjugated by simple 
electrostatic adsorption to gold nanoparticles of different sizes in the range 13 – 
60 nm and tested for their ability to bind with resulting colour shifts due to SPR 
effects. It has been reported previously that, in order to observe the aggregation 
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induced colour shift, the gap between the nanoparticles should be less than the 
average diameter of the individual gold nanoparticles (Kreibig, Schmitz et al. 
1987; Elghanian, Storhoff et al. 1997). In that case, the size of the nanoparticles is 
related to the size of the biomolecules. This was evaluated in a model system 
with the lysozyme and anti-lysozyme interaction, where a red shift was observed 
with 13 nm gold nanoparticles. In order to verify the optimum size range of the 
nanoparticles to achieve such a colour shift, OMP85 and anti-OMP85 antibody 
molecules were conjugated with 13, 30, 40, 50 and 60 nm gold nanoparticles. 
 
The optimal pH and the minimum amount of OMP85 antigen and anti-OMP85 
antibody required for optimal coating of the particles by charge adsorption were 
determined by a series of concentration-dependent experiments and by 
isothermal titration. A critical flocculation concentration assay, based on the red 
to blue colour change of the native gold nanoparticles in the presence of high salt 
concentrations, were used to determine the optimum protein-colloidal gold ratio 
required for effective surface coverage for increased stability (as indicated by no 
red to blue colour change). The colloidal aggregation observed under these 
conditions for the uncoated colloid was arrested due to the adsorbed protein 
molecules.  
 
The optical spectrum of a suspension of gold nanoparticles conjugated with 
OMP85 or anti-OMP85 antibody did not significantly deviate from the 
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absorption spectrum of the bare gold nanoparticle suspension not showing a 
broadening of the spectrum or formation of a new absorption band. With all size 
fractions of nanoparticles after conjugation, a 3-5 nm shift of the plasmon peak 
was observed compared to that of the original gold nanoparticles. The probable 
reasons responsible for this shift were explained in Chapter 3 (Hayat 1991; Nath 
and Chilkoti 2002). These assembled protein-gold nanoparticle bioconjugates in 
aqueous suspension maintained their activity with enhanced stability and similar 
pH dependence. This clearly indicates that the protein conjugated gold 
nanoparticles have a high dispersivity in suspension without aggregation and in 
addition showed long-term stability at 4°C. 
 
During the coupling experiment in the presence of a particular salt concentration, 
no colour shift was observed with different size nanoparticle combinations 
except in the case of 50 nm gold nanoparticles. With the coupling of 50 nm gold 
nanoparticles conjugated with OMP85 and anti-OMP85, a broadening of the 
spectrum and the formation of a new absorption band at wavelengths longer 
than 600 nm was observed, indicating particle aggregation. Binding resulted in 
an immediate change in the SPR signal, which was observed as a colour shift, 
indicating directly the presence of a specific interaction. No colour shift was 
observed in case of the controls which occurred with only either gold 
nanoparticle-OMP85 conjugates or gold nanoparticle-anti-OMP85 antibody 
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conjugates demonstrating that the aggregation was due to the OMP85-anti-
OMP85 antibody specific interaction.  
  
In the case of plain gold nanoparticles, the addition of electrolytes caused 
flocculation as a result of the shielding of the repulsive double-layer charges 
which normally stabilise them. Whereas, the presence of a minimal quantity 
(CFC) of electrolytes in the protein-conjugated nanoparticle suspensions may 
help to keep the conjugated proteins in flexible conformation rather than as a 
rigid mass. This may provide better access of the antigen to the antibody. It has 
been reported that nearly 20% of the attached protein molecules are not available 
for coupling. This is most likely to be caused by steric hindrance effects, which 
prevents some of the adsorbed proteins from binding to targets. Thus presence of 
low levels of electrolytes can increase the probability of specific antigen-antibody 
interaction, when conjugated to gold nanoparticles. 
 
The SPR effect becomes negligible when the gap between the nanoparticles is 
larger than about 2.5 times the short-axis length (Su, Wei et al. 2003). As the 
spacing between particles was reduced by less than their average diameter, the 
surface plasmon resonance peak was shifted to higher wavelength and this shift 
is well described as an exponential function of the gap between the two particles 
(Sidhaye, Kashyap et al. 2005). Because the colour change depends on the 
nanoparticle spacing, the size of the nanoparticles is a defining characteristic of 
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the system considering the size of the proteins and antibodies. Thus, smaller 
nanoparticles with an average diameter much lesser than the size of the protein 
are likely to be ineffective in yielding a colour shift. This is indicative of the 
reason why the colour shift was observed only in the case of 50 nm gold 
nanoparticles. The average diameter of the 60 nm gold nanoparticles may be 
greater than the distance between the nanoparticles brought about by the 
coupling of OMP 85 and anti-OMP 85 antibody and hence the colour shift was 
not observed. 
 
Liu et al.. used nanoparticles with larger sizes, to accelerate the rate of colour 
change (Liu and Lu 2004). It is known that the optical properties of a 
nanoparticle aggregate are dominated by their size, rather than the number of 
nanoparticles in the aggregate. Therefore, a lower degree of aggregation would 
be required to give the same spectral shift with larger nanoparticles, and the time 
required for the colour change should be decreased (Liu and Lu 2004). This was 
indeed what was observed. The colour change approached completion in less 
than 10 min for 50nm nanoparticles. Formation of large aggregates, which 
changes the proximity of colloidal gold nanoparticles in suspension cause large 
changes in the absorbance spectrum of the colloidal suspension due to long-
range coupling of surface plasmons. 
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During the antigen-antibody induced aggregation process of gold nanoparticles, 
the change in visible absorbance, and shift toward longer wavelengths, is 
proportional to the concentration of ligand involved and occurs according to the 
kinetics of the interaction process. Such quantitative results may be obtained by 
monitoring the ratio of extinction at the plasmon peak (532 nm) to the 600-800 
nm. This ratio was higher with separated nanoparticles of red colour, while a 
lower ratio was associated with aggregated nanoparticles of blue colour. 
 
The combination of OMP85 and anti-OMP85 antibody affinity binding detection 
system shows the advantages such as, a very short procedure time, no fading of 
the signal and high spatial resolution. Therefore, this new approach potentially 
offers an addition to other methods for the diagnosis of meningitis.  
Nevertheless, it was noted that the assay, as conducted at room temperature was 
not completely reproducible, even from the same batch of conjugate preparation. 
 
There may be different factors responsible for affecting the reproducibility of the 
system. The aggregation rate depends primarily on the collision frequency of the 
particles, which is directly related to the concentration of gold nanoparticle 
conjugates within the analyte solution. Ligand-conjugated gold nanoparticles 
need to maintain good dispersion and long-term stability for use as signal 
amplification probes. Several methods have been used to improve the 
dispersivity in aqueous suspension by controlling the ligand density on the 
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surface of the gold nanoparticles and by utilizing surfactants like Tween-20 have 
definitely increased the stability of the particles. 
  
Gold nanoparticle aggregation depends on the coverage of the monolayer 
formed on the colloidal gold surface and that the antigen/antibody concentration 
used for conjugation was the critical concentration to observe specific 
aggregation of gold nanoparticles in this system. There is thus a critical surface 
concentration for each protein, at which the gold nanoparticles may be 
appropriately stabilised with room available for the coupling of surface 
plasmons to occur between the particles. 
 
Nanoparticles may also be covalently cross-linked to a specific functional group 
on a targeted biomolecule (Li, He et al. 2007) such that this site-specificity allows 
it to be conjugated at a position remote from the binding site so that it does not 
interfere with substrate binding. Specific peptides in place of proteins and Fab' 
fragments in place of whole antibodies may also be used with small size 
nanoparticles (Lee, Oh et al. 2006). Consequently, a single connection between 
two particles could produce differences in the antigen-binding affinities of the 
remaining uncoupled surface-attached antibodies, depending on their proximity 
to the interparticle cross-link (Shenton, Davis et al. 1999). The ability to fabricate 
the nanoparticle aggregates with controlled connectivity requires a specific 
design approach of the antibody-antigen interface. Indeed, the versatility of 
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using gold nanoparticles in association with antigen-antibody engineering may 
ultimately make it possible to assemble a wide range of nanoparticle-based 
diagnostic assays against different pathogens. 
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Chapter 5 
 
Quartz Crystal Microbalance as an Immunosensor 
 
 
5.1. Introduction 
The combination of highly specific recognition properties of biological 
macromolecules and the sensitivity of various transducers, such as optical, 
thermal, gravimetric, electrochemical and surface acoustic wave sensors, has led 
to the development of sensitive and selective biosensors as valuable tools in 
analytical biochemistry. Acoustic wave sensors based on the piezoelectric 
properties of materials such as quartz crystal resonators demonstrate a linear 
relationship between mass adsorbed on to the surface and the resonant 
frequency of the crystal in air or a vacuum (Vidal, Garcia-Ruiz et al. 2003). 
 
When an electrical field is applied through the quartz crystal, the inner dipoles 
are reorientated to create a mechanical strain. In 1920, Cady used the reverse 
piezoelectric effect in which case, mechanical vibrations of the crystal were 
observed due to deformation under an alternate electric field. The degree of 
deformation in a piezoelectric quartz crystal depends on the applied potential 
(Shana and Josse 1994). When the applied potential is altered, an oscillatory 
motion is generated, which then forms an acoustic wave in the material. It was 
found that, when this arrangement was included in an appropriate electronic 
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circuit, the measured oscillation frequency was close to the resonant frequency of 
the quartz crystal and this generated the maximum wave amplitude. Ultrasonic 
waves are also generated when the quartz crystal is vibrating near its resonant 
frequency. Thus, a modification of the mass or the thickness of the resonator, led 
to a resonant frequency variation. In biosensors, mass changes occuring on the 
crystal surface due to the various biomolecular interactions, are measured.  
 
A biosensor is an analytical tool consisting of two components: a receptor and a 
detector. The receptor is responsible for the selectivity of the sensor and the 
biorecognition elements that act as receptors include antibodies, enzymes 
(Bentley, Atkinson et al. 2001) or whole living cells (Nomura and Okuhara 1982). 
The transducer translates the biophysical or biochemical signal into an electrical 
signal, which is measured by the detector. Thus, similar principle applies to a H-
electrode, an oxygen electrode or a piezoelectric crystal (Figure 5.1.). 
 
 
 
 
 
 
 
Figure 5.1. Schematic for a general Biosensor (Bogdan 2005) 
Receptor/ 
Molecular 
recognition 
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One promising simple form of a detector that fits the above criteria is the Quartz 
Crystal Microbalance (QCM). The QCM is a piezoelectric mass-sensing device 
that detects changes in frequency of the crystal due to changes in mass on the 
surface of the crystal. 
 
Application of biosensors to biological samples became possible only after 
suitable oscillator circuits which could operate in liquids were developed 
(Suleiman and Guilbault 1991). The selectivity provided by the biological 
coatings together with the intrinsic sensitivity of the piezoelectric (PZ) devices 
and the ability to oscillate the crystal in liquid medium have induced a rising 
interest in this class of sensors (Castillo, Gaspar et al. 2004). Biosensors are being 
used in a variety of different fields, ranging from pesticides to biological 
weapons.  
 
As mentioned earlier, biosensors based on acoustic wave propagation utilize a 
piezoelectric material such as quartz crystal. Depending on the cut-angle of the 
quartz mother crystal, different resonator types may be obtained with 
frequencies ranging from 5×102 to 3×108 Hz. Acoustic waves cover a frequency 
range of 14 orders of magnitude, starting from 10-2 Hz (seismic waves) and 
extending to 1012 Hz (thermoelastic excited phonons). The acoustic resonators 
generally oscillate in a narrow frequency range of 106-109 Hz. The four common 
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types of acoustic resonators are surface-acoustic-wave (SAW) resonator, acoustic-
plate-mode (APM) resonator, flexural-plate-wave (FPW) resonator and 
thickness-shear-mode (TSM) resonator, also known as the quartz-crystal 
microbalance (Martin, Frye et al. 1994). Here, only TSM resonators are discussed 
as it is relevant to the study. 
 
5.1.1. Thickness-Shear-Mode (TSM) Sensors (Quartz-Crystal 
Microbalances)  
TSM resonators are also referred as bulk-acoustic-wave (BAW) resonators or as 
quartz-crystal microbalances (QCMs) (Buttry and Ward 1992). TSM devices work 
due to the acoustic wave propagation inside a quartz plate.  
 
The active element of a QCM is formed by a thin round plate of AT-cut quartz 
crystal (cut with an angle of 35.25° to the z-axis or 35° 10  with respect to the 
optical axis) with two gold electrodes deposited on the two opposite sides. These 
electrodes allow an alternating electrical field to be applied and the quartz crystal 
oscillates near its resonant frequency or at an overtone. When a mass is added or 
removed, this is considered as an increase or a decrease of the crystal’s thickness 
(Sauerbrey 1959) and thus as a result, the resonance frequency decreases (Turner 
2000). In general, the classical working frequencies for QCM range between 5 
MHz to 10 MHz. 
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QCM can measure the mass and the thickness of an analyte bound in real time. 
Many platforms based on TSM sensors, have been developed for the analysis of 
binding specificities, affinities, kinetics and conformational changes associated 
with a molecular recognition event (Buttry and Ward 1992). Even though 
flexural-plate-wave (FPW) or surface-acoustic-wave (SAW) sensors are more 
sensitive in comparison to TSM resonators, TSM sensors are widely preferred 
due to their robust nature, availability, and affordable electronics.  
 
5.1.2. The QCM Operating Principle 
Lostis (Lostis 1958), Sauerbrey (Sauerbrey 1959) and Stockridge (Stockbridge 
1965) all derived equations to explain the relationship between the resonant 
frequency of an oscillating piezoelectric crystal and the mass loaded on the 
crystal surface (Kumar 2000). Although, each one of them followed a different 
path and came to a similar conclusion, the Sauerbrey equation is most widely 
accepted equation to describe this relationship between mass and frequency 
change (Sauerbrey 1959).  
 
where ∆f is the frequency change in oscillating crystal in Hz, and  
 ∆m is the mass of deposited film in g  
 f0 is the resonant frequency of the crystal or the initial standing wave, 
 A is the active area of the crystal surface in cm2 (between electrodes),  
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 ρq is the density of quartz, 
µq is the shear modulus of quartz, and 
vq is the shear wave or oscillation wave velocity with in the quartz crystal.  
 
Studies of the spatial distribution of the differential mass sensitivity on the QCM 
crystal have found that the sensitivity is maximum in the centre of the quartz 
crystal and decreases towards the borders of the crystal  (Sauerbrey 1959; Buttry 
and Ward 1992). However, if the thickness of the electrodes is too thin (usually 
less than 500 Å), the resonant frequencies and thus the mass sensitivities of the 
entire crystal surface is very similar. The frequency shift obtained can be 
corrected to minimize these bulk effects (Schumacher, Borges et al. 1985; Urbakh 
and Daikhin 1994). 
 
5.1.2.1. Sauerbrey relationship limitations 
The equation is valid only when the following conditions are fulfilled: (i) the 
resonator is operated either in air or vaccum, (ii) the adsorbed mass is distributed 
evenly over the crystal. (iii) ∆m is much smaller than the mass of the crystal itself 
(less than 1%), (Lu and Lewis 1972; Bandey, Martin et al. 1999) and (iv) the 
adsorbed mass is rigidly attached, with no slip or inelastic deformation in the 
added mass due to the oscillatory motion. 
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The Sauerbrey equation is valid only for thin, rigid, uniform and purely elastic 
added layers. The deposition of the layer is thus treated as a thickening of the 
crystal mass (Muratsugu, Ohta et al. 1993) and thus is assumed that the added 
layer possessing the same acoustic properties. It does not apply for thick films, 
viscous liquids, elastic solids, and viscoelastic bodies, since the density would 
change and viscous coupling would change. These limitations are in general due 
to a non-ideal behaviour of the added film. 
 
Biomolecules bound to a sensor surface cannot be considered completely rigid 
because biological systems operate in liquid environments and also the 
biomolecules coordinate with water which will enhance the sensor signal. Due to 
high damping with liquid loads, the development of special oscillator circuits 
was necessary to operate in liquids (Ward and Delawski 1991; Josse, Lee et al. 
1998). The amplitude of vibration is usually 10-20 nm in air and is reduced in 
water to a mere 1-2 nm (Cooper and Singleton 2007).  
 
However, using radio-isotope labelling methods, Muratsugu and coworkers 
have shown that under a liquid environment, the linear relationship between 
mass and frequency response will persist with a coefficient of about 4 
maintaining the frequency-to-mass relationship (Muramatsu, Tamiya et al. 1988). 
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This was then further developed by Kanazawa (1997), who expanded the model 
to Newtonian (viscous and lossy) liquids. The following equation describes the 
frequency shift for liquid- loaded sensor surface in which the liquid is defined by 
its density ρ1 and viscosity η1:  
 
in which µq is the shear modulus in x-direction and ρq is the density of the 
crystal. This equation can be derived by calculation of an effective mass loading 
based on the penetration depth of the transversal wave propagated from the 
crystal surface into the liquid.  
 
5.1.2.2. Dissipation factor 
For systems operating under vacuum, in gas or in liquid, energy is lost, that is 
dissipated, during oscillation (Buttry and Ward 1992). For example, energy is lost 
in liquids due to frictional losses within the liquid as well as between the 
adsorbate and the liquid (Uttenthaler, Kolinger et al. 1998). 
 
Kasemo and co-workers first described the quartz crystal microbalance with 
dissipation (QCM-D) technique, that measures the mechanical properties of an 
adsorbate, such as viscosity, elasticity, density and thickness. This QCM-D 
technique allows the resonance frequency and dissipation factor to be monitored 
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simultaneously (Buttry and Ward 1992; Rodahl, Hook et al. 1997). In this 
technique a quartz plate is excited with a frequency generator and the free decay 
of the oscillation is recorded by switching off the source and the procedure is 
repeated each second. The dissipation factor together with the resonance 
frequency is obtained by a curve fit. The Quality factor, Q is simply the inverse of 
D and sometimes this Q factor, Q, is used instead of dissipation. 
 
Other factors which affect the frequency of the crystal include, the surface 
roughness (Martin, Granstaff et al. 1991; Yang and Thompson 1993), water 
trapped in surface cavities (Buttry and Ward 1992) etc. The frequencies shifts 
obtained could be corrected to minimize these bulk affects. 
 
5.1.3. Applications 
The first analytical application of a PZ detector was reported by King in 1964 
(King 1964). The initial applications of the piezosensors were limited to 
measurement in the gas phase, because of the common belief at the time that 
stable oscillations could not be obtained in the liquid phase. However, with the 
development of new powerful oscillator circuits, it was shown that quartz 
crystals can oscillate in contact with solution (Martin and Hager 1989) and that 
enabled this technique to be introduced into bioanalytical applications. Since 
then, there has been a growing interest in the design of biosensors capable of 
detection in the areas of health eg. clinical diagnosis and environmental 
  223
monitoring eg. food and water-quality control. Although there is an extensive 
literature on the applications of QCM in various fields, the application only 
relevant to this present study is discussed.  
 
5.1.3.1. Analysis of protein-protein interactions using QCM technique  
QCM has been employed for the study of a range of protein-protein interactions. 
To continuously monitor the frequency during protein-protein interactions, a 
continuous liquid-phase piezoelectric biosensor for kinetic immunoassay was 
developed by Davis and Leary (Davis and Leary 1989), facilitating the observation 
of both the extent and the kinetics of these interactions. A number of protein-
protein interactions have been studied such as, specific interactions of proinsulin 
C and engineered anti-C peptide antibodies (Caruso, Rodda et al. 1997) and the 
affinity of myocardial infarction marker troponin T for α-tropomyosin (Salvay, 
Grigera et al. 2003). The QCM technique has also been used to study the influence 
of cations, anions and solvent on protein–protein interactions (Wang, Jiang et al. 
1998). 
 
5.1.3.2. Piezoimmunosensors  
Despite the established ELISA technique (Engvall 1980), the development of 
rapid, simple and label-free immunosensors based on piezoelectric transducers 
has been widely investigated due to their attractive applications in mass sensitive 
detection (Suleiman and Guilbault 1994). Such immunosensors are valued 
because, if there is an antibody against a particular analyte, an immunosensor 
  224
may be developed to recognize it. The piezoelectric immunosensor, as one of the 
most sensitive analytical instruments developed to date. 
 
5.1.3.2A. Immobilization 
In general, the immobilization of proteins is accomplished by a range of methods 
including, (a) simple physisorption (Voros 2004), or (b) by electrostatic 
interaction (Zhi and Haynie 2004), or (c) by covalently linking through amines 
(Melles, Anderson et al. 2005), or (d) using thiol-containing compounds (Zhu, 
Bilgin et al. 2001), or (e) attachment by affinity interactions. The recent 
immobilization methods use materials such as a silanized layer (Babacan, 
Pivarnik et al. 2000), sol–gel matrices (Unen, Engbersen et al. 2001), polymer 
membrane (Su and Li 2004), Langmuir-Blodgett film (Walter, Bussow et al. 2000), 
or self-assembled monolayer (SAM) (Angenendt, Glokler et al. 2003). However, 
simple nonspecific immobilization techniques on flat surfaces utilize soft 
membranes such as PVDF (Walter, Bussow et al. 2000) and nitrocellulose 
membrane (Joos, Schrenk et al. 2000) or poly(L-lysine). 
 
Antibody immobilization is a very important step for successful fabrication of a 
piezoelectric immunosensor. Antibodies immobilized on a solid-phase surface 
usually show less binding activity than that of soluble antibodies (Sokoll and 
Chan 1999), likely due to a combination of steric-hindrance effects of the 
molecules on the solid-phase (Kele, Nagy et al. 2006) and the random orientation 
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of the antibody molecules on solid-phase surface (Herr, Throckmorton et al. 
2005). Thus, there is a requirement to develop improved methods for the 
immobilization of antibodies in a highly oriented manner with increased binding 
activity.  
 
Affinity tag based immobilization techniques include, such as biotin, hexa-His 
tag, or glutathione S-transferase (GST), avidin coated surfaces, (Schäferling, Riepl 
et al. 2003) Ni-NTA-coated (Zhu, Bilgin et al. 2001), and glutathione coated 
surfaces (Kawahashi, Doi et al. 2003), Protein A or Protein G coated surfaces to 
immobilize immunoglobulin G (IgG) (Byung-Keun, Young-Kee et al. 2003), 
respectively. 
 
5.1.3.2B. Immunosensing in the gaseous phase 
Coating of a PZ crystal with an antigen was first demonstrated by Shons et al. 
(Shons, Dorman et al. 1972) on a surface precoated with a low surface energy 
plastic coating, nyebar C (30% solution in 1-3 di [trifluoromethyl] benzene), 
providing a layer capable of forming hydrophobic bonds with proteins such as 
BSA. An improved indirect assay method for the determination of antigens was 
reported by Oliveira et al. (Oliveira and Silver 1980). A method for determination 
of both the type of antibody subclass and the concentration of antibody present 
was patented by Rice (Rice 1980; Rice 1982). The detection of gaseous substrates 
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by PZ immunosensors was first reported by Guilbault and co-workers (Ngeh-
Ngwainbi, Foley et al. 1986). 
 
5.1.3.2C. Immunoassay in the liquid phase 
The detection of analytes in solution reported before have been carried out by 
comparing the resonant frequency of the crystal before and after exposure to the 
test sample and the frequency measurement were subsequently carried in the gas 
phase. However, in 1982, Nomura and Okuhara (Nomura and Okuhara 1982) 
were the first to design a device capable of operating in fluids, which became the 
starting point for the development of a new class of bioanalytical tools. 
  
The first online detection of antibody-antigen reactions in aqueous solutions 
originally started with the work of Roederer and Bastiaans on SAW sensors  
(Roederer and Bastiaans 1983; Roederer and Bastiaans 1988) to detect human IgG 
in solution. Thompson et al. (Thompson, Arthur et al. 1986) evaluated the 
response of a AT-cut quartz plate device, applied for the the detection of IgG in 
solution under various conditions including stationary and flowing water, 
change of interfacial chemistry, and different aqueous viscosities. 
 
Unlike the above mentioned findings, Muramatsu et al. (Muramatsu, Dicks et al. 
1987) demonstrated that an immobilized layer of protein A placed on the surface 
of crystals modified with (ϒ-aminopropy1)triethoxy-silane could be successfully 
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utilized to determine the concentration of IgG and its subclass in solution. 
Piezoimmunosensors have also been used for the quantitative detection of 
antigen present in sample solution, in a number of studies including tumour 
necrosis factor (Liu, Tang et al. 2004) and human and rabbit IgG (Zhang, Mao et 
al. 2004). A QCM-based immunoassay for the detection of HSA, an early 
indicator of renal disease in diabetic patients have been reported (Sakti, Lucklum 
et al. 2001).  Assays for detection of disease-associated antibodies have also been 
developed for Schistosoma japonicum (Wang, Wang et al. 2002), Toxoplasma 
gondii (Wang, Li et al. 2004) and anti-sperm antibodies (Shen, Tan et al. 2006). 
 
Specific clinical markers can also be analyzed using QCM including plasma 
vitellogenin (Oshimaa, Nakajimaa et al. 2005), cholinesterase (Halámeka, Tellera 
et al. 2006), α-fetoprotein (Chou, Hsu et al. 2002), human ferritin (Chou, Hsu et al. 
2002) and ceruloplasmin (Wang, Li et al. 2004). QCM-D also has also been 
utilized for studying antigen and antibody interactions (Lu, Morimoto et al. 2003) 
and hemocompatibility of biomaterials (Ebersole, Miller et al. 1990; Fawcett, 
Craven et al. 1998). 
 
5.1.3.3. QCM-based detection of microorganisms 
Piezoelectric immunosensors haven also been used for direct detection of 
bacteria. Generally, primary or capture antibodies are immobilized onto gold 
coated AT-cut quartz crystal and the specific binding of bacteria onto the 
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immobilized antibodies ultimately results in decrease of the sensor’s resonant 
frequency. 
 
A number of piezoelectric immunosensors have been developed for rapid 
detection of bacteria including Salmonella typhimurium (Muramatsu, Kajiwara et 
al. 1986), S. paratyphi (Bao, Deng et al. 1996), E. coli O157:H7 (Suleiman and 
Guilbault 1994; Ben-Dov, Willner et al. 1997; Ivnitski, Abdel-Hamid et al. 1999; 
Dmitri Ivnitski 2000)., E. coli K12, Chlamydia trachomatis, Yersisinia pestis, Candida 
albicans (Sato, Endo et al. 1995; Sato, Serizawa et al. 1998), Shigella dysenteriae, 
Staphylococcus epidermidis (Hengerer, Decker et al. 1999) etc. and this has been 
summarized in several reviews (Bizet, Gabrielli et al. 1995). These 
immunosensors generally have a detection limit of 105–107 CFU/mL and show 
minimum or no cross reactivity towards related species. 
 
As an alternative to whole cell capture-based assays, Su et al.. (2001) developed a 
test for Salmonella enteritidis by immobilizing the bacteria to detect the 
corresponding antibodies in 1/100 diluted chicken serum and egg-white 
samples, with a clinical specificity of 100 and 92.9%, respectively (Su, Low et al. 
2001). Direct screening using QCM and virus-specific antibodies has been 
applied to human serum from patients with dengue fever virus infection (Wu, Su 
et al. 2005). 
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The detection of bovine ephemeral fever virus was demonstrated in minutes, 
potentially leading to a rapid diagnostic technique (Lee and Chang 2005). 
Amounts as low as 1 ng of two orchid viruses was detected acoustically by 
immobilizing specific virus antibodies on the sensor surface (Eun, Huang et al. 
2002). Other viral immunoassays reported include those for Tobacco Mosaic Virus 
(TMV) (Rice 1980) herpes simplex type I (HSV1) (Cooper, Dultsev et al. 2001), 
and influenza (Amano and Cheng 2005). A sensitive technique for analyzing 
phage libraries within a short time by using a flow injection system, was also 
achieved by the quartz-crystal microbalance (Tian, Wei et al. 2004). 
 
5.1.4. Amplification of the QCM signal 
Besides the unique optical properties of the gold nanoparticles, the particles also 
have been applied as signal enhancers for QCM based detection (Kim, Baek et al. 
2007). DNA-conjugated nanoparticles have been used to enhance the signal 
produced upon hybridization to a surface-bound single-stranded template 
(Taton, Mirkin et al. 2000; Wang, Xu et al. 2001; Ha, Kim et al. 2004; He and Liu 
2004; Liu, Tang et al. 2004). They were also used to increase the surface area 
available to immobilize the DNA template on a sensor (Liu, Li et al. 2005). 
Detection sensitivity is generally around 10-15–10-16 M, however, Mo et al.. 
reported zeptomolar (10-21 M) sensitivity for the detection of specific nucleic acid 
(Mo, Wang et al. 2005). Different size nanoparticles were used in the range 10-
60nm however, it has been shown that 20 nm is the optimal particle size for 
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maximal sensitivity. The larger particles were found to suffer from weaker 
binding to the surface and are therefore lost on exposure to flow across the 
sensor surface (Tao, Jian et al. 2003). 
 
A unique strategy using gold nanoparticles as signal amplification probes for the 
high-sensitive detection of the streptavidin–biotin interaction on a QCM device 
has been reported (Kim, Baek et al. 2007). Recently, amplification schemes similar 
to sandwich ELISA have been reported (Kolinger, Uttenthaler et al. 1995). Two 
approaches using an amplified mass immunosorbent assay (AMISA) concept 
and a reusable polyvinyl-ferrocene (PV-FC) film coated on the crystal, have been 
described for the detection of adenosine 5’-phosphosulfate (APS) reductase and 
human chorionic gonadotropin (hCG) respectively.  
 
A method designated as latex piezoelectric immunoassay (LPEIA), was 
developed for immunoassay of C-reactive protein (CRP), a marker for acute 
inflammation (Kurosawa, Tawara et al. 1990). In this method, the amplification of 
the frequency shift was observed using antibody-coated latex without any film 
on the crystal. Antibody-coated latex beads were also employed in an assay for 
identification of degradation products of fibrinogen and fibrin (Aizawa, 
Kurosawa et al. 2003). Thus, acoustic sensor technology is thus regarded as a 
highly interdisciplinary and has added advances and improvements ranging 
from from electrical engineering to cell biology.  
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5.2. Materials and Methods 
 
5.2.1. Materials 
Monodisperse suspensions of gold nanoparticles with an average 50 nm particle 
diameter were obtained from British Biocell (UK), while bovine serum albumin 
(BSA), N,N-dimethyl formamide (DMF) and absolute ethanol and methanol were 
obtained from Sigma-Aldrich, USA. Casein was obtained from Ajax chemicals 
Ltd, PVDF membrane (0.45 µm) from Millipore, USA and the 5 MHz gold coated 
QCM sensors were obtained from Maxtek Inc., USA.  
 
The working buffer used in these experiments was 0.1M phosphate buffer (PB) 
pH 7.4. Piranha solution (1:3 H2O2 (30% v/v) : conc. H2SO4), 0.1N NaOH, 0.1N 
HCl were all prepared using analytical reagent grade chemicals. In all instances, 
high purity deionized water was used as a diluent.  
 
5.2.2. QCM instrumentation 
The RQCM Quartz crystal microbalance (Maxtek Inc., USA) allows simultaneous 
measurement of crystal frequency and crystal resistance. The RQCM was used 
with a standard 25 mm diameter polished AT-cut quartz crystal wafer with 
circular electrodes on both sides and coated by gold disc-shaped films deposited 
on chromium underlayers (Figure 5.2.). The electrode area was approximately 
133 mm2 (Maxtek model No. 149211-2). The crystals were mounted in a Maxtek 
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CHT-100 crystal holder which was connected to a flow cell to create a 100 µl flow 
cell.  
   
Figure 5.2. The images of gold coated QCM crystals used in this study. 
 
A high performance phase lock oscillator circuit of the system initiates the 
oscillation of the crystal by a voltage pulse and the crystal is then driven at its 
resonance frequency to achieve the series resonance. The frequency of the 
vibrating crystal was monitored by a multifunction frequency counter. This 
circuit is capable of supporting heavily loaded crystals, up to 5,000 Ohms 
resistance. This circuit also incorporates a potentiometer to adjust the crystal 
capacitance cancellation thus reducing errors caused by stray capacitance of the 
system. This is is essential for accurate measurements in lossy films. This has 
enabled to measure frequency and crystal resistance to a high degree of accuracy 
over wide operating conditions. A software program (RQCM data log program) 
facilitated remote operation and the data acquisition. 
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5.2.3. QCM crystal pre-treatment 
The fabrication of the immunoassay system on 5 MHz AT-cut quartz crystals 
commenced with cleaning the crystals by the following chemical treatment. The 
crystals were pre-treated with 1M NaOH for 10 min, 1M HCl for 10 min, and 
then with Piranha etch solution, in sequence, to obtain a clean gold surface. After 
pre-treatment, the crystals were rinsed with ethanol and water successively and 
dried at room temperature under a nitrogen atmosphere prior to use. 
 
 
5.2.4. Operation of flow-cell 
After the pre-treatment, the 5 MHz AT-cut quartz crystal was mounted in an 
acrylic crystal holder between two O-ring seals inserted in a Teflon cell with 
leads, so that only the gold surface of the crystal was in contact with the liquid. 
The crystal surface was exposed to a 100 µl chamber which was connected to a 
syringe pump (Razel, USA; Model No. A-99.EZ) through 1/16” Teflon tubing 
(Upchurch Scientific Inc., USA). The sample solutions were injected through a 
manually controlled six-way valve (VICI, Cheminert, USA; Model No. 06S-
0373L). All fittings and connectors were obtained from FIA Lab Instruments Inc., 
USA.  
 
The crystal holder was placed at an angle of 30° and sealed to air in order to 
remove the potential of air bubbles remaining on the crystal after filling from the 
dry state and to allow air bubbles in the liquid phase to pass out without 
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adhering to the crystal. This placement of the crystal holder also alters the liquid 
meniscus in order to avoid reflection of induced longitudinal waves at the air-
liquid interface which in turn influence the resonant frequency of the quartz 
crystal. A constant flow rate of 3.0 mL hour–1 was maintained through out the 
experiment. 
 
5.2.5. Preparation of the Self Assembled Monolayer (SAM)-based 
immunosensor  
Rabbit anti-OMP85 polyclonal antibodies purified by protein A sepharose 
chromatography were used (Chapter 2) in these studies. Anti-OMP85 antibodies 
were immobilized by direct adsorption onto the gold surface of the crystals. 
Anti-OMP85 antibody solution (200 µl of 0.5 mg/mL) in PB was spread over the 
entire Au electrode surface and incubated at 4 °C overnight. The excess antibody 
was removed by rinsing with PB. The antibody-modified crystals were then 
saturated with 1% (w/v) Casein dissolved in PB for at least 1 h to block 
unreacted and nonspecific binding sites on the crystal surface. After rinsing with 
PB, the crystals were dried under nitrogen. The crystals were then mounted into 
a crystal holder and washed with PB until a steady/stable base line was 
achieved. OMP85 conjugated 50 nm gold nanoparticle suspension (Chapter 3) 
was then injected and resulting frequency changes were monitered. 
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5.2.6. Deposition of PVDF film on QCM crystal by spin coating 
PVDF solution was prepared by dissolving 75 mg of PVDF membrane (Millipore, 
USA) in 1.0 mL N,N-dimethyl formamide at 60 °C for 5 minutes. A 100 µl aliquot 
of the PVDF solution was then spin coated on to the surface of a QCM electrode, 
using a Laurell Technologies model WS-400A-6NPP spin coater, at increasing 
speed in the range of 0-5000 rpm at an acceleration of 50 rpm/sec for 2 minutes. 
The spinning process was repeated twice. The crystal was removed from the spin 
coater and then washed thoroughly with double distilled water to remove any 
residual DMF and dried in a vacuum oven at 60 ºC  for 30 – 60 minutes. The 
deposited PVDF film was uniform and dried during the spin coating procedure. 
The film on other parts of the crystal apart from the gold surface was manually 
removed, so that only the gold surface was coated with PVDF. The coated 
crystals were stored at room temperature in a clean chamber until used. 
 
5.2.7. Surface characterisation of PVDF coating 
The PVDF film coating on the QCM crystal surface was characterized by the 
following techniques: 
  
5.2.7.1. Scanning Electron Microscopy (SEM) studies 
SEM was performed on the PVDF film coating using a Philips XL30 microscope, 
to obtain the information about the structural morphology of the deposition. 
PVDF coated QCM crystals were affixed to aluminium pegs with carbon tape 
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and sputter coated with gold for 60 sec at 0.016 mA (Agron plasma) using a SPI-
Module Sputter Coater (SPI Supplied Division of Structure Probe, Inc).  
 
Then, the crystal was placed inside the microscope's vacuum column through an 
air-tight door. Emitted from a tungsten source, the high energy electron beam 
which typically has an energy ranging from a few hundred eV to 30 keV is 
focused into a very fine focal spot sized 0.4 nm to 5 nm. As the electron beam hits 
each spot on the sample, due to the energy exchange between the electron beam 
and the sample, secondary electrons are deflected from its surface. A detector 
counts these electrons and sends the signals to an amplifier. The final image is 
built up from the number of electrons emitted from each spot on the sample.  
 
This scanning electron microscope has a magnification range from 15x to 
200,000x and a resolution of 5 nanometers. The resulting images were scanned on 
a digital imaging system by computer enhancement. Images of fresh PVDF film 
coating were taken before and after using the crystal multiple times. Also, an 
approximate estimation of the film thickness was obtained from the SEM cross 
section images at 25,000X magnification. 
 
5.2.7.2. Atomic Force Microscopy (AFM) studies 
The Atomic Force Microscopy (AFM) (Binnig et al.. 1986) measurements were 
performed with a Nanoscope IIIa Multimode scanning 
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Instruments Inc., Santa Barbara, CA, USA) in order to achieve information about 
the surface morphology of the PVDF coated QCM surfaces. The images were 
scanned in tapping mode (Martin et al.. 1987, Zhong et al.. 1993) in air with a 
sharp tip attached to a cantilever (Vecco, USA). Rectangular phosphorus doped 
silicone tips (0.5-2.0 ohm-cm) with a spring constant of 40N/m were used in the 
frequency range of 100-500kHz. The thickness of the cantilever was 4 micrometer 
with back side coating of 40nm aluminium. Tip region of contact (ROC) was 
<10nm with tipROC max of 12.5 nm, front  and back and side angles of the tip 
were 15°, 25° and 17.5° respectively. Scan speed was varied depending on the 
scan size without affecting the quality of the image. When a laser beam is 
directed onto the cantilever, the deflection of the cantilever is detected with a 
photo detector. Both the height and roughness profiles of the PVDF surface and 
the attachment of the whole cell NM bacteria on the sensor surface were 
analysed. 
 
  
5.2.7.3. Network analyzer studies 
An Agilent E5100A Netwrok analyzer was used to study the impedance profile 
of the crystal before and after coating with PVDF layer. A Pi-network test fixture 
was used in the data acquition process. The dissipation change was measured by 
periodically switching off the driving power to the thickness-shear-mode 
oscillation of the sensor crystal and recording the decay of the damped 
oscillation. 
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5.3. Results 
In these studies, the use of QCM was explored to develop a real time 
immunoassay for OMP85 antigen and to assess the applicability for the 
development of a biosensor for detection of Neisseria meningitidis.  
 
5.3.1. Self Assembled Monolayer (SAM) based Immunosensor 
The clean gold surface on the QCM crystal coated with anti-OMP85 antibodies 
was washed in situ with 0.1M PB pH 7.4. The excess anti-OMP85 antibody and 
casein molecules were removed by PB wash and a stable base line was achieved. 
Introduction of OMP85 antigen conjugated with 50 nm gold nanoparticle, on the 
QCM crystal surface resulted in frequency changes, corresponding to the antigen 
concentration. Figure 5.3 shows the time and concentration dependent frequency 
changes upon the exposure of the anti-OMP85 antibody layer to 6.25 µg/mL 
OMP85-conjugated to 50 nm gold nanoparticle. The frequency change for the 
same amount of antigen without the gold nanoparticles was not measurable in 
this QCM system (data not shown).  
 
However, the frequency shifts due to the specific antigen-antobody interactions 
were varied and sometimes unobservable. For reasons not clear, the system was 
not stable and the measured frequency change was variable with high noise 
levels. In order to address these issues with stability and noise, a PVDF film with 
protein A layer on QCM was utilized as an alternate approach.    
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Figure 5.3. Changes in frequency as a function of time following the sequential 
exposure of the antibody coated quartz crystal to the OMP85 conjugated 50 nm 
gold nanoparticles. The grey area indicates the OMP85 and anti-OMP85 antibody 
binding event and resulting frequency change. 
 
5.3.2. Real-time measurements using a PVDF coated QCM 
immunosensor 
A method for the preparation of preparation of a PVDF solution was developed 
and used to spin coat the QCM crystals. This method was desribed in section 
5.2.6. 
 
5.3.2.1. Real time analysis of the in situ preparation of a Immunosensor 
Before an experiment, the RQCM instrument was warmed up for at least two 
and half hours with or without a crystal in the holder. The PVDF-coated 5 MHz 
AT-cut quartz crystal was mounted in an acrylic crystal holder between two O-
∼40 Hz 
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ring seals, so that only the coated surface of the crystal was in contact with the 
liquid. Analytical grade methanol was injected for 3 minutes to pre-wet the 
PVDF membrane. After wetting the PVDF film with methanol for 5 minutes, 
0.1M PB pH 7.4 was passed through the chamber to remove the methanol and 
obtain a stable base line. The crystal resistance was observed in the range of 500-
600 Ohms. Similar resistances were recorded following the application of 
subsequent film coatings. If necessary, capacitance cancellations were carried out 
to lock the crystal frequency. The frequency shift was recorded as a function of 
time at an interval of 5 s using the RQCM data log program on a computer.  
 
The detection of OMP85 target antigen molecules using this approach was as 
follows: The PVDF coating was washed using 0.1M phosphate buffer pH 7.4 
until a steady baseline was achieved overnight. Following the observation of a 
steady baseline, a layer of protein A was  first adsorbed on the PVDF coated Au 
surface of the QCM electrode by passing a solution of 100 ug/mL protein A at a 
flow rate of 3.0 mL hour-1. After the protein A baseline was stabilised (shift less 
than 1 Hz min−1), excess protein A was removed by washing with 0.1M PB (pH 
7.4). The PB wash was continued until another stable baseline was observed for 
5-10 minutes. Subsequent blocking of unbound sites using 1% (w/v) casein in PB 
on the sensing interface was then carried out at a similar flow rate. Excess casein 
solution was removed with PB until a baseline was achieved for a further 5-10 
minutes.  
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Following the stabilisation of the QCM response, the protein A - sepharose 
purified anti-OMP85 antibody solution (100 µg/mL) was then injected for 
binding to the surface immobilized protein A molecules and allowed to bind 
until a stable base line was observed. After rinsing with PB to remove the excess 
antibodies, finally the cognate antigen, OMP85 was allowed to specifically bind 
with the anti-OMP85 antibodies by passing 20 µg/mL OMP85 antigen over the 
crystal surface at the same flow rate. After achieving the stable baseline 
frequency, excess OMP85 antigen was flushed with PB to obtain a steady 
baseline (Figure 5.4.).  
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Figure 5.4. Changes in frequency following sequential exposure of the PVDF 
coated quartz crystal to the OMP85 antigen alone.  
 
∼55 Hz 
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5.3.3. Enhancement of mass sensitivity using gold nanoparticles 
The gold nanoparticles were used to enhance the mass sensitivity and 50 nm 
gold nanoparticles conjugated with OMP85 antigen was passed over the protein 
A immobilized anti-OMP85 antibody layer and the frequency change was 
monitored. When the antigen was added without gold nanoparticles at 20 
µg/mL OMP85 concentration, a ~55 Hz frequency shift was observed (Figure 
5.4.), whereas, at 300 ng/mL concentration, the temporal response curves could 
not be distinguished from the baseline of the negative control curve. For 
example, with 5 µg/mL OMP85-gold nanoparticle suspension (as measured by 
Bradford assay) injected in the QCM cell, a large decrease of the microbalance 
frequency, ∆f = 130 Hz, was observed (Figure 5.5.). For the same amount of 
antigen without gold nanoparicles, a frequency shift of 22 Hz was observed. For 
the entire range of concentrations analyzed (300ng-20µg/mL OMP85), a five fold 
increase in the sensitivity was observed with the use of 50nm gold nanoparticles 
(Table 5.1.). 
 
OMP85 Conc. (µg/mL) 
∆f with gold 
nanoparticle 
∆f without gold 
nanoparticle 
20 250 55 
10 185 32 
5 130 22 
2.5 90 15 
1.25 65 10 
0.625 40 6 
0.312 12 4 
Table 5.1. QCM response for various concentrations of OMP85 antigen both with 
and without gold nanoparticles. 
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Figure 5.5. A flow through experiment showing detected frequency changes in 
response to sequential addition of protein A (100 µg/mL), casein (0.1%), anti-
OMP85 antibody (100 µg/mL) and 50 nm gold nanoparticle conjugated OMP85 
antigen (5 µg/mL). 
 
All frequency changes due to different binding events were monitored step by 
step in real time (Figure 5.5. and 5.6.). In every step, the frequency change 
reached a plateau after a variable period of time which indicated no further 
change in the mass on the crystal surface. Once a stable base line was established 
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at each step, replacement of the protein solution by buffer solution (PB) did not 
produce any noticeable change in the frequency response. This indicates that the 
possible effect of variations in bulk density and viscosity due to fluid exchange 
were negligible. Except for the antibody step, the resonant frequency of the 
crystal reached a baseline very quickly in all other steps and the stable 
frequencies obtained at different times were almost identical. A prolonged 
baseline, stable over few hours with a noise level less than ± 1 Hz when PB was 
flowing across the crystal surface at 3.0 mL/hour was also demonstrated. 
 
 
Figure 5.6. A schemtatic representation of a piezoelectric immunosensor used in 
these studies in the order of addition of different layers of biomolecules. 
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To test the reproducibility of the immunosensor, the QCM response to different 
concentrations of OMP85 antigen, was determined in duplicates. An inter-assay 
variation of 5-10Hz was observed with the various concentrations. This result 
indicates that the proposed piezoimmunosensor could provide reproducible 
determination of OMP85 antigen. 
 
5.3.4. Dose–response curves  
It can be seen that for the entire OMP85 working concentration range of 300 ng–
20 µg/mL, the higher the concentration, the greater the sensor responses (Figure 
5.7a., 5.7b. and 5.7c.), and a nonlinear relationship between frequency change 
and amount of OMP85-gold nanoparticle conjugate was observed (Table 5.1.).  
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(a) 20 µg/mL OMP 85 antigen – 250 Hz Frequency shift 
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(b) 2.5 µg/mL OMP 85 antigen – 130Hz Frequency shift 
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∼250 Hz 
  ∼130 Hz 
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(c) 300 ng/mL OMP 85 antigen – 12 Hz Frequency shift 
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Figure 5.7. Changes in frequency as a function of time following the sequential 
exposure of the PVDF coated quartz crystal to OMP85 protein conjugated to 50 
nm gold nanoparticle. (a) 20 µg/mL, (b) 2.5 µg/mL and (c) 300 ng/mL. The grey 
area indicates the gold nanoparticle-OMP85 and anti-OMP85 antibody binding 
event and subsequent frequency change. All the responses after the Ag-Ab 
binding event are the washing steps. 
 
 
The specificity of biosensor was assessed using BSA conjugated gold 
nanoparticles as a non-specific antigen. No non-specific interaction was observed 
using upto 20 µg/mL BSA-gold nanoparticle conjugate, illustrating the 
specificity of the sensor (Figure 5.8a.). The dip immediately after the introduction 
of the BSA coated nanoparticle suspension might have occurred due to the 
  ∼12 Hz 
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viscosity difference between the solutions. The microbalance frequency remained 
constant when neat 50 nm gold nanoparticle suspensions were injected onto the 
QCM surface coated with protein A/anti-OMP85 antibodies (Figure 5.8b.). 
Nanoparticles were blocked with casein to prevent non-specific Au-protein 
binding. 
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(b) Neat gold nanoparticles - 0 Hz Frequency shift 
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Figure 5.8. Changes in frequency following the exposure of the PVDF coated 
quartz crystal with protein A and anti-OMP85 antibody to (a) BSA conjugated 50 
nm gold nanoparticles and (b) neat gold nanoparticles. No change in frequency 
was observed. The grey area indicates the injection of neat/BSA conjugated gold 
nanoparticles and subsequent elution without binding to the immobilised 
anibodies. 
 
 
 
5.3.5. Calibration curve for the detection of OMP85 
A calibration curve was constructed using OMP85 antigen at different 
concentrations in the range of 300 ng - 20 µg/mL on the antibody-coated crystals, 
which resulted in differing frequencies accordingly, all significantly 
distinguishable from the background noise. Calibration curves were obtained for 
both gold nanoparticle-OMP85 conjugates and OMP85 alone on the sensor.  
  0 Hz 
  250
 
 The calibration curve determined from the net frequency changes showed 
significant linearity over a range from 300 ng/mL to 20 µg/mL of OMP85 target 
molecule (5.9a. and 5.9b.) These experiments clearly indicate that gold 
nanoparticles can be used to enhance the detection limits of the conventional 
QCM detection systems. 
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Figure 5.9. The calibration curve determined from the net frequency changes 
upon OMP85 and anti-OMP85 antibody interactions and the difference in 
frequency measured with and without conjugation with gold nanoparticles. The 
concentration of OMP85 target molecules ranged from 300 ng/mL to 20 µg/mL 
resulting frequency changes were in the range from 10 to 250 Hz. (a). The 
calibration curve determined from the net frequency changes by OMP85 target 
molecules with different concentrations and additional frequency changes due to 
OMP85 conjugated gold nanoparticles.  (b) The calibration graph of frequency 
decrease vs. logarithm of antigen concentration is linear within the same 
detection range. 
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5.3.6. Regeneration of immunosensor 
After each run, the used QCM crystals were regenerated by injecting the elution 
buffer solution (0.1 M Glycine-HCl, pH 3.0) to release antigen–antibody 
complexes from the protein A layer. Washing continued until return to the 
original protein A baseline was observed. The glycine solution removed all 
biological layers except the protein A and casein layers, which could be seen 
from the frequency base line. Finally methanol was applied to remove the 
protein A and casein layers as well and followed by PB wash until the initial 
baseline was achieved. The crystal was reused for the subsequent experiments.  
 
Using this regeneration method, the coated crystals were reused up to 25 times 
without significant loss of protein binding activity. One important observation 
was that the crystal base resistance increased with each use. After 20-25 uses, the 
PVDF film from the crystal surface was removed with an acetone wash and re-
coated with a fresh PVDF solution to regenerate the PVDF layer. 
 
5.3.7. Analysis of whole cell NM bacteria by the immunosensor 
 
To evaluate the designed sensor for the detection of whole cell bacteria with and 
without Au nanoparticles attachment, sheep anti-NM polyclonal antibody were 
immobilized using protein G on the sensor surface. Formalin treated N. 
meningitides cell suspension at a concentration of 300 x 106 cfu L-1 were prepared. 
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Figure 5.10. indicates a 7 Hz frequency shift upon attachment of the 100 cfu/mL 
cells. However with PBS wash, the frequency change was reduced to 4 Hz net 
change. For the same concentration of bacteria conjugated with 50 nm gold 
nanoparticles, significant frequency shift (17 Hz) was observed but notably this 
occurred in the opposite direction (Figure 5.11.). Similar response in the opposite 
direction was observed with large number of bacteria (3 x 104 cfu/ml) injected 
onto the sensor surface. 
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Figure 5.10. Changes in frequency following the exposure of the PVDF coated 
quartz crystal to N. meningitidis whole cells. A net frequency shift of 4 Hz was 
observed for 100 cfu/mL bacteria. 
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Figure 5.11. Changes in frequency following the exposure of the PVDF coated 
quartz crystal to N. meningitidis whole cells conjugated with 50 nm gold 
nanoparticles. A net frequency shift of 17 Hz was observed in the opposite 
direction for 100 cfu/mL bacteria. 
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Figure 5.12. Changes in frequency following the exposure of the PVDF coated 
quartz crystal to N. meningitidis whole cells. For a total of 2 x 104 cfu/mL, a 
frequency shift was observed in the opposite direction with the response 
reaching the pre-antibody attachment base-line. 
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5.3.8. Surface characterisation of PVDF coating 
 
5.3.8.1. Scanning Electron Microscopy (SEM) studies 
SEM images clearly showed the uniform distribution of the polymer. PVDF 
formed a thin, porous, rough and rigid structure on the QCM surface (Figure 
5.13a. and 5.13b). These pores are predicted to be hydrophobic pockets based on 
the structural similarity to the pores in the PVDF membrane (Figure 5.14.), which 
also indicates that dissolution conditions didn’t alter the structural features of the 
PVDF membrane. A distorted structure of the film after multiple uses was 
observed as seen in Figure 5.15. An estimation of the film thickness was found to 
be less than 1 µm, as measured from the cross section of the film (Figure 5.16.).  
 
  
   (a)      (b) 
Figure 5.13. PVDF film distribution on the QCM magnification at (a) 500x and (b) 
10000X. 
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Figure 5.14. PVDF membrane structure at 10000X magnification. 
 
 
 
 
  
Figure 5.15. Distorted PVDF film structure after multiple runs on the same film. 
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Figure 5.16. The cross sectional view of the PVDF film coated on the QCM crystal 
showing the thickness of the film. 
 
5.3.8.2. Network analysis 
A network analyzer was used to monitor the frequency shift and the acoustic 
damping of admittance at the crystal resonance frequency after film deposition 
(Figure 5.17 and Figure 5.18). The film quality was quantified by calculating the 
Q  factor of the crystal, which represents the rate at which an oscillating system 
dissipates its energy. The higher the Q  factor, the better the quality of the QCM 
resonator, and the lower the dissipation of oscillation energy in the resonating 
system. 
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Figure 5.17. The impedance behavior of 5 MHz quartz in the presence and 
absence of the PVDF film coating. An alternating electric field was applied to the 
crystal causing an oscillary motion. As the field is switched off, the amplitude of 
the oscillation declines. The rate at which it declines depends on the energy 
dissipation. 
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Figure 5.18. Changes in energy dissipation as a function of time obtained from 
the QCM measurements for the same sequence of events as displayed in Figure 
5.14. 
 
5.3.8.3. Atomic Force Microscopy studies 
The surface profile of the PVDF film on the quartz crystal was also monitered by 
AFM. Tapping mode was used, in order to avoid the sample deformation when 
imaging polymeric materials such as PVDF presents. An atomic force 
microscopy image of the PVDF modified crystal surface is presented in Figure 
5.16., which was similar to the image obtained from SEM. The polymer 
distribution was rough and the root mean square roughness (RMS) of the coating 
was found to be 247.99 nm, respectively, which can be seen in Figure 5.19. The 
3D image of the roughness distribution profile can be seen in Figure 5.20. The 
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contrast between the AFM images of a plain gold surface area and the area 
covered by PVDF film allows the rough estimation of the thickness of the film to 
be approximately 79.68 nm (Figure 5.21.). AFM images (Figure 5.22. and Figure 
5.23.) of the bacteria attached QCM sensor confirmed the presence of bacteria.   
 
 
Figure 5.19. AFM image of the PVDF film coating on the QCM surface. 
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Figure 5.20. AFM image showing the roughness distribution of the PVDF film 
coating on the QCM surface 
 
 
Figure 5.21. Height analysis of the PVDF film by atomic forece microscopy to 
determine the approximate thickness of the layer. 
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Figure 5.22. AFM image of a N. meningitides bacterium attached to the sensor 
surface through protein G and anti-NM antibody immobilization. 
 
 
Figure 5.23. Height and section analysis of the QCM sensor surface also indicates 
the presence of attached bacteria (approximately 1 µm size). 
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5.4. Discussion 
The piezoelectric crystal sensor is becoming a very powerful analytical tool 
because of the established relationship for the change in frequency to the analyte 
concentration with high sensitivity. Being a label free assay, piezoelectric 
immunosensing methods, offer an alternative to existing conventional methods. 
In this chapter, a highly selective QCM based immunosensor was designed for 
the rapid diagnosis of meningococcal meningitis using OMP85 and anti-OMP85 
antibody as a model system. 
 
AT cut crystals with polished surface are very popular in QCM techniques 
because of their excellent frequency versus temperature characteristics (low 
df/dt) over a wide range of temperatures and they are specially designed for 
operation in liquids. The mass sensitivity of a 5 MHz quartz crystal is 
approximately 0.057 Hz cm2 ng-1, which is approximately 100 times higher than 
that of an electronic fine-balance which has a sensitivity of 0.1 g. Thus, it is ideal 
to choose a coating that will undergo highly selective chemical or physical 
binding with the analyte to be detected.  
 
The flow-through QCM biosensors have drawn increasing attention due to their 
ease for automation of the process (Rickert, Brecht et al. 1997). After fixing the 
crystal in the crystal holder, capacity cancellations were done to lock the crystal 
frequency in the system. Proper capacitance cancellations are required to assure 
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true series resonance operation of the crystal oscillator, and to eliminate 
frequency and resistance errors. 
  
Antibody immobilization is a vital step in successful development of a 
piezoelectric immunosensor. Apart from affiinity based and chemical 
immobilization methods, antigens or antibodies are frequently immobilized by 
the simple physisorption on clean gold surfaces (Sargent and Sadik 1998). The 
stability of those immobilized molecules does not differ significantly from the 
covalently coupled ones. However, problems arising from these immobilization 
techniques are the nondirectional orientation of the molecules on the surface and 
thus some of the antigen or antibody molecules are not accessible for binding. In 
this study, the frequency shift observed for the binding of a particular 
concentration of OMP85 antigen, was much less in comparision to the frequency 
shift observed for the same amout of antigen bound on the PVDF coated crystal 
with protein A bound antibody. This reflects the importance of using protein A 
and the directional orientation of the antibody molecues for maximum 
sensitivity.  
 
PVDF (average molecular weight, M w = 530,000) transfer membrane is a 
naturally hydrophobic, unsupported transfer membrane. Its exceptional tensile 
strength and high binding capacity make these membranes ideal for use in 
Western blots, immunoblotting, protein sequencing, MS analysis and solid phase 
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assays. PVDF membranes are also used in various detection systems which 
includes, radioactive, chromogenic, chemiluminescent, fluorescent, and 
chemifluorescent techniques. Its high binding capacity, prevents protein from 
passing through the membrane, and has a low background that provides an 
excellent signal-noise ratio. Also, PVDF film exhibits piezoelectric, pyroelectric 
and ferroelectric properties and which all have been utilized in sensors and 
actuators including modal transducers, electromechanical transducers, 
biomedical photoacoustic imaging arrays, infrared imaging arrays, and 
fingerprint sensors. 
 
Deposition of uniform ultrathin film on a quartz crystal is a crucial point to 
achieve stable and reproducible results each time. Interpretation of adsorption 
phenomena is strongly influenced by the surface roughness of quartz resonators 
(Beck, Pittermann et al. 1992; Martin, Frye et al. 1993). Hence, smooth surfaces are 
required when operating in fluids so as to avoid frequency shifts arising from 
changes in surface energies (Martin, Frye et al. 1993). There are various methods 
for depositing PVDF films on a substrate such as casting, spray, sputtering, spin, 
self-assembling, evaporation and the Langmuir–Blodgett technique. Each 
method has its strengths and shortcomings. For example, with the casting 
method it is possible to deposit a thicker polymeric film, but there is a poor 
control on the amount of material deposited.  
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Spin coating is a simple and fast technique to prepare thin films of best 
uniformity in a repeatable manner. The film formation, its thickness and 
roughness can be controlled by varying parameters such as solution 
concentration, solvent properties, spinning speed, acceleration and spinning time 
(Emir, Zhong et al. 2006). In this work, PVDF film coating on QCM crystal surface 
was ahieved by spincoating of a PVDF solution prepared as described in section 
5.2.6. The primary aim was to obtain sufficiently smooth and fully covered films 
of PVDF, which would work in the RQCM instrument. 
 
After careful trials, the PVDF concentration was optimized (75 mg/mL) to 
achieve the same resistance (500-600 Ohms) each time. The spinning was 
repeated twice to yield a more compact structure following drying of the 
membrane. The film on the silica surface surrounding the electrode was 
manually peeled off so that only the film remains on the gold surface. This was 
done principally to reduce the mass load on the crystal and so that the crystal 
frequency could be locked in the system. An interesting observation was that the 
film was loosely bound on the silica surface, where as on the gold surface it was 
tightly bound and hence there was not slip against the electrode surface of the 
quartz crystal during oscillation. PVDF coated crystals may be stored dry for 
long periods of time at room temperature. Prior to use, dried membrane coated 
crystals must be wet by soaking in 100% methanol. 
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PVDF is an inherently hydrophobic polymer, so aqueous buffers cannot 
penetrate the pore structure. It has been generally considered that the pore 
structure must be made accessible by a prewetting step with methanol so that 
proteins can interact with the PVDF membrane. Methanol also assists in 
removing any complexed SDS from the protein molecules (Mozdzanowski and 
Speicher 1992) and thereby increases the probability that a protein molecule will 
bind to the membrane. Once the membrane is wetted, protein binding may be 
achieved by simply bringing the protein into contact with the membrane. 
Because binding occurs throughout the depth of the membrane, the binding 
capacity is determined by the internal surface area of the pores (Mansfield, 1994). 
Complete wetting with methanol was evident by a change in the membrane’s 
appearance from opaque to semi-transparent.  
 
Due to the hydrophobic character and the steric constraints of the surrounding 
PVDF layer, the physical adsorption of antibody molecules directly within the 
PVDF polymer may induce a marked loss of their recognition activity. Also, the 
antibody molecules buried in the porous structures may drastically reduce the 
accessibility to the immobilized antibody molecules. Such limitations may hinder 
the formation of specific antigen– antibody bonding. 
 
Although many immobilization methods have been studied and applied to 
piezoelectric immunosensor developments, it is usually necessary to determine a 
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suitable immobilization method for each biological material in a particular 
application (Blonder, Ben-Dov et al. 1997). In clinical immunoassays, it is 
preferable that antibodies are immobilized with highly controlled orientation 
and the steric-hindrance effect must be reduced (Sokoll and Chan 1999) so as to 
maximize their antigen-binding efficiency and attain ultimate sensitivity and 
selectivity of immunoassay (Lee and Chang 2005). Protein A is a polypeptide 
isolated from Staphylococcus aureus that binds specifically to immunoglobulin 
molecules, especially IgG antibodies, through the Fc domain without interacting 
at the antigen site. Protein A layer might also be serving as an intervening 
“spacer” matrix to extend the immobilized antibodies away from the surface and 
makes them more accessible to the antigens. This property permits the formation 
of tertiary complexes consisting of protein A, antibody and antigen. 
 
Protein A has been widely utilized for oriented immobilization of antibodies and 
constructions of piezoelectric immunosensors (Muramatsu, Dicks et al. 1987; 
Konig and Gratzel 1994; Babacan, Pivarnik et al. 2000). It was shown that Protein 
A-based piezoelectric immunosensor was more favorable than the 
polyethylenimine-glutaraldehyde method in detecting S. typhimurium due to its 
stability and better reproducibility of the immobilization layers (Babacan, 
Pivarnik et al. 2000). A Protein-A based SPR immunosensor has been developed 
for detection of E. coli O157:H7 (Fratamico, Strobaugh et al. 1998). The 
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immobilization of Protein A caused a highly insulating layer, and the insulation 
was further improved by antibody immobilization and protein binding. 
 
Blocking any unbound or non-specific sites on the layer to maximize the signal-
to-noise ratio was was necessary because of the inherent affinity of the polymeric 
surface for proteins. Also interstitial places between hydrophobic pores might 
have been filled with protein A and Casein molecules as a result of their smaller 
size.  
 
After washing with phosphate buffer to remove any excess casein from the 
transducer surface, anti-OMP85 antibody solution was injected. Being a 
directional coupling between protein A and antibody molecules, this particular 
step took more than an hour to reach the base line. As the hydrophobic pores in 
the PVDF film were filled with protein A and casein molecules, antibodies 
should only bind to the protein A molecules. On the other hand, without protein 
A molecules, antibodies would have penetrated into the porous structure of the 
membrane and only those antibody molecules on the very top layer of the 
surface may actually be available for antigen binding. Antibody molecules 
embedded within the pore structure may not participate in the overall reaction.  
 
 After washing with PB to clear any excess antibody, OMP85 antigen conjugated 
with 50 nm colloidal gold nanoparticles was introduced. It is shown that, the 
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resonant frequency of the sensor decreased over time due to the binding of 
OMP85 antigen onto the immobilized antibodies, and the time to reach a plateau 
ranged from 5 to 15 minutes. The total mass of macromolecules deposited onto 
the electrode was directly proportional to the frequency change of the QCM. 
When the different molecules were bound onto the crystal surface, the roughness 
range of the crystal was decreased and thus the resistance. 
 
It is well known that the behavior of a piezoelectric sensor in solution is much 
different to that in air. In solution, in addition to surface mass change due to 
specific or nonspecific adsorption, variation of surface viscoelasticity and 
solution density and viscosity can all result in a frequency change of the quartz 
crystal (Martin, Granstaff et al. 1991). Other important parameters that influence 
the resonant frequency of the quartz crystal in solution are the ionic strength and 
dielectric constant of the electrolyte. To avoid the possible error resulting from 
different additions of solutions or samples, the frequency changes of each step 
were monitored with PB wash for more than 5 minutes (after the achieving the 
base line for each sample) until equilibrium was reached. When it was 
equilibrated with the phosphate buffer, the crystal could reach a new equilibrium 
generally within 3 min after replacement injection, and the baseline was stable 
over many hours with a noise level less than ±1 Hz.  
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The maximum frequency increase due to washing with PB was less than 1.0 Hz, 
which was negligible when compared to multilayer frequency shifts when 
protein solutions were added. Further addition of PB after the protein layers 
have been resulted in no change total frequency of the crystal, indicating that 
specific adsorption of the protein layer has occurred.  
 
For small biomolecule detection at low concentrations, it may be quite difficult to 
obtain observable and direct signals. This is mainly due to the lack of mass 
sensitivity of the commonly used QCM instruments, as they generally employ 5 
to 10 MHz quartz crystals  (Zhang, Feng et al. 1997). Besides their use in 
colorimetric assays, gold nanoparticles can be used in mass detection techniques 
to amplify the mass of analytes thereby increasing the sensitivity of the assay, as 
noted previously. The conjugation of colloidal gold nanoparticles to 
macromolecules can retain the activity of biomolecules and enhance the 
immobilized amount of biomolecules (Chu, Zhao et al. 2006; Tripathi, 
Kandimalla et al. 2006).  
 
This sensitivity was sufficient to directly detect the binding event between the 
OMP85 alone and the specific antibody layer. Conjugated gold nanoparticles 
were used as signal amplification probes for high-sensitive detection of target 
antigen at very low concentrations. First, in contrast to the direct binding of 
antigen with immobilized antibody on bulk gold surfaces, OMP antigen was 
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bound on gold nanoparticle surfaces. Second, the high surface-to-volume ratio of 
the assembled gold nanoparticles may greatly enhance the immobilization 
density of bound proteins. The OMP85 antigen was then detected directly by the 
frequency change observed as it bound to the specific antibodies. The present 
immunoassay system exhibited the analytical performance such as sensitivity, 
precision, accuracy, analytical time, stability and reproducibility needed for 
quantification of the OMP85 antigen. 
 
To ensure that the frequency change was due to the OMP85 and anti-OMP85 
antibody interaction, neat gold nanoparticles without antigen were injected onto 
the PVDF coated crystal containing protein A and anti-OMP85 antibodies. No 
frequency change was observed and this observation led to the following 
conclusions: (a) the interactions between anti-OMP85 antibody and OMP85 
antigen was specific as reflected by the frequency change, (b) neat nanoparticles 
didn’t bind to the either PVDF or antibody coated QCM crystal and (c) changes 
due to solution viscosity were negligible as the measurable signal was constant 
when the nature of the solution was modified. Moreover, 90 % of the signal was 
obtained within 10 minutes. 
 
Stability and regeneration of immunosensors are crucial to consider for the 
development of practical immunosensors. Commonly, the regeneration of 
immunosensors is achieved by releasing the antigen–antibody complexes 
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adsorbed electrostatically from the sensing surface with a strong base and high 
ionic strength salt (NaOH+NaCl). Janshoff et al. (Janshoff, Steinem et al. 1996) 
used proteases to regenerate the sensor surfaces. In this study, 0.1M glycine-HCl, 
pH 2.3 solution was used to release antigen–antibody complexes from the 
biorecognition surface to regenerate the active surface. An erratic response was 
observed with 0.1M glycine pH 3.0 solution and this might be due to a difference 
in viscosity of the solutions and changes in temporal excess flow pressure on the 
crystal. Final treatment with methanol not only removed the protein A and 
casein layers, but also wetted the membrane for the next experiment. 
 
Evidence of restoration of the initial resonance frequencies revealed that the 
dissociation of the antigen–antibody complex was successfully attained. Up to 
20-25 repetitive assays were achieved without significant loss of detection 
sensitivity, showing high reusability and stability in the successive assays. After 
reusing for more than 25 times, then, the sensitivity of the immunosensor 
declined very sharply. This was performed twice with consistent results.  
 
Typical calibration curves of the immunosensor for 50 nm gold nanoparticle 
conjugated with different concentrations of OMP85 were obtained and the 
frequency shift was directly proportional to the antigen concentration. To clarify 
the amplification characteristics of the gold nanoparticle conjugation, the 
calibration curves of the frequency responses without nanoparticle conjugation 
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were also obtained for each concentration of OMP85 anigen. The calibration 
curve was linear over the same OMP85 concentration range. After comparing the 
difference in the frequency shifts between the OMP85–gold nanoparticle 
conjugates and the nanoparticles alone, it was found that there was five fold 
increase in the sensitivity with nanoparticle conjugation. 
 
The developed immunosensor was able to detect the whole cell NM bacteria. At 
low numbers (100 cfu/mL) normal frequency shift with 4 Hz net response was 
observed. Initial 7 Hz shift was reduced to 4 Hz after PB wash, which might be 
due to the removel of unbound bacteria from the sensor surface. After PB wash, 
when bacteria were re-injected, 3 Hz frequency shift was observed, and with the 
subsequent PB wash, response had gone back to the initial base line. This 
suggests that, excess or unbound bacteria were removed from the sensor surface 
with PB wash.  
 
However, with the same concentration of bacteria attached with gold 
nanoparticles and also with excess number of bacteria, there was a significant 
frequency response but notably this occurred in the opposite direction. It was 
observed that with a 6 x 104 cfu/mL, the frequency trace rises to the frequency 
which is equivalent to the initiation of the antibody attachment. This suggests 
that, under the shear force of the oscillating QCM crystal and the high surface to 
volume ratio of the bacteria, might be removing the specifically bound antibodies 
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from the surface as indicated by the frequency returning to the initial pre-Ab 
attachment state. Previous QCM studies have employed cell detachment as a 
detection mechanism. Dultsev et al.. (2001) showed that specifically adsorbed 
bacteriophage could be detected by breaking the interaction between proteins 
displayed on a phage coat and ligands on the surface of a QCM (Dultsev, Speight 
et al. 2001). Gryte et al.. (1993) used 5 MHz QCM crystal to monitor the 
attachment and detachment of anchorage-dependent mammalian cells on a 
surface (Gryte, Ward et al. 1993). In both cases the frequency rose upon 
detachment following immunorecognition. Future experimentation with small 
gold nanoparticles with lower inertial shear force and determining the optimum 
dilution of bacteria may produce continuous attachment and frequency changes 
in the same direction as the initial case. 
 
As a control experiment, protein A was used instead of protein G for binding 
with sheep IgG. This resulted in no binding of sheep IgG to the protein A layer 
and subsequently, NM cells were shown not to bind to this protein A layer. 
Indirectly, it shows that, bacteria do not adhere to the surface non-specifically 
under flow conditions. Perhaps, a more valid alternative control experiment 
would be to test the immunosensor with binding of NM cells to a control 
antibody (IgG) of the same species. 
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The QCM resonator system can be considered as an electric or electromechanical 
system. The Q  factor of the QCM as an electric resonating system represents the 
resistance of the system, but as an electromechanical resonator, the Q  factor 
represents the level of mechanical friction that causes the decay of the oscillation 
energy. An increase of the QCM surface roughness causes a higher frequency 
shift and a higher mechanical friction and thus damping of the oscillation energy. 
There are three factors that must be optimized in order to produce a polymer 
coated QCM with a high Q  factor, suitable for use in the PLL oscillator system in 
a liquid medium. They are: (i) the mass load, (ii) the film uniformity (mass 
distribution and uniform morphology), and (iii) the surface roughness. 
 
In order to measure the dissipation factor of the crystal due to PVDF coating, an 
impedance analysis was performed in the range of the resonance frequencies of 
the quartz. The observed significant dissipation changes suggest that the PVDF 
layer adsorbed on the Au electrode forms a compact structure, being elongated 
outward from the sensing surface. Network analysis revealed that the motional 
resistance R, which is indicative of energy loss, changes in the same fashion as 
the serial resonance frequency (Figure 5.17 and Figure 5.18). A lower mass load, 
and uniform film thickness, improved the coating quality and caused less 
damping of the QCM oscillation energy, whilst maintaining a sufficiently high Q  
factor of the resonating crystal. 
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To study surface morphology of thin films on a micro-scale, the films were 
characterized by atomic force microscope (AFM). The results showed that the 
polymer distribution was uniform and the roughness may be attributed to the 
porous nature of the polymer. To reduce the surface roughness of the coating, an 
extra layer for PVDF may be applied to the QCM. But, if the porous stuructures 
in the film become too deep, the protein A and anti-OMP85 antibody layers may 
be buried, which will result in a decrease of the sensitivity. Similar results were 
obtained from different scanning regions, which indicated the uniform 
distribution of the polymer film. AFM studies on the sensor surface utilized for 
the detection of bacteria, revealed that the bacteria was attached to the antibody 
(Figure 2.22. and Figure 2.23.).  
 
The PVDF film coating on the QCM was analyzed by SEM to study the 
morphology and thickness of the coating. Though the actual PVDF membrane 
used to make the film had a thickness of 140-250 µm, on the QCM it formed a 
thin layer that may be due to its self-limiting growth. The pore size formed in the 
film was comparable to the pore size in the actual membrane. After using the 
same crystal multiple times, the sensitivity of the crystal was drastically reduced 
which was evident by the SEM pictures which shows the distorted structure 
(Figure 5.12.).  
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This work advances the design and evaluation of a QCM based model biosensor 
for the rapid diagnosis of meningococcal meningitidis. In this study using the 
real-time QCM measurements, a novel strategy has been developed for the high-
sensitivity detection of target biomolecules with very low concentrations on a 
quartz crystal microbalance (QCM) device using gold nanoparticles as signal 
amplification probes. The protein A/protein G affinity-based approach 
preserved the access of the antigen to the oriented immobilized antobody and 
facilitated macromolecular interactions. Without protein A/ptotein G based 
immobilization, owing to the severe steric hindrance of three-dimensional 
network of the polymer, the antibodies may not have been so accessible to the 
antigen.  
 
The QCM method used in this work is operationally attractive because of its 
simplicity and suitability for in situ measurement. The results show the 
specificity of the QCM immunosensor and the determination of OMP85 antigen 
and the whole cell bacteria based on gold nanoparticle conjugation is practically 
free of interference from nonspecific binding events. This has shown that the use 
of PVDF modified QCM crystals can successfully and reproducibly be employed 
in the detection of protein antigens as well as whole cell bacteria. 
 
Direct measurements are attractive when compared with classical colorimetric 
tests, such as ELISA, where several steps are necessary to obtain an optimal 
  278
signal, which are, of course, time consuming. QCM detection of the analyte can 
occur online and is label-free within minutes to specifically detect any 
macromolecule. However, the obtained sensitivity of piezoimmunosensors is 
lower than that of an ELISA assay. The sensitivity of the flow-through 
immunosensor could possibly be further improved by decreasing flow rate 
and/or increasing sample running time although reducing analytical speed. The 
sensitivity of the QCM immunosensor, however, might be improved by using 10 
MHz or higher frequency crystals (Uttenthaler, Schraml et al. 2001), at the same 
time, noise levels should be reduced.  
 
The results presented in this chapter suggest that the use of gold nanoparticle 
protein conjugates in this immunosensor allow for the determination of OMP85 
antigen down to 300 ng/mL and the bacteria to 100 cfu/mL. Previous studies on 
QCM immunosensor have reported similar findings. Piezoelectric immunoassays 
for the detection of human serum albumin, have been reported with the 
sensitivity in the clinically relevant range, 20-200 µg/mL (Sakti, Lucklum et al. 
2001). Using the SAM based method on 10 MHz crystal, Tsai et al., (2005) 
reported about the development of an immunosensor for the detection of α-
fetoprotein, with an observable 10 Hz frequency shift for 500 ng/mL protein 
concentrations (Tsai and Lin 2005). With a 27 MHz quartz crystal, Bizet et al. had 
reported a frequency shift of 150 Hz for 5 µg/mL antibody concentration (Bizet, 
Gabrielli et al. 1999). Where as, with 5 MHz QCM crystal using gold 
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nanoparticles as signal amplification probes, Kim et al. had achieved 3.3 Hz 
frequency shift for a 50 ng/mL biotin  concentration (Kim, Baek et al. 2007). 
Amplification of the 10 MHz QCM response by back-filling immobilization of 
nanogold on biorecognition surface was reported with a detection range of 3.0-50 
ng/mL protein concentration.  
 
All the previously published reports claims to have detected the bacteria in the 
concentration range of 105–107 CFU/mL (Muramatsu, Kajiwara et al. 1986; 
Suleiman and Guilbault 1994; Sato, Endo et al. 1995; Bao, Deng et al. 1996; Ben-
Dov, Willner et al. 1997; Sato, Serizawa et al. 1998; Hengerer, Decker et al. 1999; 
Ivnitski, Abdel-Hamid et al. 1999; Dmitri Ivnitski 2000). However, a tremendous 
improvement in terms of sensitivity has been achieved with this designed 
immunosensor where, a significant QCM response was observed with bacterial 
concentration as low as 100 cfu/mL. Furthermore, direct measurements without 
time-consuming sample preparation are possible in complex matrices such as 
body fluids. The sensor configuration meets the sensitivity, selectivity, and 
response time requirements of such a platform technology. This QCM 
methodology provides a valuable contribution to both qualitatively and 
quantitatively identify the meningococcal antigen and to demonstrate the 
potential power of QCM technique both as a research and a diagnostic tool. 
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Chapter 6 
 
 
Summary and Conclusion 
 
The traditional techniques used for the diagnosis of meningococcal meningitis 
are slow, expensive, need skilled operators, and require additional steps of 
sample pre-treatment that will increase the time and cost of these tests. Thus, 
there is a clear need for rapid, accurate and affordable detection techniques for 
meningococcal meningitis to ensure prompt treatment. 
 
The primary aim of this project was to develop a model immunodiagnostic assay 
for the rapid, specific and sensitive detection of meningitis, using a highly 
conserved OMP85 antigen and its cognate receptor, anti-OMP85 antibody as 
model system. Two individual approaches were tested in this regard, both 
utilising gold nanoparticle-protein conjugates, but with different applicability. 
Conjugation of the proteins to gold nanoparticles resulted in increased stability 
of the nanoparticles, but also retained the native protein structure as reflected by 
maintenance of the specific recognition capabilities of the colloid-bound antigen 
and antibodies.  
 
6.1. Surface Plasmon Resonance based colour shift assay 
The surface plasmon resonance based colour shift experiment due to coupling of 
gold nanoparticles mediated by the specific interaction of OMP85 and anti-
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OMP85 antibody molecules, demonstrated that the nanoparticles can be 
potentially used as molecular labels for detection of N. meningitidis infection. The 
relationship between the size of nanoparticles, the size of the proteins and the 
occurrence of the surface plasmon resonance based colour shift was established 
in this study. Also, the importance of the presence of electrolytes for the coupling 
process was identified. The coupling behaviour of gold nanoparticles was 
investigated by UV-visible absorption spectrophotometry and TEM analysis. 
However, for reasons that are not clear, this colour shift assay method was not 
reproducible. The major problem observed was, at times the particles were either 
too stable or else they tended to aggregate in the presence of the same electrolyte 
concentration. Once these problems are overcome, this method has many 
desirable features including rapid detection, a colorimetric response, good 
selectivity and little or no required instrumentation. The results obtained from 
these studies take our understanding of nanoparticle-based diagnostics one step 
further towards developing detection methods that may eventually be used as 
point of care diagnostic tests. 
 
6.2. Quartz Crystal Microbalance as an immunosensor 
Due to the problems associated with the reproducibility of the colour shift assay, 
QCM was chosen as an alternative approach towards developing a working 
model assay for the rapid diagnosis of meningococcal infection. The 
development of the QCM based immunosensor included the highly successful 
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novel immobilisation composite architecture which consisted of PVDF film 
coating on the QCM crystal surface and the directional orientation of antibodies 
using protein A molecules. This allowed the fabrication of a QCM immunosensor 
with control over selectivity, sensitivity and functionality with gold 
nanoparticles as signal amplification probes to improve the detection limit that 
may equal or surpass those achieved by more widely accepted optical 
techniques. Additional features of this technique include a rapid response time, a 
requirement for only a single analyte-specific antibody, less interference from 
non-analyte components, and kinetic data is obtained with high resolution and 
real time monitoring of all events. These results in this study offer a real 
alternative approach for the clinical diagnosis of meningococcal infection 
without the need for sample preparation.  
 
6.3. Future directions of the surface plasmon resonance based 
colour shift assay 
There are currently no known commercial diagnostic tests for pathogens 
available that are based on this concept of coupled gold nanoparticles-induced 
colour shift. The major problem with the technique is reproducibility which may 
be addressed by fine tuning of the conjugation process to determine optimum 
concentration of the protein required which stabilise the gold nanoparticles with 
sufficient space available between the particles for the resulting SPR induced 
colour shift. 
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As a future development, new probes can be engineered so that the gold 
nanoparticle label can be positioned away from the binding site so it does not 
interfere with binding. For example, specific peptides instead of whole antigens 
and Fab’ fragments instead of whole antibody, labelled to gold nanoparticles 
may have several advantages over whole protein labelling. These advantages 
include the requirement of smaller nanoparticles over large ones, great control 
over the conjugation process and the smaller protein molecules more likely to be 
in their native conformation. Once established, this technique may be expanded 
for development of sensitive and rapid medical diagnostic assays for a range of 
pathogens. 
 
6.4. Future Direction of the QCM-based immunosensor 
The use of coated piezoelectric devices as immunochemical sensors for the 
detection of meningococcal infection is very promising and should be considered 
as a viable alternative to other immunodetection methods. In future work based 
on this study, other types of nanoparticles and of various sizes may be studied as 
signal enhancement probes for high sensitivity detection. To improve the 
stability of the device, all electronic oscillator components could be 
thermostatically controlled and better shielded from external environmental 
influnces. In order to further increase the sensitivity for minor component 
analysis, crystals with operational frequency of greater than or equal to 10 MHz 
with higher mass sensitivity and optimised noise levels may be used.  
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Polymers used as sensor coatings enable a variety of modifications of 
composition and functionality, enabling optimum adaptation of the sensitive 
surface to the analyte. Besides their selectivity and low cost, QCM 
immunosensors can be easily automated and developed as simple portable 
devices, which would allow a rapid detection of meningococcal infection at the 
point of care setting. This raises an exciting possibility of using quartz crystal 
arrays for high throughput screening of a range of different from a clinical 
sample at one time. 
 
Instead of CSF, serum samples may be analysed for detection of anti-OMP85 and 
anti-capsular antibodies. The detection of the antigen in blood could constitute a 
more convenient method of screening high-risk populations. Monoclonal 
antibodies against the SR1 peptide may be used as target receptors with high 
specificity for N. meningitidis serogroup B bacteria. Based on the insights 
achieved through these studies, and following further characterisation studies, 
SR1 could be used as a versatile molecular marker and open new avenues in the 
diagnostic as well as therapeutic management of meningitis.  
 
Thus, the results of this study demonstrate that it is feasible to detect 
meningococcal meningitis rapidy with a great control over sensitivity and 
selectivity. Moreover, there is scope for the development of a hybrid technique 
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with enhanced sensitivity for example, by combining the quartz-crystal 
microbalance with other detection techniques. It envisaged that once optimised, 
these techniques would serve as prototypes for more generic tests for the rapid 
diagnosis of a range of bacterial and viral pathogens. However, this step from 
research to product development and commercial availability remains a 
significant one. 
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Appendix 1: List of Gram negative bacteria used for cross-
ractive studies and the disease caused by the respective 
bacteria 
 
 
Bacteria  Pathogenesis 
Neisseria meningitidis  Meningitis 
Neisseria meningitidis MC58  Meningitis 
Neisseria meningitidis 
serogroup A strain  
 Meningitis 
Neisseria gonorrhoeae  Gonorrhoea 
Chromobacterium violaceum  Human infection caused by Chromobacterium violaceum is 
rare, but when it occurs it is associated with a high 
mortality rate. Human infections are reported from 
several continents, particularly Australia, South 
America, and Southeast Asia where the typical disease 
presentation includes cutaneous inflammation, sepsis, 
liver abscesses and ocular infections. Currently there are 
no vaccines. 
Bordetella pertussis  Causes whooping cough 
Acinetobacter sp. ADP1  can cause hospital acquired infections 
Escherichia coli  one of the foremost causes of food poisoning 
Pseudomonas fluorescens  Commensal bacteria have emerged as an important 
disease factor in human Crohn's disease (CD) and 
murine inflammatory bowel disease (IBD) models. 
Many pseudomonas live in a commensal relationship 
with plants. P. fluorescens Pf-5 provides a framework for 
future studies to understand the biological basis of 
biocontrol as an alternative to the use of chemical 
pesticides for control of insects of public health 
importance. 
Pseudomonas aeruginosa  is a leading cause of opportunistic infection among 
persons with compromised immune systems 
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Salmonella enterica subsp. 
enterica serovar Typhi str. 
CT18 
 causes typhoid fever and is a leading cause of human 
gastroenteritis and is used as a mouse model of human 
typhoid fever 
Salmonella enterica subsp. 
enterica serovar Paratyphi A 
str. 
 is a cause of Enteric fever 
Vibrio alginolyticus  V. alginolyticus is one of many Gram-negative 
bacteria of marine origin with worldwide distribution, 
having been isolated from Europe, Australia, 
Japan,Hawaii, and North America. Recent exposure to 
seawater usually antedates the isolation of V. 
alginolyticus from humans. V alginolyticus is a 
halophilic Vibrio first recognized as being pathogenic in 
humans in 1973. Wound infections account for 71% of V 
alginolyticus infections. Ear infections are also seen with 
this organism. Gastroenteritis was thought to be a rare 
presentation of V alginolyticus infection, but it accounted 
for 12% of infections in one series. Other clinical 
syndromes reported in association with V alginolyticus 
infection include chronic diarrhoea in a patient with 
AIDS, conjunctivitis, and post-traumatic intracranial 
infection. Infections of the ear (otitis media and otitis 
externa) are another important source of isolates of V. 
alginolyticus. V. alginolyticus has rarely been recovered 
from sputum and an eye socket. Ocular infection due to 
this organism is extremely rare. 
Vibrio vulnificus  Causes potentially fatal food poisoning 
Vibrio cholerae  Causes Cholera 
Vibrio parahaemolyticus  Causes food-borne gastroenteritis 
Vibrio sp. Ex25  Causes Cholera 
Shigella dysenteriae  The illness caused by Shigella (shigellosis- bacillary 
dysentery) accounts for less than 10% of the reported 
outbreaks of food borne illness in this country. Shigella 
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rarely occurs in animals; principally a disease of 
humans except other primates such as monkeys and 
chimpanzees. The organism is frequently found in water 
polluted with human feces. 
Haemophilus influenzae  Naturally-acquired disease caused by Haemophilus 
influenzae seems to occur in humans only. It was 
mistakenly thought to be the cause of the disease 
influenza, and it was named accordingly. Haemophilus 
influenzae is highly adapted to its human host. It is 
present in the nasopharynx of approximately 75 percent 
of healthy children and adults. It is rarely encountered 
in the oral cavity and it has not been detected in any 
other animal species. 
In infants and young children (under 5 years of age), 
Haemophilus influenzae type b causes bacteraemia and 
acute bacterial meningitis Occasionally, it causes 
epiglottitis (obstructive laryngitis), cellulitis, 
osteomyelitis, and joint infections. Nontypable H. 
influenzae causes ear infections (otitis media) and 
sinusitis in children. Initially H. influenzae invades the 
nasopharyngeal mucosa before spreading to the lower 
respiratory tract where the organism invades and 
destroys the mucous membranes producing 
bronchiolitis, peribronchiolitis, and/or interstitial 
lesions and is associated with respiratory tract infections 
(pneumonia). 
Legionella pneumophila   Causes Legionnaires' disease 
Pasteurella multocida  is a pathogenic bacteria causing many serious diseases 
in humans and animals. This bacterium is the causative 
agent of fowl cholera in chickens and turkeys, 
hemorrhagic septicaemia in cattle, atrophic rhinitis in 
pigs, and infections in humans from dog and cat bites. 
Patients tend to exhibit swelling, cellulitis and bloody 
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drainage at the wound site. Infection may move to 
nearby joints where it can cause swelling and arthritis. 
Brucella abortus  causes Brucellosis (spontaneous abortion in cattle and 
undulant fever in humans). Brucellosis is passed on to 
humans by drinking infected unpasteurised milk or 
from contact with discharges from cattle or goats that 
abort their foetus. It is unlikely that this disease would 
be spread from person to person. Symptoms include 
intermittent or irregular fever of variable duration, 
headache, weakness, profuse sweating, chills, weight 
loss and generalized aching. Antibiotic treatment will 
cure the condition. 
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Appendix 2: Buffers and Reagents 
 
10X PAGE Running Buffer. Tris Base (3% w/v), Glycine (14.4% w/v) and SDS 
(1% w/v) was dissolved in dH2O, pH 8.3.   Dilution of 1X was used for 
electrophoresis. 
 
Acrylamide/bisacrylamide solution: A 40% (w/v) solution was prepared 
containing 38.67% (w/v) ultra pure acrylamide and 1.33% (w/v) bisacrylamide 
(Bio-Rad, USA) 
 
Ammonium Persulfate (10%). Ammonium Persulfate (100 mg) was dissolved in 
1 mL of dH2O and filter sterilised through a 0.22 µM syringe filter.   The solution 
was stored at 4°C wrapped in foil for up to 3 months. 
 
Ampicillin.  Ampicillin (500 mg/vial) was dissolved in 5 mL of sterile water, 
giving a stock solution of 100 mg/mL.  One mL aliquots were stored frozen at –
20°C.  The ampicillin was added to media or other solution at the final 
concentration of 100 µg/mL. 
 
Blocking Solution. Skim milk (5%) was dissolved in TBS. 
 
Coomassie Destaining Reagent. Ethanol (10% v/v) and Acetic Acid (10% v/v) 
was diluted in dH2O. 
 
Coomassie Stain. Coomassie Brilliant Blue R-250 (0.05% w/v) was dissolved in 
methanol (250 mL) and Acetic Acid (50 mL).  After the Coomassie Brilliant Blue 
had dissolved, the solution was diluted to 500 mL with dH2O (Final 
concentration 50% Methanol, 10% Acetic Acid). 
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ELISA Substrate Solution.  Equal volumes of reagent A and reagents B of TMB 
substrate was mixed immediately before use. 
 
Elution buffer (50 mM Tris-HCl, 150 mM NaCl and 0.1 mM EDTA; pH 7.5)  
 
Elution Buffer pH: 8.0. 50 mM Na2HPO4 pH 7.8, 300 mM NaCl, 250 mM 
Imidazole, 0.05 %   Tween 20 / 0.2% Triton X-100. Adjust pH to 8.0 using NaOH. 
 
Extraction / Solubilization buffer 50 mM Tris-HCl pH 7.5, 8 M urea, 1 mM    
DTT, 2 mM    reduced Glutathione, 0.2 mM oxidized Glutathione, 1 mM    PMSF* 
*PMSF is instable in aqeous solutions and added to the buffer at he point 
described in the protocol. 
 
Folding buffer 50mM HEPES pH7.5, 0.2M NaCl, 1mM DTT, 1M NDSB256 
 
Horse Blood Agar Trypticase Soya Broth (3% w/v) and Bacteriological Agar (1% 
w/v) were dissolved in deionised H2O and autoclaved at standard conditions.  
After the agar had cooled, Horse blood (5% w/v) was added to the agar and the 
medium poured into petri dishes. 
 
Isoproply-β-D thiogalactopyranoside (IPTG) (0.1 M) Stock Solution. IPTG (1.2 
g) was dissolved in 50 mL of sterile water, filter sterilised and stored at 4°C 
 
Kanamycin.  Kanamycin was made up as a stock solution of 50 mg/mL in sterile 
water and stored in 1 mL aliquots at -20°C. The working concentration of 
Kanamycin was 50 µg/mL. 
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Luria Bertoni Broth Tryptone (1% w/v), Yeast Extract (0.5% w/v), and NaCl 
(0.5% w/v) was dissolved in deionised H2O and autoclaved at standard 
conditions. 
 
Lysis Buffer (for enzymatic lysis) 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 5mM 
DTT, 5% Glycerol, 0.35mg/ml lysozyme, 1% Triton X-100, 1mM PMSF (Add just 
before doing experiment)  
 
Lysis buffer (for sonication) 50 mM Tris-HCl pH 7.5, 200 mM NaCl, 5 mM DTT 
and 1mM PMSF 
 
Modified SDS-PAGE sample buffer for gold nanoparticle analysis. 0.6 mL of 
0.1M Tris-HCL (pH 6.8), 5.0 mL 50% glycerol, 2.0 mL 10% SDS, 1.0 mL 1% 
bromophenol blue and 1.4 mL H20 
 
PBS. 0.01 M phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium 
chloride, pH 7.4. 
 
PBS/T. Phosphate buffer (0.01 M), 0.0027 M potassium chloride and 0.137 M 
sodium chloride, pH 7.4, autoclaved at standard conditions.   Tween 20 (0.05% 
v/v) was then added. 
 
Renaturation buffer 2 mM reduced glutathione and 0.2 mM oxidized 
glutathione 
 
SDS-PAGE Sample Buffer. Tris-HCl (125 mM, pH 6.8), SDS (2% w/v), β-
mercaptoethanol (5% w/v), Bromophenol blue (0.02% w/v) and glycerol (25% 
v/v) in dH2O. 
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Solubilisation/Extraction buffer (50 mM Tris-HCl pH 7.5 containing 8 M urea, 1 
mM DTT, 2 mM reduced Glutathione, 0.2 mM oxidised Glutathione, 1 mM 
PMSF)  
 
Solubilization buffer 50mM HEPES-NaOH pH7.5, 6M guanidine HCl, 25mM 
DTT 
 
Stock solutions 1 mg/ml DNase and in water, 100 mM PMSF 
(phenylmethylsulfonyl fluoride) in isopropanol, 1M MgCl2, 1% Triton X-100, 5 
mM sodium carbonate buffer pH 9.4, 10 mM sodium phosphate buffer pH 7.4, 
1% bovine serum albumin (BSA), 0.1% sodium azide  
 
TBS. Tris Base (10 mM) and NaCl (500 mM) was dissolved in deionised H2O, pH 
7.4, then autoclaved at standard conditions. 
 
TBS/Tween. Tween 20 (0.05% (v/v)) was added to TBS. 
 
Wash buffer (pH: 8.0) 50 mM Na2HPO4 pH 7.8, 300 mM NaCl, 20   mM 
Imidazole, 0.05 %   Tween 20 / 0.2% Triton X-100 
 
SDS-PAGE Resolving gel (12.5%). 
Reagents Volume 
Water 4.22 mL 
1.5 M Tris (pH 8.8) 2.5 mL 
10% SDS 0.1 mL 
Bis-Acrylamide (40%) 3.135 mL 
10% Ammonium persulfate 0.05 mL 
TEMED 0.01 mL 
Total volume 10 mL 
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SDS-PAGE Stacking gel (4%). 
Reagent Volume 
Water 3.580 mL 
0.5 M Tris (pH 6.8) 1 mL 
10% SDS 0.04 mL 
Bis-Acrylamide (40%) 0.375 mL 
10% Ammonium persulfate 0.01 mL 
TEMED 0.0005 mL 
Total 5 mL 
 
SDS-PAGE loading buffer was added to samples to be analysed in a 4:1 sample 
to buffer ratio.   Prepared samples were then heated to 100°C for 10 min in a heat 
block.   SDS-PAGE gel wells were loaded with 20 µL of sample using a syringe.  
SDS-PAGE was performed at 80 V for 30 min  then 180 V for 50 min. 
 
